"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,NL,B,NL 185285 B,118-788-900-909-830,1989-10-02,1989,NL 7701694 A,1977-02-17,US 72095076 A,1976-09-07,"WERKWIJZE VOOR HET BEREIDEN VAN BIOLOGISCH ACTIEVE COPOLYMEREN, DIE EEN TRIORGANOTINGROEP BEVATTEN, WERKWIJZE VOOR HET BEREIDEN VAN EEN BIOLOGISCH ACTIEF PREPARAAT MET EEN ALDUS BEREID COPOLYMEER ALSMEDE WERKWIJZE VOOR HET BESCHERMEN VAN MATERIAAL TEGEN SCHADELIJKE ORGANISMEN MET BEHULP VAN EEN ALDUS BEREID COPOLYMEER.",,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/118-788-900-909-830,Patent Application,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/06;;C08F30/00;;C08F30/04;;C08F2/00;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
2,NO,L,NO 770643 L,081-194-269-305-023,1978-03-08,1978,NO 770643 A,1977-02-25,US 72095076 A,1976-09-07,FREMGANGSMAATE TIL FREMSTILLING AV BILOLOGISK AKTIVE KOPOLYMERER,,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/081-194-269-305-023,Abstract,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/06;;C08F2/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
3,AU,B2,AU 519613 B2,047-620-455-541-86X,1981-12-10,1981,AU 1979/045392 A,1979-03-21,US 89195378 A,1978-03-31,EXTRACTION OF RUBBER FROM PLANT MATERIALS,,US AGRICULTURE,BUCHANAN RUSSELL A,,https://lens.org/047-620-455-541-86X,Granted Patent,no,0,1,7,7,0,C08C4/00;;Y10S524/926;;Y10S528/933;;C08C4/00;;Y10S528/933;;Y10S524/926,B29D23/24;;C08C4/00,,0,0,,,,EXPIRED
4,US,A,US 2459867 A,124-526-939-685-392,1949-01-25,1949,US 62206645 A,1945-10-12,US 62206645 A,1945-10-12,Gunnery training device,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B,,https://lens.org/124-526-939-685-392,Granted Patent,no,4,1,1,1,0,F41G3/26;;F41G3/26,F41G3/26,,0,0,,,,EXPIRED
5,NO,C,NO 146204 C,048-801-983-686-674,1982-08-18,1982,NO 770643 A,1977-02-25,US 72095076 A,1976-09-07,FREMGANGSMAATE TIL FREMSTILLING AV BIOLOGISK AKTIVE POLYMERER,,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/048-801-983-686-674,Granted Patent,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/00;;C08F2/06;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
6,US,A,US 2470468 A,111-488-040-323-987,1949-05-17,1949,US 71891746 A,1946-12-28,US 71891746 A,1946-12-28,Ground trainer for aircraft,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B,,https://lens.org/111-488-040-323-987,Granted Patent,no,3,5,1,1,0,F41G9/025;;F41G9/025,F41G9/02,,0,0,,,,EXPIRED
7,DE,A1,DE 2705440 A1,143-319-981-823-16X,1978-03-09,1978,DE 2705440 A,1977-02-09,US 72095076 A,1976-09-07,VERFAHREN ZUR HERSTELLUNG VON BIOLOGISCH AKTIVEN POLYMEREN,,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,"M & T CHEMICALS, INC., WOODBRIDGE, N.J., US (1985-06-27)",https://lens.org/143-319-981-823-16X,Patent Application,no,1,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/00;;C08F2/06;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
8,US,A,US 1942471 A,070-690-373-026-562,1934-01-09,1934,US 66429833 A,1933-04-04,US 66429833 A,1933-04-04,Operator's position equipment,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B,,https://lens.org/070-690-373-026-562,Granted Patent,no,0,1,1,1,0,H04M5/08;;H04M5/08,H04M5/08,,0,0,,,,EXPIRED
9,DK,C,DK 151344 C,181-350-290-147-506,1988-06-27,1988,DK 56477 A,1977-02-10,US 72095076 A,1976-09-07,"FREMGANGSMAADE TIL FREMSTILLING AF BIOLOGISK AKTIVE, TRIORGANOTINHOLDIGE COPOLYMERE",,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/181-350-290-147-506,Granted Patent,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/00;;C08F2/06;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
10,DK,B,DK 151344 B,011-747-312-189-565,1987-11-23,1987,DK 56477 A,1977-02-10,US 72095076 A,1976-09-07,"FREMGANGSMAADE TIL FREMSTILLING AF BIOLOGISK AKTIVE, TRIORGANOTINHOLDIGE COPOLYMERE",,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/011-747-312-189-565,Patent Application,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/06;;C08F2/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
11,AU,A,AU 1979/045392 A,156-936-708-614-776,1979-10-04,1979,AU 1979/045392 A,1979-03-21,US 89195378 A,1978-03-31,EXTRACTION OF RUBBER FROM PLANT MATERIALS,,US AGRICULTURE,BUCHANAN RUSSELL A,,https://lens.org/156-936-708-614-776,Patent Application,no,0,0,7,7,0,C08C4/00;;Y10S524/926;;Y10S528/933;;C08C4/00;;Y10S528/933;;Y10S524/926,B29D23/24;;C08C4/00,,0,0,,,,EXPIRED
12,AU,A,AU 1977/022283 A,049-390-893-242-474,1978-08-24,1978,AU 1977/022283 A,1977-02-15,US 72095076 A,1976-09-07,BIOLOGICALLY ACTIVE ORGANOTIN POLYMERS,,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/049-390-893-242-474,Patent Application,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/00;;C08F2/04;;C08F2/06;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
13,US,A,US 2619549 A,132-107-660-284-704,1952-11-25,1952,US 6786748 A,1948-12-29,US 6786748 A,1948-12-29,Toll supervisory operator's telephone circuit,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B,,https://lens.org/132-107-660-284-704,Granted Patent,no,5,0,1,1,0,H04M3/60;;H04M3/60,H04M3/60,,0,0,,,,EXPIRED
14,US,A,US 2636944 A,167-546-558-383-663,1953-04-28,1953,US 6786848 A,1948-12-29,US 6786848 A,1948-12-29,Recording-completing cord and trunk circuits,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B,,https://lens.org/167-546-558-383-663,Granted Patent,no,4,0,1,1,0,H04M5/08;;H04M5/08,H04M5/08,,0,0,,,,EXPIRED
15,US,A1,US 2017/0083992 A1,071-434-461-317-945,2017-03-23,2017,US 201615269261 A,2016-09-19,US 201615269261 A;;US 201562220554 P,2015-09-18,Method of Facilitating Business Transactions,A method for facilitating the completion of a real estate transaction over the Internet includes the steps of presenting at least one manually-entered datum on an electronic document to a first party; providing a first party field adjacent to each of the at least one manually-entered datums for entering comments on the electronic document; transmitting the electronic document to a second party; providing a second party field adjacent to each of the first party fields for entering comments on the electronic document; transmitting the electronic document to the first party; and creating and storing a digital copy of each of the transmitted electronic documents as a HyperText Markup Language (HTML) file.,BUCHANAN RUSSELL T,BUCHANAN RUSSELL T,SHGI CORPORATION (2017-05-08),https://lens.org/071-434-461-317-945,Patent Application,yes,1,0,1,1,0,G06Q50/16;;G06Q50/16;;G06Q10/10;;G06Q10/10;;G06Q20/10;;G06Q20/10,G06Q50/16;;G06Q10/10;;G06Q20/10,,0,0,,,,DISCONTINUED
16,NL,C,NL 185285 C,143-885-749-389-828,1990-03-01,1990,NL 7701694 A,1977-02-17,US 72095076 A,1976-09-07,"WERKWIJZE VOOR HET BEREIDEN VAN BIOLOGISCH ACTIEVE COPOLYMEREN, DIE EEN TRIORGANOTINGROEP BEVATTEN, WERKWIJZE VOOR HET BEREIDEN VAN EEN BIOLOGISCH ACTIEF PREPARAAT MET EEN ALDUS BEREID COPOLYMEER ALSMEDE WERKWIJZE VOOR HET BESCHERMEN VAN MATERIAAL TEGEN SCHADELIJKE ORGANISMEN MET BEHULP VAN EEN ALDUS BEREID COPOLYMEER.",,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/143-885-749-389-828,Granted Patent,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/06;;C08F30/00;;C08F30/04;;C08F2/00;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
17,US,A,US 4136131 A,186-609-446-077-105,1979-01-23,1979,US 89195378 A,1978-03-31,US 89195378 A,1978-03-31,EXTRACTION OF RUBBER OR RUBBERLIKE SUBSTANCES FROM FIBROUS PLANT MATERIALS,"Fibrous plant materials, such as from the Guayule shrub, which contain rubber or other rubberlike polymeric hydrocarbons, are subjected to the simultaneous action of compressive and shear forces to reduce them to a coherent, shaped plastic mass, thereby enabling efficient and economical solvent extraction of the rubber or rubberlike hydrocarbons.",US AGRICULTURE,BUCHANAN RUSSELL A,,https://lens.org/186-609-446-077-105,Granted Patent,yes,9,53,7,7,0,C08C4/00;;Y10S524/926;;Y10S528/933;;C08C4/00;;Y10S528/933;;Y10S524/926,B29D23/24;;C08C4/00,260816G,0,0,,,,EXPIRED
18,MX,E,MX 4261 E,171-287-537-671-202,1982-03-08,1982,MX 541077 U,1977-02-04,US 72095076 A,1976-09-07,METODO MEJORADO PARA PREPARAR POLIMEROS PESTICIDAS DE TRIORGANO-ESTANO,,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/171-287-537-671-202,Limited Patent,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/00;;C08F2/06;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,07-1;;07-87,0,0,,,,EXPIRED
19,NO,B,NO 146204 B,066-006-957-552-621,1982-05-10,1982,NO 770643 A,1977-02-25,US 72095076 A,1976-09-07,FREMGANGSMAATE TIL FREMSTILLING AV BIOLOGISK AKTIVE POLYMERER,,M & T CHEMICALS INC,RUSSELL DAVID BUCHANAN,,https://lens.org/066-006-957-552-621,Unknown,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/00;;C08F2/06;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
20,US,A,US 2451609 A,066-593-869-790-426,1948-10-19,1948,US 62206745 A,1945-10-12,US 62206745 A,1945-10-12,Arresting hook device for grounded aircraft pilot trainers,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B,,https://lens.org/066-593-869-790-426,Granted Patent,no,6,1,1,1,0,G09B9/085;;G09B9/085,G09B9/08,,0,0,,,,EXPIRED
21,EP,A1,EP 1813102 A1,001-915-449-787-758,2007-08-01,2007,EP 05773020 A,2005-08-15,GB 2005003186 W;;GB 0418152 A,2004-08-13,REMOTE PROGRAM PRODUCTION,,RPPTV LTD,BUCHANAN WILLIAM;;BRADBURY RUSSELL,,https://lens.org/001-915-449-787-758,Patent Application,yes,0,0,6,6,0,G11B27/034;;G11B27/105;;G06F16/00;;G11B27/034;;G11B27/034;;G11B27/105;;G11B27/105;;H04N5/76;;H04N5/262;;H04N5/262;;H04N21/23439;;H04N21/23439;;H04N21/84;;H04N21/84;;H04N21/8405;;H04N21/8405;;H04N21/854;;H04N21/854,H04N5/76;;G06F17/30;;G11B27/034;;G11B27/10;;H04N5/262;;H04N7/24,,1,0,,,See references of WO 2006016185A1,DISCONTINUED
22,US,A,US 3714087 A,124-924-914-317-888,1973-01-30,1973,US 3714087D A,1972-02-28,US 23009872 A;;US 5818770 A,1970-07-24,"POWDERED RESORCINOL-FORMALDEHYDE TREATED POLYSACCHARIDE-REINFORCED ELASTOMER MASTERBATCHES, COMPOUNDS, AND RESULTING VULCANIZED RUBBERS","Powdered elastomer masterbatches are prepared by grinding dried rubber curds which contain highly effective reinforcing agents. Such finely comminuted elastomer masterbatches provide stable powdered rubber compounds when blended with usual powdered curatives and fine particle fillers. These powdered rubber compounds are formed into finished vulcanized rubber articles by direct heat-compression molding, by extrusion from a simple machine, or by injection molding without prior high shear mixing.",US AGRICULTURE,BUCHANAN R;;RUSSELL C,,https://lens.org/124-924-914-317-888,Granted Patent,no,1,10,1,2,0,C08J3/22;;C08J3/22;;C08L21/00;;C08L21/00,C08J3/22;;C08L21/00,C3L LDB           LDB;;C3L L400          LDB,0,0,,,,EXPIRED
23,GB,A,GB 2433810 A,136-991-557-275-338,2007-07-04,2007,GB 0706063 A,2007-03-28,GB 2005003186 W;;GB 0418152 A,2004-08-13,Remote program production,"A method of compiling an audio/video work from a plurality of pieces of editable material via a computer network comprising a central server and one or more remote stations, the method comprising storing as said pieces of editable material together with information unique to each piece of material and timing information; providing data representing said material and information to a user at a remote location via the computer network according to requests received from the user; selecting editable material or portions of said editable material and noting the information associated with the selected material or portions of said material; and forwarding the noted information to the central server where the noted information is stored for further use.",RPPTV LTD,BUCHANAN WILLIAM;;BRADBURY RUSSELL,,https://lens.org/136-991-557-275-338,Patent Application,no,5,0,6,6,0,G11B27/034;;G11B27/105;;G06F16/00;;G11B27/034;;G11B27/034;;G11B27/105;;G11B27/105;;H04N5/76;;H04N5/262;;H04N5/262;;H04N21/23439;;H04N21/23439;;H04N21/84;;H04N21/84;;H04N21/8405;;H04N21/8405;;H04N21/854;;H04N21/854,G11B27/034;;G06F17/30;;G11B27/10;;H04N5/262;;H04N5/76,G4A AUDB          UDB;;G4A AUXX          UXX,1,0,,,"PATENT ABSTRACTS OF JAPAN, vol. 2003, no. 12, 5 December 2003 & JP 2003 256432 A (TELECOMMUNICATION ADVANCEMENT ORGANIZATION OF JAPAN; SONY CORP), 12 September 2003, abstract",DISCONTINUED
24,WO,A1,WO 2006/016185 A1,061-546-592-167-944,2006-02-16,2006,GB 2005003186 W,2005-08-15,GB 0418152 A,2004-08-13,REMOTE PROGRAM PRODUCTION,"A method of compiling an audio/video work from a plurality of pieces of editable material via a computer network comprising a central server and one or more remote stations, the method comprising storing as said pieces of editable material together with information unique to each piece of material and timing information; providing data representing said material and information to a user at a remote location via the computer network according to requests received from the user; selecting editable material or portions of said editable material and noting the information associated with the selected material or portions of said material; and forwarding the noted information to the central server where the noted information is stored for further use.",RPPTV LTD;;BUCHANAN WILLIAM;;BRADBURY RUSSELL,BUCHANAN WILLIAM;;BRADBURY RUSSELL,,https://lens.org/061-546-592-167-944,Patent Application,yes,5,1,6,6,0,G11B27/034;;G11B27/105;;G06F16/00;;G11B27/034;;G11B27/034;;G11B27/105;;G11B27/105;;H04N5/76;;H04N5/262;;H04N5/262;;H04N21/23439;;H04N21/23439;;H04N21/84;;H04N21/84;;H04N21/8405;;H04N21/8405;;H04N21/854;;H04N21/854,G11B27/034;;G11B27/10;;H04N5/262,,1,0,,,"PATENT ABSTRACTS OF JAPAN vol. 2003, no. 12 5 December 2003 (2003-12-05)",PENDING
25,AT,T1,AT E483215 T1,109-703-185-295-806,2010-10-15,2010,AT 06765023 T,2006-07-19,GB 0515460 A;;US 70273205 P;;GB 2006002689 W,2005-07-27,VERIFIKATION DER AUTHENTIZITÄT,"An article identification method comprises: determining a signature from an article based upon an intrinsic characteristic of the article comparing the determined signature to a stored signature, splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA HOLDINGS LTD,COWBURN RUSSELL;;BUCHANAN JAMES,,https://lens.org/109-703-185-295-806,Granted Patent,no,0,0,7,22,0,G07D7/004;;G06K7/10;;G06K19/10,,,0,0,,,,INACTIVE
26,US,A,US 3480572 A,120-066-110-848-92X,1969-11-25,1969,US 3480572D A,1968-01-31,US 70184368 A,1968-01-31,STARCH RESIN REINFORCED RUBBERS,,US AGRICULTURE,BUCHANAN RUSSELL A;;RUSSELL CHARLES R,,https://lens.org/120-066-110-848-92X,Granted Patent,no,4,8,1,1,0,C08L3/02;;C08L9/06;;C08L21/00;;C08L61/00;;C08L93/00;;C08L9/06;;C08L61/00;;C08L21/00;;C08L93/00;;C08L3/02,C08L21/00,260/172,0,0,,,,EXPIRED
27,US,A,US 3673136 A,017-054-138-282-380,1972-06-27,1972,US 3673136D A,1970-07-24,US 5818770 A,1970-07-24,"POWDERED POLYSACCHARIDE-REINFORCED ELASTOMER MASTERBATCHES, COMPOUNDS, AND RESULTING VULCANIZED RUBBERS","Powdered elastomer masterbatches are prepared by grinding dried rubber curds which contain highly effective reinforcing agents. Such finely comminuted elastomer masterbatches provide stable powdered rubber compounds when blended with usual powdered curatives and fine particle fillers. These powdered rubber compounds are formed into finished vulcanized rubber articles by direct heat-compression molding, by extrusion from a simple machine, or by injection molding without prior high shear mixing.",US AGRICULTURE,BUCHANAN RUSSELL A;;RUSSELL CHARLES R,,https://lens.org/017-054-138-282-380,Granted Patent,no,6,15,1,2,0,C08J3/226;;C08J2409/00;;C08L3/02;;C08L9/04;;C08L9/08;;C08L21/00;;C08L97/005;;C08L9/08;;C08L3/02;;C08L9/04;;C08L97/005;;C08J2409/00;;C08L21/00;;C08J3/226,C08L21/00,C3L LDB           LDB;;C3L L400          LDB;;C3L L416          LDB;;C3M ML            ML;;C3M M133          ML;;C3M M163C         ML;;C3M M300          ML,0,0,,,,EXPIRED
28,AT,T1,AT E418766 T1,117-786-336-717-567,2009-01-15,2009,AT 06765021 T,2006-07-19,GB 0515465 A;;US 70289705 P,2005-07-27,SIGNATUR FÜR ZUGANGS-TOKEN,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL;;BUCHANAN JAMES,,https://lens.org/117-786-336-717-567,Granted Patent,no,0,0,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,,,0,0,,,,INACTIVE
29,DE,A1,DE 3215154 A1,039-387-674-684-109,1982-11-25,1982,DE 3215154 A,1982-04-23,GB 8112658 A,1981-04-23,TROCKENKUEHLTURM,,LUMMUS CO,BUCHANAN RUSSELL CHARLES MICHA,,https://lens.org/039-387-674-684-109,Patent Application,no,0,1,13,14,0,F28B1/06;;F28G1/166;;Y10S165/90;;F28G1/166;;F28B1/06;;Y10S165/90,F28B1/06;;F28G1/16,,0,0,,,,DISCONTINUED
30,CN,A,CN 1523253 A,127-203-210-055-84X,2004-08-25,2004,CN 200410005885 A,2004-02-20,US 37138103 A,2003-02-21,Method of controlling a dual clutch transmission,一种在换档期间控制双离合器变速装置的每个离合器传递扭矩的方法：确定何时已经命令换档；检测前序离合器从动构件的速度；确定离合器转换的所需离合器扭矩和滑动曲线；检测后继离合器从动构件的速度；根据前序离合器从动构件的速度、离合器扭矩和滑动曲线以及后继离合器从动构件的速度，确定目标发动机速度曲线；同时控制每个离合器传递的扭矩，通过线性减小前序离合器传递的扭矩同时以反比例线性增加后继离合器传递的扭矩，使得变速装置的扭矩输出从前序离合器转换到后继离合器上，并造成发动机遵循目标发动机速度曲线；一旦后继离合器传递所有输出扭矩，改变后继离合器上的压力，以便造成发动机继续遵循目标发动机速度曲线，从而保持车辆速度。,BORGWARNER INC,MELISSA LEMON RUSSELL BUCHANAN,,https://lens.org/127-203-210-055-84X,Patent Application,no,0,10,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,F16H61/04;;B60K17/00;;B60K17/02;;B60W10/02;;B60W10/06;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/06;;F16H61/682;;F16H61/688,,0,0,,,,EXPIRED
31,US,A1,US 2009/0063633 A1,169-901-821-438-42X,2009-03-05,2009,US 57367905 A,2005-08-15,GB 0418152 A;;GB 2005003186 W,2004-08-13,REMOTE PROGRAM PRODUCTION,"A method of compiling an audio/video work from a plurality of pieces of editable material via a computer network comprising a central server and one or more remote stations, the method comprising storing as said pieces of editable material together with information unique to each piece of material and timing information; providing data representing said material and information to a user at a remote location via the computer network according to requests received from the user; selecting editable material or portions of said editable material and noting the information associated with the selected material or portions of said material; and forwarding the noted information to the central server where the noted information is stored for further use.",BUCHANAN WILLIAM;;BRADBURY RUSSELL,BUCHANAN WILLIAM;;BRADBURY RUSSELL,RPPTV LIMITED (2007-07-26),https://lens.org/169-901-821-438-42X,Patent Application,yes,48,0,6,6,0,G11B27/034;;G11B27/105;;G06F16/00;;G11B27/034;;G11B27/034;;G11B27/105;;G11B27/105;;H04N5/76;;H04N5/262;;H04N5/262;;H04N21/23439;;H04N21/23439;;H04N21/84;;H04N21/84;;H04N21/8405;;H04N21/8405;;H04N21/854;;H04N21/854,G06F15/16;;G11B27/034;;G11B27/10;;H04N5/262,709/205,0,0,,,,DISCONTINUED
32,US,A1,US 2008/0286873 A1,068-089-528-838-305,2008-11-20,2008,US 80338807 A,2007-05-14,US 80338807 A,2007-05-14,Method and device for reducing positron emitting isotope labeled carbon dioxide to positron emitter isotope labeled carbon monoxide via metal oxide,"A method and device for reducing positron emitter isotope labeled CO 2 to positron emitter isotope labeled CO generally includes introducing a volume of positron emitter isotope labeled CO 2 into a first heated reaction vessel comprising a metal oxide, such as Iron (II) Oxide such that the CO 2 is reduced to CO upon contact with the Iron (II) Oxide. The volume is then transferred to a second reaction vessel to remove any un-reacted CO 2 , preferably, via a soda-lime trap. The volume is then transferred to a target, e.g., a storage vessel or subject. The CO 2 includes one of [ 11 C] or [ 15 O]. The first reaction vessel is, preferably, heated to a temperature of between 900 and 1000° C., and more preferably, to between 925 and 975° C., and even more preferably, to approximately 950° C. Preferably, the Iron (II) Oxide powdered and has a particle size of about −10 mesh.",SIEMENS MEDICAL SOLUTIONS,BUCHANAN CHARLES RUSSELL;;WILLIAMSON ANDREW,SIEMENS MEDICAL SOLUTIONS USA INC (2007-07-13),https://lens.org/068-089-528-838-305,Patent Application,yes,2,0,2,2,0,G21G1/001;;G21G1/001;;G21G2001/0094;;G21G2001/0094,G01N23/00;;C12M1/00,436/57;;422/159,0,0,,,,INACTIVE
33,GB,B,GB 2461253 B,056-583-252-324-255,2012-11-21,2012,GB 0809502 A,2008-05-23,GB 0809502 A,2008-05-23,Linearisation of scanned data,,INGENIA HOLDINGS LTD,COWBURN RUSSELL;;BUCHANAN DAVID RALPH,,https://lens.org/056-583-252-324-255,Granted Patent,no,2,0,7,7,0,G07D7/2033;;H04N2201/0081;;H04N2201/04731;;H04N2201/04787;;H04N2201/04791;;H04N2201/3236;;H04N2201/0471;;H04N2201/04734;;H04N2201/04737;;H04N2201/04768;;G06K7/10544;;G07D7/12;;G07D7/20;;G06V10/42;;G07D7/2033;;H04N2201/04731;;H04N2201/3236;;H04N2201/04791;;H04N2201/0081;;H04N2201/04787;;H04N2201/0471;;H04N2201/04734;;H04N2201/04768;;H04N2201/04737,G07D7/12;;G06K7/10;;G06K9/52;;G07D7/20,,0,0,,,,INACTIVE
34,CA,A,CA 266615 A,002-166-834-328-639,1926-12-14,1926,CA 266615D A,,CA 266615T A,,SLACK TAKE-UP DEVICE,,RUSSELL DUNCAN M;;BUCHANAN JAMES,BUCHANAN JAMES;;RUSSELL DUNCAN M,,https://lens.org/002-166-834-328-639,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
35,GB,A,GB 2356895 A,152-725-767-373-946,2001-06-06,2001,GB 9912884 A,1999-06-04,GB 9912884 A,1999-06-04,Vacuum pump,"The pump comprises a rotor having conduits provided with venturi outlets 8a facing in a direction opposite to that in which the rotor rotates, the rotor being contained within a housing having baffles 7, for inhibiting rotation of fluid contained within the housing. Upon rotation of the rotor, fluid passing over the outlets draws fluid out of the conduits thereby evacuating apparatus which is connected to the conduits via conduits 9a. The housing is vented via a vent 10, reservoir 1, and draining conduit 12. The conduits 8, and outlets 8a may be arranged in a spiral and the pump may alternatively comprise stationary conduits and a rotatable housing.",WHITE RUSSELL;;BUCHANAN NIGEL ALEXANDER,WHITE RUSSELL;;BUCHANAN NIGEL ALEXANDER,,https://lens.org/152-725-767-373-946,Patent Application,no,4,0,2,2,0,F04D17/168,F04D17/16,F1C CE            CE;;F1C C107          CE;;F1C C307          CE;;F1C C601          CE,0,0,,,,DISCONTINUED
36,GB,A,GB 2461253 A,064-262-216-107-213,2009-12-30,2009,GB 0809502 A,2008-05-23,GB 0809502 A,2008-05-23,Linearisation of scanned data using relative speed between scan head and scanned article,A system for obtaining a signature from a scan area on the surface of an article 50 comprises: a signature generator that generates the signature from scattered coherent radiation detected from a plurality of regions on the surface by using relative motion between the article and a scan head 20 comprising a coherent radiation source 14 and photodetectors 16 to obtain a set of data points comprising a group of data points from each region; an imaging detector 58 that captures a sequence of images of the surface of the article 50 during the relative motion; and a processor that calculates the instantaneous velocity of the relative motion; whereby the signature generator uses the instantaneous velocity to linearise the groups of data points within the set of data points before generating the signature of the article from the set of data points.,INGENIA HOLDINGS,COWBURN RUSSELL;;BUCHANAN DAVID RALPH,,https://lens.org/064-262-216-107-213,Patent Application,no,2,0,7,7,0,G07D7/2033;;H04N2201/0081;;H04N2201/04731;;H04N2201/04787;;H04N2201/04791;;H04N2201/3236;;H04N2201/0471;;H04N2201/04734;;H04N2201/04737;;H04N2201/04768;;G06K7/10544;;G07D7/12;;G07D7/20;;G06V10/42;;G07D7/2033;;H04N2201/04731;;H04N2201/3236;;H04N2201/04791;;H04N2201/0081;;H04N2201/04787;;H04N2201/0471;;H04N2201/04734;;H04N2201/04768;;H04N2201/04737,G07D7/12;;G06K7/10;;G06K9/52;;G07D7/20,,0,0,,,,INACTIVE
37,CN,C,CN 100434768 C,037-893-899-327-216,2008-11-19,2008,CN 200410005885 A,2004-02-20,US 37138103 A,2003-02-21,Method of controlling a dual clutch transmission,,BORGWARNER INC,RUSSELL LEMON;;MARK BUCHANAN;;MELISSA KOENIG,,https://lens.org/037-893-899-327-216,Granted Patent,no,8,1,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,F16H61/04;;F16H61/06;;B60K17/00;;B60K17/02;;B60W10/02;;B60W10/06;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/682;;F16H61/688,,0,0,,,,EXPIRED
38,US,A,US 2233282 A,037-116-505-496-089,1941-02-25,1941,US 29036639 A,1939-08-16,US 29036639 A,1939-08-16,Telephone system,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B;;KOECHLING CHARLES D,,https://lens.org/037-116-505-496-089,Granted Patent,no,0,6,1,1,0,H04Q3/00;;H04Q3/00,H04Q3/00,,0,0,,,,EXPIRED
39,EP,B1,EP 1449708 B1,078-816-312-954-56X,2006-04-19,2006,EP 04250675 A,2004-02-09,US 37137803 A,2003-02-21,Method of controlling a dual clutch transmission,,BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC. (2005-05-25),https://lens.org/078-816-312-954-56X,Granted Patent,yes,6,6,8,8,0,B60W2510/0241;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2540/10;;B60W2710/0644;;B60W2710/0661;;F16D48/06;;F16D2500/1026;;F16D2500/10412;;F16D2500/1086;;F16D2500/30426;;F16D2500/3061;;F16D2500/30806;;F16D2500/50224;;F16D2500/7044;;F16D2500/70454;;F16H3/006;;F16H3/0915;;F16H61/0437;;F16H61/688;;F16H2306/52;;F16H2312/02;;F16D2500/5048;;B60W30/18027;;F16H61/0437;;B60W2510/0241;;F16H2306/52;;F16D2500/7044;;F16D2500/3061;;F16D2500/50224;;B60W2540/10;;B60W2710/0661;;F16D2500/1026;;F16H2312/02;;F16D2500/30806;;F16H3/0915;;F16D48/06;;F16H3/006;;F16D2500/70454;;F16H61/688;;B60W2510/1005;;B60W2510/1015;;B60W2710/0644;;F16D2500/30426;;B60W2510/0604;;F16D2500/10412;;F16D2500/1086;;F16D2500/5048,B60W10/02;;B60W10/10;;F16D48/06;;F16H3/00;;F16H3/091;;F16H61/04;;F16H61/68;;F16H61/688,,0,0,,,,EXPIRED
40,GB,B,GB 2426100 B,119-895-686-443-733,2007-08-22,2007,GB 0509635 A,2005-05-11,GB 0509635 A,2005-05-11,Authenticity vertification,,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/119-895-686-443-733,Granted Patent,no,4,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G07C9/00;;G06F21/33;;G06F21/64;;G06K7/10;;G06K19/14;;G06V20/80;;G07B1/00;;G07B11/00;;G07B15/00;;G07D7/12;;G07D7/20;;G07F7/12,,0,0,,,,INACTIVE
41,GR,B,GR 64024 B,145-781-259-738-50X,1980-01-18,1980,GR 770154675 A,1977-10-31,US 73800176 A,1976-11-02,NOVEL BIOLOGICALLY ACTIVE COPOLYMERS,,M & T CHEMICALS INC,JOHN RICHARD BEDNARSKI;;DAVID BUCHANAN RUSSELL,,https://lens.org/145-781-259-738-50X,Granted Patent,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A23L3/34;;A01N55/04;;A23L3/3463;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
42,US,B2,US 6832978 B2,133-071-612-377-812,2004-12-21,2004,US 37138103 A,2003-02-21,US 37138103 A,2003-02-21,Method of controlling a dual clutch transmission,"
    A method of controlling the torque transferred across each clutches of a dual clutch transmission during a gear shift. The method includes the steps including determining when a shift has been commanded, sensing the speed of the driven member of the off-going clutch, determining the desired clutch torque and slip profile for the changeover of the clutches, and sensing the speed of the driven member of the on-coming clutch to determine a target engine speed profile. The method simultaneously controls the torque transfer across each clutch by linearly decreasing the torque transferred across the off-going clutch while linearly increasing the torque transferred across the on-coming clutch in an inversely proportional rate. Finally, the pressure applied to the on-coming clutch is varied, to cause the engine to continue to track the target engine speed profile so that vehicle speed is maintained. 
",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC (2003-02-10),https://lens.org/133-071-612-377-812,Granted Patent,yes,27,59,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,B60K17/00;;B60K17/02;;B60W10/02;;B60W10/06;;F16H61/04;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/06;;F16H61/682;;F16H61/688,477/174;;477/181;;477/180;;701/66;;701/67,0,0,,,,EXPIRED
43,DE,D1,DE 602006004457 D1,058-839-273-800-619,2009-02-05,2009,DE 602006004457 T,2006-07-19,GB 0515465 A;;US 70289705 P;;GB 2006002686 W,2005-07-27,SIGNATUR FÜR ZUGANGS-TOKEN,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID,"INGENIA HOLDINGS LTD., ROAD TOWN, TORTOLA, VG (2010-06-24)",https://lens.org/058-839-273-800-619,Granted Patent,no,0,0,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;G06F21/33;;G06F21/34;;G06K19/14;;G06V10/42;;G06V20/80;;G07D7/12,,0,0,,,,INACTIVE
44,NO,B,NO 149797 B,076-888-612-409-475,1984-03-19,1984,NO 781466 A,1978-04-26,US 73800176 A,1976-11-02,MIDDEL TIL BEGRENSNING AV SOPPVEKSTER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/076-888-612-409-475,Unknown,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/34;;A23L3/3463;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
45,US,A,US 2042828 A,105-867-591-506-969,1936-06-02,1936,US 972835 A,1935-03-07,US 972835 A,1935-03-07,Telephone system,,BELL TELEPHONE LABOR INC,BUCHANAN RUSSELL B;;KILLE LINDLEY A,,https://lens.org/105-867-591-506-969,Granted Patent,no,0,1,1,1,0,H04M5/08;;H04M5/08,H04M5/08,,0,0,,,,EXPIRED
46,NO,L,NO 781466 L,120-596-174-601-115,1978-05-03,1978,NO 781466 A,1978-04-26,US 73800176 A,1976-11-02,MIDDEL TIL BEGRENSNING AV SOPPVEKSTER.,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/120-596-174-601-115,Abstract,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/34;;A23L3/3463;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
47,JP,A,JP 2004251455 A,132-450-917-565-527,2004-09-09,2004,JP 2004046435 A,2004-02-23,US 37137803 A,2003-02-21,METHOD FOR CONTROLLING DOUBLE CLUTCH TRANSMISSION,"<P>PROBLEM TO BE SOLVED: To provide a method for positively controlling starting of each gear of a double type clutch transmission. <P>SOLUTION: This method is for control of torque transmitted through a clutch to supply prescribed engine acceleration related to each gear based on an engine throttle position and clutch speed change after response to change of torque transmitted through a connected clutch when an engine is accelerated to a prescribed speed based on a throttle position. It includes a step 208 to determine the engine throttle position, a step 210 to determine a currently connected gear in a transmission, a step 212 to detect speed of a driven member of the connected clutch, and a step 214 to determine a target engine speed based on the engine throttle position, the currently connected gear, and a clutch speed. Torque transmitted through the clutch is continuously changed to accelerate the engine toward the target engine speed. <P>COPYRIGHT: (C)2004,JPO&NCIPI",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,,https://lens.org/132-450-917-565-527,Patent Application,no,0,1,8,8,0,B60W2510/0241;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2540/10;;B60W2710/0644;;B60W2710/0661;;F16D48/06;;F16D2500/1026;;F16D2500/10412;;F16D2500/1086;;F16D2500/30426;;F16D2500/3061;;F16D2500/30806;;F16D2500/50224;;F16D2500/7044;;F16D2500/70454;;F16H3/006;;F16H3/0915;;F16H61/0437;;F16H61/688;;F16H2306/52;;F16H2312/02;;F16D2500/5048;;B60W30/18027;;F16H61/0437;;B60W2510/0241;;F16H2306/52;;F16D2500/7044;;F16D2500/3061;;F16D2500/50224;;B60W2540/10;;B60W2710/0661;;F16D2500/1026;;F16H2312/02;;F16D2500/30806;;F16H3/0915;;F16D48/06;;F16H3/006;;F16D2500/70454;;F16H61/688;;B60W2510/1005;;B60W2510/1015;;B60W2710/0644;;F16D2500/30426;;B60W2510/0604;;F16D2500/10412;;F16D2500/1086;;F16D2500/5048,F16D48/06;;F16H3/00;;F16H3/091;;F16H61/04;;F16H61/68;;F16H61/688,,0,0,,,,EXPIRED
48,US,B2,US 6819997 B2,184-346-804-336-943,2004-11-16,2004,US 37141803 A,2003-02-21,US 37141803 A,2003-02-21,Method of controlling a dual clutch transmission,"
    A method of controlling the pressure applied to the engaged clutch of a vehicle having a dual clutch transmission to control the torque transferred across the engaged clutch thereby providing engine speed control for each gear based on the engine throttle position. The method includes the steps of determining the engine throttle position, determining the currently engaged gear of the transmission, and sensing the speed of the clutch. An engine stall speed is selected for the current gear and engine throttle position from a look-up table, and then a target engine speed based on the engine stall speed and the clutch speed is continuously redetermined, the clutch speed increasing in response to the increasing engine speed. The method also includes determining the difference between the target engine speed and the actual engine speed and then varying the torque transferred across the clutch driving the engaged gear to cause the engine to track the target engine speed based on the difference between the target engine speed and the actual engine speed. 
",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC (2003-02-10),https://lens.org/184-346-804-336-943,Granted Patent,yes,30,52,6,6,0,B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2710/023;;B60W2710/027;;B60W2710/0644;;B60W2710/0661;;F16H15/50;;F16H61/061;;F16H61/688;;F16H2306/52;;B60W10/02;;B60W10/10;;Y10T74/19288;;Y10T74/19288;;B60W10/06;;B60W2710/0644;;B60W10/113;;B60W30/19;;F16H15/50;;B60W2510/1015;;B60W2510/0604;;B60W2710/027;;F16H61/061;;B60W2510/1005;;F16H61/688;;F16H2306/52;;B60W2710/0661;;B60W2710/023;;B60W10/02;;B60W10/10,B60W10/06;;B60W10/10;;F02D29/00;;B60W10/113;;B60W30/19;;F16D48/02;;F16H61/02;;F16H61/06;;F16H61/66;;F16H63/46,701/67;;701/68;;477/70;;477/77;;74/340,0,0,,,,EXPIRED
49,EP,A2,EP 1450074 A2,040-437-495-406-646,2004-08-25,2004,EP 04250642 A,2004-02-06,US 37138103 A,2003-02-21,Method of controlling a dual clutch transmission,"A method of controlling the torque transferred across each of the two clutches (32,34) of a dual clutch transmission (10) during a gear shift, wherein the first of the two clutches (32) is the off-going clutch and the second of the two clutches (34) is the on-coming clutch. The method includes the steps of determining when a shift has been commanded, then sensing the speed of the driven member of the off-going clutch, determining the desired clutch torque and slip profile for the changeover of the clutches, and sensing the speed of the driven member of the on-coming clutch to determine a target engine speed profile. Then, the method simultaneously controls the torque transfer across each clutch so that the torque output of the transmission will be changed over from the off-going clutch to the on-coming clutch by linearly decreasing the torque transferred across the off-going clutch while linearly increasing the torque transferred across the on-coming clutch in an inversely proportional rate to follow the clutch torque and slip profile and to cause the engine to track the target engine speed profile. Finally, the pressure applied to the on-coming clutch is varied, once the on-coming clutch is transferring all of the output torque, to cause the engine to continue to track the target engine speed profile so that vehicle speed is maintained.",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC. (2005-05-25),https://lens.org/040-437-495-406-646,Patent Application,yes,4,39,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,B60K17/00;;F16H61/04;;B60K17/02;;B60W10/02;;B60W10/06;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/06;;F16H61/682;;F16H61/688,,0,0,,,,EXPIRED
50,EP,A1,EP 2300993 A1,049-252-870-056-569,2011-03-30,2011,EP 09750055 A,2009-05-11,GB 2009001190 W;;GB 0809502 A;;US 5576608 P,2008-05-23,LINEARISATION OF SCANNED DATA,,INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID,,https://lens.org/049-252-870-056-569,Patent Application,yes,1,0,7,7,0,G07D7/2033;;H04N2201/0081;;H04N2201/04731;;H04N2201/04787;;H04N2201/04791;;H04N2201/3236;;H04N2201/0471;;H04N2201/04734;;H04N2201/04737;;H04N2201/04768;;G06K7/10544;;G07D7/12;;G07D7/20;;G06V10/42;;G07D7/2033;;H04N2201/04731;;H04N2201/3236;;H04N2201/04791;;H04N2201/0081;;H04N2201/04787;;H04N2201/0471;;H04N2201/04734;;H04N2201/04768;;H04N2201/04737,G07D7/20;;H04N1/047,,0,0,,,,DISCONTINUED
51,DK,D0,DK 64383 D0,088-354-860-500-234,1983-02-14,1983,DK 64383 A,1983-02-14,DK 484877 A;;US 73800176 A,1976-11-02,MIDDEL TIL BEKAEMPELSE AF SVAMPE PA LANDBRUGSAFGROEDER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/088-354-860-500-234,Patent Application,no,0,0,4,39,0,,A01N/;;C09D/,,0,0,,,,DISCONTINUED
52,JP,A,JP 2004251456 A,162-121-565-364-262,2004-09-09,2004,JP 2004046466 A,2004-02-23,US 37138103 A,2003-02-21,METHOD FOR CONTROLLING DOUBLE CLUTCH TRANSMISSION,"<P>PROBLEM TO BE SOLVED: To efficiently and smoothly achieve gear-shift in a double clutch transmission. <P>SOLUTION: This method for controlling clutch torque in the double clutch transmission includes a step 204 to determine a shift command timing, a step 206 to detect speed of a drive member of a disconnected clutch, a step 208 to determine clutch torque and slide curve for clutch change-over, and a step 210 to detect speed of the driven member of an engaged clutch to determine a target engine speed curve. It also includes a step 214 to linearly decrease torque transmitted through the engaged clutch, and linearly increase torque transmitted through the engaged clutch at a ratio in inverse proportion to follow the clutch torque and the slide curve to make an engine follow the target engine speed curve so as to simultaneously control torque transmitted through each clutch in such a way that output torque of the transmission is changed from the disconnected clutch into the engaged clutch. <P>COPYRIGHT: (C)2004,JPO&NCIPI",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,,https://lens.org/162-121-565-364-262,Patent Application,no,3,36,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,B60K17/00;;B60K17/02;;B60W10/02;;B60W10/06;;F16H61/04;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/06;;F16H61/682;;F16H61/688,,0,0,,,,PENDING
53,EP,A1,EP 1449708 A1,185-529-303-432-599,2004-08-25,2004,EP 04250675 A,2004-02-09,US 37137803 A,2003-02-21,Method of controlling a dual clutch transmission,"A method of controlling the torque transferred across the engaged clutch of a vehicle having a dual clutch transmission to provide predetermined engine acceleration for each gear based on the engine throttle position and subsequent changes of clutch speed that are in response to operatively varying the torque transferred across the engaged clutch as the engine accelerates to a predetermined speed based on the throttle position. The method includes the steps of determining the engine throttle position (208), determining the currently engaged gear of the transmission (210), and sensing the speed of the driven member of the engaged clutch (212). Then, a target engine speed is determined based on the engine throttle position, the currently engaged gear, and the clutch speed (216). The torque transferred across the engaged clutch is then continuously varied to cause the engine to accelerate toward the target engine speed (218).",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC. (2005-05-25),https://lens.org/185-529-303-432-599,Patent Application,yes,6,18,8,8,0,B60W2510/0241;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2540/10;;B60W2710/0644;;B60W2710/0661;;F16D48/06;;F16D2500/1026;;F16D2500/10412;;F16D2500/1086;;F16D2500/30426;;F16D2500/3061;;F16D2500/30806;;F16D2500/50224;;F16D2500/7044;;F16D2500/70454;;F16H3/006;;F16H3/0915;;F16H61/0437;;F16H61/688;;F16H2306/52;;F16H2312/02;;F16D2500/5048;;B60W30/18027;;F16H61/0437;;B60W2510/0241;;F16H2306/52;;F16D2500/7044;;F16D2500/3061;;F16D2500/50224;;B60W2540/10;;B60W2710/0661;;F16D2500/1026;;F16H2312/02;;F16D2500/30806;;F16H3/0915;;F16D48/06;;F16H3/006;;F16D2500/70454;;F16H61/688;;B60W2510/1005;;B60W2510/1015;;B60W2710/0644;;F16D2500/30426;;B60W2510/0604;;F16D2500/10412;;F16D2500/1086;;F16D2500/5048,B60W10/10;;F16D48/06;;B60W10/02;;F16H3/00;;F16H3/091;;F16H61/04;;F16H61/68;;F16H61/688,,0,0,,,,EXPIRED
54,EP,A1,EP 1450063 A1,056-480-325-041-554,2004-08-25,2004,EP 04250337 A,2004-01-22,US 37141803 A,2003-02-21,Method of controlling a dual clutch transmission,"A method of controlling the pressure applied to the engaged clutch of a vehicle having a dual clutch transmission to control the torque transferred across the engaged clutch thereby providing engine speed control for each gear based on the engine throttle position. The method includes the steps of determining the engine throttle position, determining the currently engaged gear of the transmission, and sensing the speed of the clutch. An engine stall speed is selected for the current gear and engine throttle position from a look-up table, and then a target engine speed based on the engine stall speed and the clutch speed is continuously redetermined, the clutch speed increasing in response to the increasing engine speed. The method also includes determining the difference between the target engine speed and the actual engine speed and then varying the torque transferred across the clutch driving the engaged gear to cause the engine to track the target engine speed based on the difference between the target engine speed and the actual engine speed.",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC. (2005-05-25),https://lens.org/056-480-325-041-554,Patent Application,yes,6,4,6,6,0,B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2710/023;;B60W2710/027;;B60W2710/0644;;B60W2710/0661;;F16H15/50;;F16H61/061;;F16H61/688;;F16H2306/52;;B60W10/02;;B60W10/10;;Y10T74/19288;;Y10T74/19288;;B60W10/06;;B60W2710/0644;;B60W10/113;;B60W30/19;;F16H15/50;;B60W2510/1015;;B60W2510/0604;;B60W2710/027;;F16H61/061;;B60W2510/1005;;F16H61/688;;F16H2306/52;;B60W2710/0661;;B60W2710/023;;B60W10/02;;B60W10/10,B60W10/06;;B60W10/10;;F02D29/00;;B60W10/113;;B60W30/19;;F16D48/02;;F16H61/02;;F16H61/06;;F16H61/66;;F16H63/46,,0,0,,,,EXPIRED
55,DE,D1,DE 602004032281 D1,086-601-272-834-441,2011-06-01,2011,DE 602004032281 T,2004-01-22,US 37141803 A,2003-02-21,Verfahren zur Steuerung eines Doppelkupplungsgetriebes,,BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,,https://lens.org/086-601-272-834-441,Granted Patent,no,0,0,6,6,0,B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2710/023;;B60W2710/027;;B60W2710/0644;;B60W2710/0661;;F16H15/50;;F16H61/061;;F16H61/688;;F16H2306/52;;B60W10/02;;B60W10/10;;Y10T74/19288;;Y10T74/19288;;B60W10/06;;B60W2710/0644;;B60W10/113;;B60W30/19;;F16H15/50;;B60W2510/1015;;B60W2510/0604;;B60W2710/027;;F16H61/061;;B60W2510/1005;;F16H61/688;;F16H2306/52;;B60W2710/0661;;B60W2710/023;;B60W10/02;;B60W10/10,F02D29/00;;B60W10/06;;F16D48/06;;B60W10/10;;B60W10/113;;B60W30/19;;F16D48/02;;F16H61/02;;F16H61/06;;F16H61/66;;F16H63/46,,0,0,,,,EXPIRED
56,EP,B1,EP 1450063 B1,112-443-557-603-276,2011-04-20,2011,EP 04250337 A,2004-01-22,US 37141803 A,2003-02-21,Method of controlling a dual clutch transmission,,BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC. (2005-05-25),https://lens.org/112-443-557-603-276,Granted Patent,yes,6,0,6,6,0,B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2710/023;;B60W2710/027;;B60W2710/0644;;B60W2710/0661;;F16H15/50;;F16H61/061;;F16H61/688;;F16H2306/52;;B60W10/02;;B60W10/10;;Y10T74/19288;;Y10T74/19288;;B60W10/06;;B60W2710/0644;;B60W10/113;;B60W30/19;;F16H15/50;;B60W2510/1015;;B60W2510/0604;;B60W2710/027;;F16H61/061;;B60W2510/1005;;F16H61/688;;F16H2306/52;;B60W2710/0661;;B60W2710/023;;B60W10/02;;B60W10/10,F02D29/00;;B60W10/06;;F16D48/06;;B60W10/10;;B60W10/113;;B60W30/19;;F16D48/02;;F16H61/02;;F16H61/06;;F16H61/66;;F16H63/46,,0,0,,,,EXPIRED
57,CA,A,CA 368850 A,004-293-836-209-89X,1937-09-21,1937,CA 368850D A,,CA 368850T A,,TELEPHONE SYSTEM,,WESTERN ELECTRIC CO,BUCHANAN RUSSELL BENNETT;;KILLE LINDLEY ARTHUR,,https://lens.org/004-293-836-209-89X,Granted Patent,no,0,0,1,1,0,,,,0,0,,,,EXPIRED
58,NO,C,NO 147718 C,005-048-747-984-322,1983-06-01,1983,NO 773714 A,1977-10-28,US 73800176 A,1976-11-02,FREMGANGSMAATE TIL FREMSTILLING AV EN BIOLOGISK AKTIV KOPOLYMER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/005-048-747-984-322,Granted Patent,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/3463;;A23L3/34;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
59,KR,A,KR 20040075766 A,128-308-150-896-336,2004-08-30,2004,KR 20040011267 A,2004-02-20,US 37138103 A,2003-02-21,METHOD FOR CONTROLLING DOUBLE CLUTCH TRANSMISSION FOR CONTROLLING TORQUE TRANSMITTED BY OFF-GOING CLUTCH AND ON-COMING CLUTCH,"PURPOSE: A method for controlling a double clutch transmission is provided to transmit torque to the clutches efficiently by actively controlling gear shifting and changing the pressure to the on-coming clutch. CONSTITUTION: To control torque transmitted by an off-going clutch and an on-coming clutch in shifting gears, the command of shifting is decided(204). The speed of a driven member of the off-going clutch is detected(206), and the clutch torque and the slip profile for changeover of the clutch are decided(208). The speed of the driven member of the on-coming clutch is detected(210). The desired engine speed profile is decided according to the speed of the driven member of the off-going clutch, the clutch torque and slip profile and the speed of the driven member of the on-coming clutch(212). Torque transmission through the clutch is controlled simultaneously for changeover from the off-going clutch to the on-coming clutch(214). Pressure to the on-coming clutch is changed to detect the desired engine speed profile(216).",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,,https://lens.org/128-308-150-896-336,Patent Application,no,0,3,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,B60K17/00;;F16H61/04;;B60K17/02;;B60W10/02;;B60W10/06;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/06;;F16H61/682;;F16H61/688,,0,0,,,,EXPIRED
60,DK,A,DK 484877 A,195-591-967-326-22X,1978-05-03,1978,DK 484877 A,1977-11-01,US 73800176 A,1976-11-02,BIOLOGISK AKTIVE COPOLYMERE,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/195-591-967-326-22X,Patent Application,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/3463;;A23L3/34;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,DISCONTINUED
61,NO,C,NO 149797 C,034-622-430-790-998,1984-06-27,1984,NO 781466 A,1978-04-26,US 73800176 A,1976-11-02,MIDDEL TIL BEGRENSNING AV SOPPVEKSTER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/034-622-430-790-998,Granted Patent,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/34;;A23L3/3463;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
62,AU,A,AU 1977/030196 A,096-066-389-202-270,1979-05-10,1979,AU 1977/030196 A,1977-10-31,US 73800176 A,1976-11-02,BIOLOGICALLY ACTIVE ORGANO TIN-CONTAINING COPOLYMERS,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/096-066-389-202-270,Patent Application,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A23L3/34;;A01N55/04;;A23L3/3463;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
63,US,A1,US 2004/0166990 A1,181-485-662-319-419,2004-08-26,2004,US 37138103 A,2003-02-21,US 37138103 A,2003-02-21,METHOD OF CONTROLLING A DUAL CLUTCH TRANSMISSION,"
   A method of controlling the torque transferred across each of the two clutches of a dual clutch transmission during a gear shift, wherein the first of the two clutches is the off-going clutch and the second of the two clutches is the on-coming clutch. The method includes the steps of determining when a shift has been commanded, then sensing the speed of the driven member of the off-going clutch, determining the desired clutch torque and slip profile for the changeover of the clutches, and sensing the speed of the driven member of the on-coming clutch to determine a target engine speed profile. Then, the method simultaneously controls the torque transfer across each clutch so that the torque output of the transmission will be changed over from the off-going clutch to the on-coming clutch by linearly decreasing the torque transferred across the off-going clutch while linearly increasing the torque transferred across the on-coming clutch in an inversely proportional rate to follow the clutch torque and slip profile and to cause the engine to track the target engine speed profile. Finally, the pressure applied to the on-coming clutch is varied, once the on-coming clutch is transferring all of the output torque, to cause the engine to continue to track the target engine speed profile so that vehicle speed is maintained. 
",BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC (2003-02-10),https://lens.org/181-485-662-319-419,Patent Application,yes,26,39,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,B60K17/00;;F16H61/04;;B60K17/02;;B60W10/02;;B60W10/06;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/06;;F16H61/682;;F16H61/688,477/174,0,0,,,,EXPIRED
64,DE,T2,DE 602004000650 T2,107-803-223-618-297,2006-09-07,2006,DE 602004000650 T,2004-02-09,US 37137803 A,2003-02-21,Steuerverfahren für ein Doppelkupplungsgetriebe,,BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,,https://lens.org/107-803-223-618-297,Granted Patent,no,0,1,8,8,0,B60W2510/0241;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2540/10;;B60W2710/0644;;B60W2710/0661;;F16D48/06;;F16D2500/1026;;F16D2500/10412;;F16D2500/1086;;F16D2500/30426;;F16D2500/3061;;F16D2500/30806;;F16D2500/50224;;F16D2500/7044;;F16D2500/70454;;F16H3/006;;F16H3/0915;;F16H61/0437;;F16H61/688;;F16H2306/52;;F16H2312/02;;F16D2500/5048;;B60W30/18027;;F16H61/0437;;B60W2510/0241;;F16H2306/52;;F16D2500/7044;;F16D2500/3061;;F16D2500/50224;;B60W2540/10;;B60W2710/0661;;F16D2500/1026;;F16H2312/02;;F16D2500/30806;;F16H3/0915;;F16D48/06;;F16H3/006;;F16D2500/70454;;F16H61/688;;B60W2510/1005;;B60W2510/1015;;B60W2710/0644;;F16D2500/30426;;B60W2510/0604;;F16D2500/10412;;F16D2500/1086;;F16D2500/5048,B60W10/02;;B60W10/10;;F16D48/06;;F16H3/00;;F16H3/091;;F16H61/04;;F16H61/68;;F16H61/688,,0,0,,,,EXPIRED
65,FR,A1,FR 2369305 A1,100-051-536-864-41X,1978-05-26,1978,FR 7731894 A,1977-10-24,US 73800176 A,1976-11-02,COPOLYMERES A ACTIVITE BIOLOGIQUE CONTENANT UN FRAGMENT TRIORGANOETAIN,"<P>Suivant l'invention, le gonflement indésirable des copolymères biologiquement actifs dans lesquels une partie des motifs récurrents présente un fragment triorganoétain (R3 Sn-) est réduit par incorporation d'un agent de réticulation dans les copolymères. </P><P>Les propriétés physico-chimiques des copolymères réticulés les rendent plus utilisables comme biocides, en particulier comme agents toxiques antisalissures, que les polymères décrits dans les techniques antérieures.</P>",M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/100-051-536-864-41X,Patent Application,no,5,3,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/3463;;C08F2/00;;C08F2/04;;C08F2/06;;A23L3/34;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
66,US,A1,US 2004/0166992 A1,182-694-427-673-79X,2004-08-26,2004,US 37137803 A,2003-02-21,US 37137803 A,2003-02-21,METHOD OF CONTROLLING A DUAL CLUTCH TRANSMISSION,"
   A method of controlling the torque transferred across the engaged clutch of a vehicle having a dual clutch transmission to provide predetermined engine acceleration for each gear based on the engine throttle position and subsequent changes of clutch speed that are in response to operatively varying the torque transferred across the engaged clutch as the engine accelerates to a predetermined speed based on the throttle position. The method includes the steps of determining the engine throttle position, determining the currently engaged gear of the transmission, and sensing the speed of the driven member of the engaged clutch. Then, a target engine speed is determined based on the engine throttle position, the currently engaged gear, and the clutch speed. The torque transferred across the engaged clutch is then continuously varied to cause the engine to accelerate toward the target engine speed. 
",BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC (2003-02-10),https://lens.org/182-694-427-673-79X,Patent Application,yes,25,38,8,8,0,B60W2510/0241;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2540/10;;B60W2710/0644;;B60W2710/0661;;F16D48/06;;F16D2500/1026;;F16D2500/10412;;F16D2500/1086;;F16D2500/30426;;F16D2500/3061;;F16D2500/30806;;F16D2500/50224;;F16D2500/7044;;F16D2500/70454;;F16H3/006;;F16H3/0915;;F16H61/0437;;F16H61/688;;F16H2306/52;;F16H2312/02;;F16D2500/5048;;B60W30/18027;;F16H61/0437;;B60W2510/0241;;F16H2306/52;;F16D2500/7044;;F16D2500/3061;;F16D2500/50224;;B60W2540/10;;B60W2710/0661;;F16D2500/1026;;F16H2312/02;;F16D2500/30806;;F16H3/0915;;F16D48/06;;F16H3/006;;F16D2500/70454;;F16H61/688;;B60W2510/1005;;B60W2510/1015;;B60W2710/0644;;F16D2500/30426;;B60W2510/0604;;F16D2500/10412;;F16D2500/1086;;F16D2500/5048,F16D48/06;;F16H3/00;;F16H3/091;;F16H61/04;;F16H61/68;;F16H61/688,477/181,0,0,,,,EXPIRED
67,EP,A3,EP 1450074 A3,058-124-052-570-232,2010-06-09,2010,EP 04250642 A,2004-02-06,US 37138103 A,2003-02-21,Method of controlling a dual clutch transmission,"A method of controlling the torque transferred across each of the two clutches (32,34) of a dual clutch transmission (10) during a gear shift, wherein the first of the two clutches (32) is the off-going clutch and the second of the two clutches (34) is the on-coming clutch. The method includes the steps of determining when a shift has been commanded, then sensing the speed of the driven member of the off-going clutch, determining the desired clutch torque and slip profile for the changeover of the clutches, and sensing the speed of the driven member of the on-coming clutch to determine a target engine speed profile. Then, the method simultaneously controls the torque transfer across each clutch so that the torque output of the transmission will be changed over from the off-going clutch to the on-coming clutch by linearly decreasing the torque transferred across the off-going clutch while linearly increasing the torque transferred across the on-coming clutch in an inversely proportional rate to follow the clutch torque and slip profile and to cause the engine to track the target engine speed profile. Finally, the pressure applied to the on-coming clutch is varied, once the on-coming clutch is transferring all of the output torque, to cause the engine to continue to track the target engine speed profile so that vehicle speed is maintained.
",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC. (2005-05-25),https://lens.org/058-124-052-570-232,Search Report,yes,6,0,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,F16H61/04;;B60K17/00;;F16H61/06;;B60K17/02;;B60W10/02;;B60W10/06;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/682;;F16H61/688,,0,0,,,,EXPIRED
68,US,A1,US 2004/0166987 A1,114-301-658-725-626,2004-08-26,2004,US 37141803 A,2003-02-21,US 37141803 A,2003-02-21,METHOD OF CONTROLLING A DUAL CLUTCH TRANSMISSION,"
   A method of controlling the pressure applied to the engaged clutch of a vehicle having a dual clutch transmission to control the torque transferred across the engaged clutch thereby providing engine speed control for each gear based on the engine throttle position. The method includes the steps of determining the engine throttle position, determining the currently engaged gear of the transmission, and sensing the speed of the clutch. An engine stall speed is selected for the current gear and engine throttle position from a look-up table, and then a target engine speed based on the engine stall speed and the clutch speed is continuously redetermined, the clutch speed increasing in response to the increasing engine speed. The method also includes determining the difference between the target engine speed and the actual engine speed and then varying the torque transferred across the clutch driving the engaged gear to cause the engine to track the target engine speed based on the difference between the target engine speed and the actual engine speed. 
",BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC (2003-02-10),https://lens.org/114-301-658-725-626,Patent Application,yes,21,18,6,6,0,B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2710/023;;B60W2710/027;;B60W2710/0644;;B60W2710/0661;;F16H15/50;;F16H61/061;;F16H61/688;;F16H2306/52;;B60W10/02;;B60W10/10;;Y10T74/19288;;Y10T74/19288;;B60W10/06;;B60W2710/0644;;B60W10/113;;B60W30/19;;F16H15/50;;B60W2510/1015;;B60W2510/0604;;B60W2710/027;;F16H61/061;;B60W2510/1005;;F16H61/688;;F16H2306/52;;B60W2710/0661;;B60W2710/023;;B60W10/02;;B60W10/10,B60W10/06;;B60W10/10;;B60W10/113;;F02D29/00;;B60W30/19;;F16D48/02;;F16H61/02;;F16H61/06;;F16H61/66;;F16H63/46,477 7,0,0,,,,EXPIRED
69,DK,A,DK 64383 A,003-459-940-114-437,1983-02-14,1983,DK 64383 A,1983-02-14,DK 484877 A;;US 73800176 A,1976-11-02,MIDDEL TIL BEKAEMPELSE AF SVAMPE PAA LANDBRUGSAFGROEDER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/003-459-940-114-437,Patent Application,no,0,0,4,39,0,,A01N/;;C09D/,,0,0,,,,DISCONTINUED
70,NO,L,NO 773714 L,017-003-493-267-388,1978-05-03,1978,NO 773714 A,1977-10-28,US 73800176 A,1976-11-02,BIOLOGISK AKTIV KOPOLYMER.,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/017-003-493-267-388,Abstract,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/3463;;A23L3/34;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
71,DK,A,DK 64283 A,128-746-691-173-149,1983-02-14,1983,DK 64283 A,1983-02-14,DK 484877 A;;US 73800176 A,1976-11-02,FLYDENDE OVERTRAEKSMIDDEL TIL BEKAEMPELSE AF VEDHAEFTNING OG VAEKST AF BEGRONINGSORGANISMER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/128-746-691-173-149,Patent Application,no,0,0,4,39,0,,A01N/;;C09D/,,0,0,,,,DISCONTINUED
72,DE,D1,DE 602004000650 D1,179-601-119-105-703,2006-05-24,2006,DE 602004000650 T,2004-02-09,US 37137803 A,2003-02-21,Steuerverfahren für ein Doppelkupplungsgetriebe,,BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,,https://lens.org/179-601-119-105-703,Granted Patent,no,0,0,8,8,0,B60W2510/0241;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2540/10;;B60W2710/0644;;B60W2710/0661;;F16D48/06;;F16D2500/1026;;F16D2500/10412;;F16D2500/1086;;F16D2500/30426;;F16D2500/3061;;F16D2500/30806;;F16D2500/50224;;F16D2500/7044;;F16D2500/70454;;F16H3/006;;F16H3/0915;;F16H61/0437;;F16H61/688;;F16H2306/52;;F16H2312/02;;F16D2500/5048;;B60W30/18027;;F16H61/0437;;B60W2510/0241;;F16H2306/52;;F16D2500/7044;;F16D2500/3061;;F16D2500/50224;;B60W2540/10;;B60W2710/0661;;F16D2500/1026;;F16H2312/02;;F16D2500/30806;;F16H3/0915;;F16D48/06;;F16H3/006;;F16D2500/70454;;F16H61/688;;B60W2510/1005;;B60W2510/1015;;B60W2710/0644;;F16D2500/30426;;B60W2510/0604;;F16D2500/10412;;F16D2500/1086;;F16D2500/5048,B60W10/10;;B60W10/02;;F16D48/06;;F16H3/00;;F16H3/091;;F16H61/04;;F16H61/68;;F16H61/688,,0,0,,,,EXPIRED
73,NO,L,NO 781465 L,176-198-035-713-676,1978-05-03,1978,NO 781465 A,1978-04-26,US 73800176 A,1976-11-02,BESTRYKNINGSMIDDEL-SAMMENSETNING.,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/176-198-035-713-676,Abstract,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/3463;;A23L3/34;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,DISCONTINUED
74,DE,D1,DE 602006017224 D1,030-282-159-003-606,2010-11-11,2010,DE 602006017224 T,2006-07-19,GB 0515460 A;;US 70273205 P;;GB 2006002689 W,2005-07-27,VERIFIKATION DER AUTHENTIZITÄT,"An article identification method comprises: determining a signature from an article based upon an intrinsic characteristic of the article comparing the determined signature to a stored signature, splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA HOLDINGS LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID,,https://lens.org/030-282-159-003-606,Granted Patent,no,0,0,7,22,0,G07D7/004;;G06K7/10;;G06K19/10,G07D7/12;;G07D7/20,,0,0,,,,ACTIVE
75,JP,A,JP 2004251447 A,036-636-704-033-602,2004-09-09,2004,JP 2004033053 A,2004-02-10,US 37141803 A,2003-02-21,CONTROL METHOD OF DUAL CLUTCH TYPE TRANSMISSION,"<P>PROBLEM TO BE SOLVED: To provide a method controlling pressure given to an engaged clutch of a vehicle with a dual clutch type transmission and controlling torque transmitted via the clutch and controlling speed of an engine for every gear related to positions of an engine throttle. <P>SOLUTION: The control method of a dual clutch type transmission includes a step 224 determining an engine throttle position, a step 226 of determining engaged transmission gears, and a step of 228 sensing speed of a clutch. An engine stalling speed is selected from a lookup table against engaged gears and the engine throttle position, and a target engine speed is continuously redetermined based on a speed of a clutch which increases in proportion to an increase in the engine stalling speed and speed of an engine. Further, the control method includes a step of calculating a difference between the target engine speed and actual engine speed, and a step of letting transmitted torque change via the clutch driving the engaged gears so as to pursue the target engine speed for the engine based on the difference between the target engine speed and the actual engine speed. <P>COPYRIGHT: (C)2004,JPO&NCIPI",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,,https://lens.org/036-636-704-033-602,Patent Application,no,0,6,6,6,0,B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2710/023;;B60W2710/027;;B60W2710/0644;;B60W2710/0661;;F16H15/50;;F16H61/061;;F16H61/688;;F16H2306/52;;B60W10/02;;B60W10/10;;Y10T74/19288;;Y10T74/19288;;B60W10/06;;B60W2710/0644;;B60W10/113;;B60W30/19;;F16H15/50;;B60W2510/1015;;B60W2510/0604;;B60W2710/027;;F16H61/061;;B60W2510/1005;;F16H61/688;;F16H2306/52;;B60W2710/0661;;B60W2710/023;;B60W10/02;;B60W10/10,B60W10/06;;B60W10/10;;B60W10/113;;B60W30/19;;F16D48/02;;F16H61/02;;F16H61/06;;F16H61/66;;F16H63/46;;F02D29/00,,0,0,,,,PENDING
76,DE,C2,DE 2705440 C2,044-038-758-944-428,1986-10-30,1986,DE 2705440 A,1977-02-09,US 72095076 A,1976-09-07,DE 2705440 C2,,"M & T CHEMICALS, INC., WOODBRIDGE, N.J., US","RUSSELL, DAVID BUCHANAN, WESTFIELD, N.J., US","M & T CHEMICALS, INC., WOODBRIDGE, N.J., US (1985-06-27)",https://lens.org/044-038-758-944-428,Granted Patent,no,0,0,34,34,0,C08F230/04;;C09D5/1643;;C08F230/04;;C09D5/1643,C08F2/04;;C08F2/00;;C08F2/06;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F230/04;;C09D5/08;;C09D5/16;;C09D133/02,,0,0,,,,EXPIRED
77,DK,D0,DK 64283 D0,083-039-248-935-58X,1983-02-14,1983,DK 64283 A,1983-02-14,DK 484877 A;;US 73800176 A,1976-11-02,FLYDENDE OVERTRAEKSMIDDEL TIL BEKAEMPELSE AF VEDHAEFTNING OG VAEKST AF BEGRONINGSORGANISMER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/083-039-248-935-58X,Patent Application,no,0,0,4,39,0,,A01N/;;C09D/,,0,0,,,,DISCONTINUED
78,US,B2,US 7858374 B2,097-271-139-940-026,2010-12-28,2010,US 80338807 A,2007-05-14,US 80338807 A,2007-05-14,Method and device for reducing positron emitting isotope labeled carbon dioxide to positron emitter isotope labeled carbon monoxide via metal oxide,"A method and device for reducing positron emitter isotope labeled CO 2 to positron emitter isotope labeled CO generally includes introducing a volume of positron emitter isotope labeled CO 2 into a first heated reaction vessel comprising a metal oxide, such as Iron (II) Oxide such that the CO 2 is reduced to CO upon contact with the Iron (II) Oxide. The volume is then transferred to a second reaction vessel to remove any un-reacted CO 2 , preferably, via a soda-lime trap. The volume is then transferred to a target, e.g., a storage vessel or subject. The CO 2 includes one of [ 11 C] or [ 15 O]. The first reaction vessel is, preferably, heated to a temperature of between 900 and 1000° C., and more preferably, to between 925 and 975° C., and even more preferably, to approximately 950° C. Preferably, the Iron (II) Oxide powdered and has a particle size of about −10 mesh.",SIEMENS MEDICAL SOLUTIONS,BUCHANAN CHARLES RUSSELL;;WILLIAMSON ANDREW C,SIEMENS MEDICAL SOLUTIONS USA INC (2007-07-13),https://lens.org/097-271-139-940-026,Granted Patent,yes,3,0,2,2,0,G21G1/001;;G21G1/001;;G21G2001/0094;;G21G2001/0094,G01N23/00;;C12M1/00,436/57;;436/165;;436/164;;422/129;;422/159,2,1,080-511-225-437-50X,10.1016/s0969-8043(97)00109-7,"Zeisler et al., Conversion of No-carrier-added [11C]carbon Dioxide to [11C]carbon Monoxide on Molybdenum for the synthesis of 11C-labelled Aromatic Ketones, 1997, Appl. Radit. Isot, vol. 48, No. 8, pp. 1091-1095.;;G Stocklin et al, Radiopharmaceuticals for Positron Emission Tomography; Methodical Aspects. Kluwer Academic Publishers. vol. 23, 1993, p. 123.",INACTIVE
79,NO,B,NO 147718 B,061-405-090-278-768,1983-02-21,1983,NO 773714 A,1977-10-28,US 73800176 A,1976-11-02,FREMGANGSMAATE TIL FREMSTILLING AV EN BIOLOGISK AKTIV KOPOLYMER,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/061-405-090-278-768,Unknown,no,0,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/3463;;A23L3/34;;C08F2/00;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,EXPIRED
80,US,B1,US 6790159 B1,102-252-641-063-669,2004-09-14,2004,US 37137803 A,2003-02-21,US 37137803 A,2003-02-21,Method of controlling a dual clutch transmission,"
    A method of controlling the torque transferred across the engaged clutch of a vehicle having a dual clutch transmission to provide predetermined engine acceleration for each gear based on the engine throttle position and subsequent changes of clutch speed that are in response to operatively varying the torque transferred across the engaged clutch as the engine accelerates to a predetermine speed based on the throttle position. The method includes the steps of determining the engine throttle position, determining the currently engaged gear of the transmission, and sensing the speed of the driven member of the engaged clutch. Then, a target engine speed is determined based on the engine throttle position, the currently engaged gear, and the clutch speed. The torque transferred across the engaged clutch is then continuously varied to cause the engine to accelerate toward the target engine speed. 
",BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC (2003-02-10),https://lens.org/102-252-641-063-669,Granted Patent,yes,26,33,8,8,0,B60W2510/0241;;B60W2510/0604;;B60W2510/1005;;B60W2510/1015;;B60W2540/10;;B60W2710/0644;;B60W2710/0661;;F16D48/06;;F16D2500/1026;;F16D2500/10412;;F16D2500/1086;;F16D2500/30426;;F16D2500/3061;;F16D2500/30806;;F16D2500/50224;;F16D2500/7044;;F16D2500/70454;;F16H3/006;;F16H3/0915;;F16H61/0437;;F16H61/688;;F16H2306/52;;F16H2312/02;;F16D2500/5048;;B60W30/18027;;F16H61/0437;;B60W2510/0241;;F16H2306/52;;F16D2500/7044;;F16D2500/3061;;F16D2500/50224;;B60W2540/10;;B60W2710/0661;;F16D2500/1026;;F16H2312/02;;F16D2500/30806;;F16H3/0915;;F16D48/06;;F16H3/006;;F16D2500/70454;;F16H61/688;;B60W2510/1005;;B60W2510/1015;;B60W2710/0644;;F16D2500/30426;;B60W2510/0604;;F16D2500/10412;;F16D2500/1086;;F16D2500/5048,F16D48/06;;F16H3/00;;F16H3/091;;F16H61/04;;F16H61/68;;F16H61/688,477/86;;477/174;;701/51,0,0,,,,EXPIRED
81,WO,A1,WO 2009/141577 A1,130-928-343-790-115,2009-11-26,2009,GB 2009001190 W,2009-05-11,GB 0809502 A;;US 5576608 P,2008-05-23,LINEARISATION OF SCANNED DATA,A system for obtaining a signature a scan area on the surface of an article comprises: a signature generator that generates the signature from scattered coherent radiation detected from a plurality of regions on the surface by using relative motion between the article and a scan head comprising a coherent radiation source and photodetectors to obtain a set of data points comprising a group of data points from each region; an imaging detector that captures a sequence of images of the surface during the relative motion; and a processor that calculates the instantaneous velocity of the relative motion; whereby the signature generator uses the instantaneous velocity to linearise the groups of data point within the set of data points before generating the signature of the article from the set of data points.,LNGENIA HOLDINGS UK LTD;;COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID,,https://lens.org/130-928-343-790-115,Patent Application,yes,29,1,7,7,0,G07D7/2033;;H04N2201/0081;;H04N2201/04731;;H04N2201/04787;;H04N2201/04791;;H04N2201/3236;;H04N2201/0471;;H04N2201/04734;;H04N2201/04737;;H04N2201/04768;;G06K7/10544;;G07D7/12;;G07D7/20;;G06V10/42;;G07D7/2033;;H04N2201/04731;;H04N2201/3236;;H04N2201/04791;;H04N2201/0081;;H04N2201/04787;;H04N2201/0471;;H04N2201/04734;;H04N2201/04768;;H04N2201/04737,G07D7/20;;H04N1/047,,3,2,046-032-889-977-057;;013-750-169-137-892,10.1016/s0030-4018(97)00546-4;;16049465;;10.1038/436475a,"HAIST T ET AL: ""Optical detection of random features for high security applications"", OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173 - 179, XP004118061, ISSN: 0030-4018;;JAMES D. R. BUCHANAN ET AL.: ""Forgery: 'Fingerprinting' documents and packaging"", NATURE, vol. 436, 28 July 2005 (2005-07-28), pages 475 - 475;;See also references of EP 2300993A1",PENDING
82,EP,B1,EP 1450074 B1,051-258-696-385-373,2014-03-19,2014,EP 04250642 A,2004-02-06,US 37138103 A,2003-02-21,Method of controlling a dual clutch transmission,,BORGWARNER INC,BUCHANAN MARK;;LEMON RUSSELL;;KOENIG MELISSA,BORGWARNER INC. (2005-05-25),https://lens.org/051-258-696-385-373,Granted Patent,yes,6,0,14,30,0,B60W10/02;;B60W10/06;;B60W10/113;;B60W30/19;;B60W2510/0638;;B60W2710/025;;B60W2710/027;;F16H3/006;;F16H61/061;;F16H61/688;;F16H63/46;;F16H2061/0444;;F16H2200/0052;;F16H2302/06;;F16H2306/14;;F16H2306/44;;F16H2306/52;;F16H63/502;;B60W10/10;;B60W30/1819;;F16H3/44;;B60W10/06;;F16H2302/06;;B60W2710/025;;B60W30/19;;F16H2306/14;;B60W10/113;;F16H3/006;;F16H2061/0444;;B60W10/02;;B60W2510/0638;;B60W2710/027;;F16H61/061;;F16H2306/52;;F16H61/688;;F16H2200/0052;;F16H63/46;;F16H2306/44;;F16H63/502;;B60W30/1819;;B60W10/10,F16H61/04;;B60K17/00;;F16H61/06;;B60K17/02;;B60W10/02;;B60W10/06;;B60W10/10;;B60W10/113;;B60W30/18;;B60W30/19;;F16D48/06;;F16H3/00;;F16H3/44;;F16H61/682;;F16H61/688,,0,0,,,,EXPIRED
83,DE,A1,DE 2749084 A1,144-858-008-791-935,1978-05-11,1978,DE 2749084 A,1977-11-02,US 73800176 A,1976-11-02,BIOLOGISCH AKTIVE COPOLYMERE,,M & T CHEMICALS INC,BEDNARSKI JOHN RICHARD;;RUSSELL DAVID BUCHANAN,,https://lens.org/144-858-008-791-935,Patent Application,no,1,0,35,39,0,A01N55/04;;C08F220/12;;C08F230/04;;C09D5/1643;;C08F220/12;;C08F230/04;;C09D5/1643;;A01N55/04,A01N55/04;;A23L3/3463;;C08F2/00;;A23L3/34;;C08F2/04;;C08F2/06;;C08F12/00;;C08F30/00;;C08F30/04;;C08F220/00;;C08F220/10;;C08F220/12;;C08F230/04;;C09D5/08;;C09D5/14;;C09D5/16;;C09D133/04;;C09D137/00,,0,0,,,,DISCONTINUED
84,US,A,US 3160552 A,124-575-826-501-439,1964-12-08,1964,US 17982062 A,1962-03-14,US 17982062 A,1962-03-14,Cellulosic pulps comprising crosslinked xanthate cereal pulps and products made therewith,,RUSSELL CHARLES R;;BUCHANAN RUSSELL A;;RIST CARL E,RUSSELL CHARLES R;;BUCHANAN RUSSELL A;;RIST CARL E,,https://lens.org/124-575-826-501-439,Granted Patent,no,8,16,1,1,0,D21H17/28;;D21H17/28,D21H17/28,,0,0,,,,EXPIRED
85,US,A,US 3442832 A,170-422-053-532-882,1969-05-06,1969,US 3442832D A,1966-09-19,US 58055566 A,1966-09-19,REINFORCED RUBBER BY COPRECIPITATION WITH STARCH XANTHANE OR PREGELATINIZED STARCH,,US AGRICULTURE,BUCHANAN RUSSELL A;;RUSSELL CHARLES R;;WEISLOGEL ORVILLE E,,https://lens.org/170-422-053-532-882,Granted Patent,no,4,4,1,1,0,C08L3/02;;C08L7/02;;C08L9/08;;C08L21/00;;C08L21/02;;C08L97/005;;C08L21/00;;C08L97/005;;C08L21/02;;C08L7/02;;C08L3/02;;C08L9/08,C08L21/00,260/17.4,0,0,,,,EXPIRED
86,TW,A,TW 200735318 A,020-226-551-180-851,2007-09-16,2007,TW 96100104 A,2007-01-02,GB 0600828 A,2006-01-16,Verification of performance attributes of packaged integrated circuits,"Packaged integrated circuits (ICs) of some types, such as processors, are graded and sold according to a performance scale, such as maximum specified clock speed, set by the manufacturer as a result of testing. As a record of this grading some part of the package, usually the upper surface, is marked with the specified performance attribute. However, criminal activity has developed where the packaging is relabelled to show a higher specification so the ICs can be fraudulently resold at a higher price. To address this problem, the invention envisages that manufacturers maintaining a product database for each packaged IC which logs not only the performance specification, but also a digital signature derived from a speckle pattern obtained from the packaging. Subsequently, any packaged IC can be rescanned to interrogate its speckle pattern and recompute the signature. The signature is then used to find the product in the database, whereby the originally specified performance attribute is retrieved. The fraud is then detectable. This method can be used to test products returned under a warranty claim, for example.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/020-226-551-180-851,Patent of Addition,no,0,0,6,6,0,G01R31/2896;;G01R31/31718;;G01R31/31719;;H01L23/544;;H01L23/573;;H01L2223/54406;;H01L2223/54413;;H01L2223/54473;;H01L2223/54486;;H01L2924/0002;;G01R31/311;;G01R31/31719;;H01L2223/54473;;H01L23/573;;H01L2223/54486;;H01L2223/54406;;G01R31/31718;;G01R31/2896;;H01L23/544;;H01L2223/54413;;H01L2924/0002,H01L23/544,,0,0,,,,PENDING
87,US,B2,US 8892556 B2,115-083-023-074-157,2014-11-18,2014,US 201013505424 A,2010-11-04,US 201013505424 A;;GB 0919664 A;;US 25994609 P;;GB 2010051844 W,2009-11-10,Optimisation,"There is described a method for implementing a system for authentication of an article based upon a signature generated from a set comprising groups of data points collected when a plurality of regions of an intrinsic surface structure of an article are sequentially subjected to coherent light and the light scattered by the intrinsic surface structure is collected. For a given system implementation, the method comprises: determining a set of parameters which influence the performance of the system; determining a definition of system performance which can be affected by the set of parameters; producing an initial population of parameter value sets, each parameter set including a value for each parameter to be used in achieving a desired system performance; determining for each parameter value set a fitness value in terms of the system performance definition; identifying mating pairs of the population in accordance with the determined fitnesses; producing a new population by crossing the mating pairs; repeating the determining of a fitness value for each parameter value set, identifying of mating pairs and producing a new population until an end criterion is satisfied; and configuring the system in accordance with a selected one of the parameter sets from the final population. Thereby, a flexible and appropriate approach to system implementation can be followed which provides high efficiency in terms of the human time input and which provides high quality reliable setup parameter values to enable a reliable and efficient system implementation to result.",COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2012-05-30),https://lens.org/115-083-023-074-157,Granted Patent,yes,100,9,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G06F17/30;;G06V10/70;;G07D7/20,707/736,41,10,013-750-169-137-892;;121-035-460-007-543;;102-840-775-673-316;;010-885-886-851-721;;046-032-889-977-057;;139-509-297-460-756;;136-658-407-268-598;;041-551-127-916-12X;;014-283-534-008-99X;;117-746-395-397-755,16049465;;10.1038/436475a;;10.1145/1120680.1120685;;10.1006/cviu.2001.0922;;10.1109/nrsc.2007.371365;;10.1016/s0030-4018(97)00546-4;;10.1109/tc.2006.138;;10.1016/j.optcom.2004.09.060;;10.1145/988772.988797;;10.1126/science.1074376;;12242435;;10.1016/s0923-5965(02)00084-x,"International Search Report and Written Opinion for PCT/GB2010/051844 mailed Feb. 17, 2011, 10 pages.;;Written Opinion of the International Search Authority for International Application PCT/BG2007/000015, mailed Jul. 16, 2008, 8 pages.;;International Preliminary Report on Patentability, dated May 24, 2012, for PCT/GB2010/051844.;;Anderson, Ross J., Security Engineering: A Guide to Building Dependable Distributed Systems, Chapter 12: Security Printing and Seals, pp. 251-253 John Wiley & Sons, Inc. (2001).;;Anonymous, ""Discs and Paper Get Biometric Identifiers,"" IEE Review, p. 23, (Dec. 2004).;;Buchanan et al., ""Fingerprinting' documents and packaging "" Nature, vol. 436, p. 475 (Jul. 2005).;;Chen et al., ""Certifying Authenticity via Fiber-Infused Paper,"" ACM SIGecom Exchanges, vol. 5, No. 3, pp. 29-37 (Apr. 2005).;;Cowburn, Russell, ""Nanotechnology-Security and Brand Protection Applications 01,"" Smart Brand and Product Protection Conference 2005, Apr. 8, 2005 to Apr. 9, 2005, pp. 1-4, London, UK.;;d'Agraives et al. ""Surface Topography, A Remarkable Method for the Identification of Seals of Structures in General,"" Commission of the European Communities Joint Research Centre-Ispra Establishment I-21020 Ispra (Va), Italy, pp. 403-409 (1981).;;Derrode S et al., ""Robust and Efficient Fourier-Mellin Transform Approximations for Gray-Level Image Reconstruction and Complete Invariant Description,"" Computer Vision and Image Understanding, Academic Press, San Diego, CA, 83(1):57-78 (Jul. 2001).;;El-Khamy S. E. et al., ""The FBG stream cipher,"" Proceedings of the 24th Radio National Science Conference {NRSC 2007) IEEE Cairo, Egypt, pp. 1-8 (Mar. 2007).;;International Search Report for Application No. PCT/GB2008/002020 mailed Jun. 10, 2005, 3 pages.;;International Search Report for Great Britain Patent Application No. GB0711461.4 dated Sep. 21, 2007, 1 page.;;Haist et al., ""Optical detection of random features for high security applications,"" Optics Communications, 147:173-179 (1998).;;Hao F. et al., ""Combining crypto with biometrics effectively,"" IEEE Transactions on Computers IEEE USA, 55(9):1081-1088 (Sep. 2006).;;Huss G. et al., ""Spatial filtering efficiency of single-mode optical fibers for stellar interferometry applications: phenomenological and numerical study,"" Optics Communications, North-Holland Publishing Co., Amsterdam, NL, 244:209-217 (Sep. 23, 2004).;;International Search Report for Great Britain Patent App. No. GB0607867.9, Aug. 22, 2006, 1 page.;;International Search Report from International App. No. PCT/GB2005/000922 filed Mar. 9, 2005, 3 pages.;;International Search Report for PCT/GB2007/002173 dated Sep. 19, 2007, 3 pages.;;International Search Report and Written Report for PCT/GB2009/001702 dated Oct. 23, 2009, 12 pages.;;International Search Report issued by UK Intellectual Property Office for GB0720673.3, dated Mar. 28, 2008, 2 pages.;;Kirovski, Darko, ""Toward an Automated Verification of Certificates of Authenticity,"" pp. 160-169 (2004).;;Kravolec, ""Plastic tag makes foolproof ID,"" Technology Research News, Oct. 2, 2002.;;Kvasnik et al., ""Image recognition using surface scattered light in a coherent optical processor,"" Image Processing and its Applications, University of Manchester Institute of Science and Technology UK, pp. 361-364 (1992).;;Pappu et al., ""Physical one-way functions,"" Science, American Association for the Advancement of Science, vol. 297. No. 5589, pp. 2026-2030 (2002).;;Ravikanth, Pappu Srinivasa. ""Physical One-Way Functions,"" pp. 3-154, Mar. 2001.;;Schneier B., ""Applied Cryptography. Protocols, Algorithms, and Source Code in C, Passage,"" Applied Cryptography, 2nd Ed., John Wiley & Sons, Inc., New York, p. 197 (1996).;;Simmons, G.J. A survey of information authentication, in Contemporary Cryptology, The Science of Information Integrity , pp. 379-419 IEEE Press (1992).;;Smalley, Eric, ""Plastic Tag makes foolproof ID,"" Technology Research News, Oct. 2, 2002.;;Smith et al., ""Microstructure Based Indicia,"" Laboratories Escher Group, pp. 1-5 (1999).;;UK Search Report for GB0812772.2 dated Nov. 6, 2008, 1 page.;;UK Search Report for GB0812773 dated Mar. 2009, 2 pages.;;Uk Search Report for GB0812773 dated Nov. 2008, 2 pages.;;Van Renesse R.L., ""Optical inspection techniques for security instrumentation,"" Proceedins of SPIE-The International Society for Optical Engineering, Vo. 2659, pp. 159-167 (Mar. 1996).;;Wilkes, Sally, ""Fighting Fraud; Document Biometrics,"" Materials World, vol. 12, No. 12, pp. 29-30 (Dec. 2004).;;Zhang D et al., ""Shape-based image retrieval using generic Fourier descriptor"" Signal Processing. Image Communication, Ellsevier Science Publishers, Amsterdam, NL 17(10):825-848 (Nov. 2002).;;Zwick/Roell-Zwick Materials testing-the new direction in extension measurement-optiXtens, 11 pages.;;Agilent Technologies, ""Agilent Data Sheet HEDS 1500,"" Agilent Technologies, www.digchip.com, 1999, 6 pages.;;European Patent Office, Notice of Opposition for EP2374111, dated Nov. 4, 2013, 20 pages.;;The International Bureau of WIPO, International Preliminary Report on Patentability and Written Opinion for PCT/GB2007/002173, dated Dec. 16, 2006, 7 pages.;;Métois, Eric et al., ""FiberFingerprint identification"" In Proc. 3rd Workshop on Automatic Identification, Mar. 2002, pp. 147-154.",INACTIVE
88,WO,A1,WO 2011/058343 A1,180-263-121-027-19X,2011-05-19,2011,GB 2010051844 W,2010-11-04,GB 0919664 A;;US 25994609 P,2009-11-10,OPTIMISATION,"There is described a method for implementing a system for authentication of an article based upon a signature generated from a set comprising groups of data points collected when a plurality of regions of an intrinsic surface structure of an article are sequentially subjected to coherent light and the light scattered by the intrinsic surface structure is collected. For a given system implementation, the method comprises: determining a set of parameters which influence the performance of the system; determining a definition of system performance which can be affected by the set of parameters; producing an initial population of parameter value sets, each parameter set including a value for each parameter to be used in achieving a desired system performance; determining for each parameter value set a fitness value in terms of the system performance definition; identifying mating pairs of the population in accordance with the determined fitnesses; producing a new population by crossing the mating pairs; repeating the determining of a fitness value for each parameter value set, identifying of mating pairs and producing a new population until an end criterion is satisfied; and configuring the system in accordance with a selected one of the parameter sets from the final population. Thereby, a flexible and appropriate approach to system implementation can be followed which provides high efficiency in terms of the human time input and which provides high quality reliable setup parameter values to enable a reliable and efficient system implementation to result",INGENIA HOLDINGS UK LTD;;COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/180-263-121-027-19X,Patent Application,yes,27,0,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G07D7/20;;G06Q10/00;;G06V10/70,,0,0,,,,PENDING
89,WO,A1,WO 2007/012821 A1,037-064-558-688-920,2007-02-01,2007,GB 2006002716 W,2006-07-20,GB 0515462 A;;US 70435405 P,2005-07-27,VERIFICATION OF THE SIGNATURE OF AN ARTICLE CREATED FROM SIGNALS OBTAINED FROM SCATTER OF COHERENT OPTICAL RADIATION FROM THE SURFACE OF THE ARTICLE,"An article verification system can comprise a first scanner operable to scan an article to create a signature based upon an intrinsic characteristic of the article and a comparator operable to compare the created signature to a plurality of stored signatures created from previous scans of a plurality of articles. More than one stored signature can be associated with each article, each signature for each article being associated with a respective different portion of each article to the other signatures for that article. Thus the system provides for an article to be checked against multiple records of that article. In some examples, a single match between the later scan and a stored record can be used to positively verify the article.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/037-064-558-688-920,Patent Application,yes,5,4,7,12,0,G07D7/121;;G07D7/003;;G06V20/80;;G06V10/145;;G06V10/42;;G07D7/121;;G07D7/003;;G06V10/42;;G06V10/145;;G06V20/80,G07D7/12;;G06V10/145;;G06V10/42,,0,0,,,,PENDING
90,US,A1,US 2009/0303000 A1,027-877-858-893-446,2009-12-10,2009,US 47121209 A,2009-05-22,US 47121209 A;;GB 0809502 A;;US 5576608 P,2008-05-23,Linearisation of Scanned Data,A system for obtaining a signature a scan area on the surface of an article comprises: a signature generator that generates the signature from scattered coherent radiation detected from a plurality of regions on the surface by using relative motion between the article and a scan head comprising a coherent radiation source and photodetectors to obtain a set of data points comprising a group of data points from each region; an imaging detector that captures a sequence of images of the surface during the relative motion; and a processor that calculates the instantaneous velocity of the relative motion; whereby the signature generator uses the instantaneous velocity to linearise the groups of data point within the set of data points before generating the signature of the article from the set of data points.,INGENIA HOLDINGS UK LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS (UK) LIMITED (2009-05-19);;INGENIA HOLDINGS LIMITED (2009-08-14),https://lens.org/027-877-858-893-446,Patent Application,yes,65,10,7,7,0,G07D7/2033;;H04N2201/0081;;H04N2201/04731;;H04N2201/04787;;H04N2201/04791;;H04N2201/3236;;H04N2201/0471;;H04N2201/04734;;H04N2201/04737;;H04N2201/04768;;G06K7/10544;;G07D7/12;;G07D7/20;;G06V10/42;;G07D7/2033;;H04N2201/04731;;H04N2201/3236;;H04N2201/04791;;H04N2201/0081;;H04N2201/04787;;H04N2201/0471;;H04N2201/04734;;H04N2201/04768;;H04N2201/04737,H04N1/40;;G06F7/04,340/5.86;;358/448,0,0,,,,DISCONTINUED
91,GB,A,GB 2476226 A,108-892-775-159-440,2011-06-22,2011,GB 0919664 A,2009-11-10,GB 0919664 A,2009-11-10,Optimisation of an authentication system using a genetic algorithm,"A method for implementing a system for authenticating an article, based upon a signature in the form of groups of data points collected when a surface structure of an article is subjected to coherent light and the light scattered by the surface structure is collected. The surface could be the paper or plastic used in a identity card or warranty document. The authentication system might include a scanner and a database of stored signatures. The method comprises: determining a set of parameters which influence the performance of the system; determining a definition of system performance; producing an initial population of parameter value sets; determining, for each parameter value set, a fitness value in terms of the system performance; identifying mating pairs of the population in accordance with the determined fitnesses; producing a new population by crossing the mating pairs; repeating the determining the process above until an end criterion is satisfied; and configuring the system in accordance with a selected parameter set from the final population. The parameters which influence the performance of the system might include filter parameters.",INGENIA HOLDINGS,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/108-892-775-159-440,Patent Application,no,1,0,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G06K7/10;;G06K7/14;;G06K19/00;;G06V10/70,,2,1,053-958-092-328-407,10.1109/icsmc.2000.884411,"W S Wijesoma et al., ""Selecting optimal personalized features for on-line signature verification using GA"", 2000, IEEE;;A Khan et al, ""Optimizing perceptual shaping of a digital watermark using genetic programming"".",INACTIVE
92,GB,B,GB 2429092 B,173-308-923-075-356,2007-10-24,2007,GB 0515465 A,2005-07-27,GB 0515465 A,2005-07-27,Token Signature Based Record Access,,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/173-308-923-075-356,Granted Patent,no,10,0,5,16,0,G06F21/35,G06F1/00;;G07C9/00,G4H HTG           TG;;G4H H14A          TG;;G4H H2P           TG;;NOT CLASSIFIED    NONE,0,0,,,,INACTIVE
93,GB,A,GB 2428948 A,002-199-938-685-199,2007-02-07,2007,GB 0515463 A,2005-07-27,GB 0515463 A,2005-07-27,Key distribution by combination with a signature obtained from a scan of an unmodified token,"A key distribution system can comprise a key packaging unit operable to combine a key with a signature based upon an intrinsic property of a security token, a channel operable to have the packaged key transmitted therethrough; and a key unpacking unit operable to unpack the key using the signature. Thereby the key can be transmitted via a non-secure channel to a recipient for use thereby, without it being possible for a third party to obtain a copy of the key by monitoring the channel. The key and signature may be combined using an exclusive OR (XOR) operation. The intrinsic property of the token is used by irradiating the token e.g. using a light scanner to obtain a speckle pattern representative of the material of the token. This pattern may then be digitised to obtain the signature. The application envisages that no special modification of the token material (e.g. invention of microelements) is required to obtain the signature. As such the token could be e.g. any credit card, business card, or a passport etc.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/002-199-938-685-199,Patent Application,no,5,6,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,H04L9/08,G1A AAJX          AJX;;G1A ACEK          CEK;;G1A AG17          AJX;;G1A AG17          CEK;;G1A AG17          TA;;G1A AG18          AJX;;G1A AG18          CEK;;G1A AG18          TA;;G1A AR7           AJX;;G1A AR7           CEK;;G1A AR7           TA;;G1A ATA           TA;;G1A AT21          AJX;;G1A AT21          CEK;;G1A AT21          TA;;G1A AT3           AJX;;G1A AT3           CEK;;G1A AT3           TA;;G1A AT4           AJX;;G1A AT4           CEK;;G1A AT4           TA;;H4P PDCSP         PDCSP;;NOT CLASSIFIED    NONE,0,0,,,,INACTIVE
94,US,B2,US 8078875 B2,054-921-703-361-968,2011-12-13,2011,US 46055806 A,2006-07-27,US 46055806 A;;GB 0515460 A;;US 70273205 P,2005-07-27,Verification of authenticity,"An article identification method can comprise: determining a signature from an article based upon an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method can also comprise splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2011-06-15),https://lens.org/054-921-703-361-968,Granted Patent,yes,110,28,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,H04L9/32;;G06V10/28;;G06V10/40;;G06V10/42,713/176;;713/156;;713/175;;713/177;;713/180;;382/100;;382/218;;358/448;;358/474;;358/488;;726/2;;726/4;;726/17;;726/27;;726/28;;726/29;;726/30;;705/5;;235/375;;235/462.01;;235/494,35,11,014-283-534-008-99X;;117-746-395-397-755;;102-840-775-673-316;;121-035-460-007-543;;041-551-127-916-12X;;013-750-169-137-892;;046-032-889-977-057;;014-283-534-008-99X;;010-885-886-851-721;;139-509-297-460-756;;136-658-407-268-598,10.1126/science.1074376;;12242435;;10.1016/s0923-5965(02)00084-x;;10.1006/cviu.2001.0922;;10.1145/1120680.1120685;;10.1145/988772.988797;;16049465;;10.1038/436475a;;10.1016/s0030-4018(97)00546-4;;10.1126/science.1074376;;12242435;;10.1109/nrsc.2007.371365;;10.1109/tc.2006.138;;10.1016/j.optcom.2004.09.060,"International Search Report issued by UK Intellectual Property Office, Mar. 28, 2008.;;Ravikanth, Pappu Srinivasa. ""Physical One-Way Functions,"" Mar. 2001.;;Zhang D et al., ""Shape-based image retrieval using generic Fourier descriptor,"" Signal Processing. Image Communication, Ellsevier Science Publishers, Amsterdam, NL 17(10):825-848 (Nov. 2002).;;Derrode S et al., ""Robust and Efficient Fourier-Mellin Transform Approximations for Gray-Level Image Reconstruction and Complete Invariant Description,"" Computer Vision and Image Understanding, Academic Press, San Diego, CA, 83(1):57-78 (Jul. 2001).;;Anderson, R., ""Security Engineering: a guide to building dependable distributed systems,"" Wiley, 251-253, 2001.;;Kravolec, ""Plastic tag makes foolproof ID,"" Technology Research News, Oct. 2, 2002.;;Smalley, Eric, ""Plastic Tag makes foolproof ID,"" Technology Research News, Oct. 2, 2002.;;Chen, Yuqun et al., ""Certifying Authenticity via Fiber-Infused Paper,"" ACM SIG ecom Exchanges, 5(3):29-37 (2005).;;Kirovski, Darko, ""Toward an Automated Verification of Certificates of Authenticity,"" pp. 160-169 (2004).;;G.J. Simmons, A survey of information authentication, in Contemporary Cryptology, The Science of Information Integrity , pp. 379-419 IEEE Press (1992).;;Zwick/Roell-Zwick Materials testing-the new direction in extension measurement-optiXtens.;;International Search Report from International App. No. PCT/GB2005/000922 filed Mar. 9, 2005.;;Buchanan, James, ""Fingerprinting Documents and Packaging,"" Nature, 436:475 (2005).;;International Search Report for Great Britain Patent App. No. GB0607867.0 (Aug. 2006).;;Haist et al., ""Optical detection of random features for high security applications,"" Optics Communications, 147:173-179 (1998) .;;Pappu et al., ""Physical one-way functions,"" Science, American Association for the Advancement of Science, vol. 297, No. 5589, pp. 2026-2030 (2002).;;Cowburn, Russell, ""Nanotechnology-Security and Brand Protection Applications 01,"" Smart Brand and Product Protection Conference 2005, Apr. 8, 2005 to Apr. 9, 2005, pp. 1-4, London, UK.;;Van Renesse R.L, ""Optical inspection techniques for security instrumentation,"" Proceedings of SPIE-The International Society for Optical Engineering, Vo. 2659, pp. 159-167 (Mar. 1996).;;Anonymous, ""Discs and paper get biometric identifiers,"" IEEE Review, vol. 50, No. 12, p. 23, (Dec. 2004).;;Wilkes, Sally, ""Fighting Fraud: Document Biometrics,"" Materials World, vol. 12, No. 12, pp. 29-30 (Dec. 2004).;;Smith et al., ""Microstructure Based Indicia,"" Laboratories Escher Group, pp. 1 -5 (1999).;;Schneier B., ""Applied Cryptography. Protocols, Algorithms, and Source Code in C, Passage,"" Applied Cryptography, 2nd Ed., John Wiley & Sons, Inc., New York, p. 197 (1996).;;El-Khamy S. E. et al., ""The FBG stream cipher,"" Proceedings of the 24th Radio National Science Conference (NRSC 2007) IEEE Cairo, Egypt, pp. 1-8 (Mar. 2007).;;Hao F. et al., ""Combining crypto with biometrics effectively,"" IEEE Transactions on Computers IEEE USA, 55 (9):1081-1088 (Sep. 2006).;;International Search Report and Written Opinion for PCT/GB2008/002020 dated Jun. 16, 2009.;;International Search Report for Great Britain Patent Application No. GB0711461.4 dated Sep. 21, 2007.;;Written Opinion for PCT/GB2007/000015 dated May 4, 2007.;;International Search Report for PCT/GB2009/001702 dated Oct. 23, 2009.;;UK Search Report for GB0812772.2 dated Nov. 6, 2008.;;UK Search Report for GB0812773 dated Mar. 2009.;;UK Search Report for GB0812773 dated Nov. 2008.;;International Search Report for PCT/GB2007/002173 dated Sep. 19, 2007.;;Huss G. et al., ""Spatial filtering efficiency of single-mode optical fibers for stellar interferometry applications: phenomenological and numerical study,"" Optics Communications, North-Holland Publishing Co., Amsterdam, NL, 244:209-217 (Sep. 23, 2004).;;Kvasnik et al., ""Image recognition using surface scattered light in a coherent optical processor,"" Image Processing and its Applications, University of Manchester Institute of Science and Technology UK, pp. 361-364 (1992).;;d'Agraives et al., ""Surface Topography, A Remarkable Method for the Identification of Seals of Structures in General,"" Commission of the European Communities Joint Research Centre-Ispra Establishment 1-21020 Ispra (Va), Italy, pp. 403-409 (1981).",INACTIVE
95,EP,A1,EP 1908028 A1,066-010-236-068-321,2008-04-09,2008,EP 06765022 A,2006-07-19,GB 2006002688 W;;GB 0515461 A;;US 70294605 P,2005-07-27,AUTHENTICITY VERIFICATION,,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2010-03-24),https://lens.org/066-010-236-068-321,Patent Application,yes,1,0,7,11,0,G06Q20/04;;G06Q20/042;;G06Q20/3674;;G06Q20/40;;G06Q20/4014;;G06V20/80;;G06Q20/04;;G06Q20/042;;G06Q20/4014;;G06Q20/40;;G06Q20/3674;;G06V20/80,G07F7/08;;G07D7/12,,4,1,128-211-157-916-634,10.1007/b137875,"RAVIKANTH P S: ""Physical One-way Functions"", THESIS AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY, XX, XX, 1 March 2001 (2001-03-01), pages 1 - 154, XP002251679;;AA KORIÄ B ET AL: ""Robust Key Extraction from Physical Uncloneable Functions"", 19 May 2005, APPLIED CRYPTOGRAPHY AND NETWORK SECURITY; [LECTURE NOTES IN COMPUTER SCIENCE;LNCS], SPRINGER-VERLAG, BERLIN/HEIDELBERG, PAGE(S) 407 - 422, ISBN: 978-3-540-26223-7, XP019010616;;TUYLS P ET AL: ""Information-theoretic security analysis of physical uncloneable functions"", FINANCIAL CRYPTOGRAPHY AND DATA SECURITY : 9TH INTERNATIONAL CONFERENCE, FC 2005, ROSEAU, THE COMMONWEALTH OF DOMINICA, FEBRUARY 28 20050228; 20050228 - 20050303 SPRINGER-VERLAG, BERLIN/HEIDELBERG, vol. 3570/2005, 28 February 2005 (2005-02-28), pages 141 - 155, XP002606939, ISBN: 978-3-540-26656-3, [retrieved on 20050101], DOI: 10.1007/11507840_15;;See also references of WO 2007012815A1",DISCONTINUED
96,CN,B,CN 101258528 B,166-249-832-808-541,2012-03-21,2012,CN 200680032538 A,2006-07-19,GB 2006002689 W;;GB 0515460 A;;US 70273205 P,2005-07-27,Authenticity verification,"An article identification method can comprise: determining a signature from an article based upon an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method can also comprise splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature,and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA TECHNOLOGY LTD,PAUL COWBURN RUSSELL;;RALPH BUCHANAN JAMES DAVID,"ENGENYA HOLDINGS CO., LTD. (2010-04-13)",https://lens.org/166-249-832-808-541,Granted Patent,no,0,0,7,22,0,G07D7/004;;G06K7/10;;G06K19/10,G07D7/12;;G07D7/20,,0,0,,,,INACTIVE
97,EP,A1,EP 1911003 A1,036-414-963-719-090,2008-04-16,2008,EP 06765046 A,2006-07-20,GB 2006002716 W;;GB 0515462 A;;US 70435405 P,2005-07-27,VERIFICATION OF THE SIGNATURE OF AN ARTICLE CREATED FROM SIGNALS OBTAINED FROM SCATTER OF COHERENT OPTICAL RADIATION FROM THE SURFACE OF THE ARTICLE,,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2010-03-24),https://lens.org/036-414-963-719-090,Patent Application,yes,0,0,7,12,0,G07D7/121;;G07D7/003;;G06V20/80;;G06V10/145;;G06V10/42;;G07D7/121;;G07D7/003;;G06V10/42;;G06V10/145;;G06V20/80,G07D7/12;;G06V10/145;;G06V10/42,,0,0,,,,DISCONTINUED
98,US,A1,US 2007/0113076 A1,036-588-769-541-276,2007-05-17,2007,US 46055506 A,2006-07-27,US 46055506 A;;GB 0515463 A;;US 70274205 P,2005-07-27,Keys,"A key distribution system can comprise a key packaging unit operable to package a key using a signature based upon an intrinsic property of a security token, a channel operable to have the packaged key transmitted therethrough; and a key unpacking unit operable to unpack the key using a signature based upon the intrinsic property of the security token. Thereby the key can be transmitted via a non-secure channel to a recipient for use thereby, without it being possible for a third party to obtain a copy of the key by monitoring the channel.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (2006-11-10);;INGENIA HOLDINGS (UK) LIMITED (2006-11-11);;INGENIA HOLDINGS LIMITED (2009-08-14);;INGENIA TECHNOLOGY LIMITED (2006-11-20),https://lens.org/036-588-769-541-276,Patent Application,yes,9,37,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,H04L9/00;;H04L9/08,713/159,0,0,,,,DISCONTINUED
99,US,A1,US 2007/0164729 A1,045-721-601-778-903,2007-07-19,2007,US 62363307 A,2007-01-16,US 62363307 A;;GB 0600828 A;;US 76187006 P,2006-01-16,Verification of Performance Attributes of Packaged Integrated Circuits,"Packaged integrated circuits (ICs) of some types, such as processors, are graded and sold according to a performance scale, such as maximum specified clock speed, set by the manufacturer as a result of testing. As a record of this grading some part of the package, usually the upper surface, is marked with the specified performance attribute. However, criminal activity has developed where the packaging is relabelled to show a higher specification so the ICs can be fraudulently resold at a higher price. To address this problem, the invention envisages that manufacturers maintaining a product database for each packaged IC which logs not only the performance specification, but also a digital signature derived from a speckle pattern obtained from the packaging. Subsequently, any packaged IC can be rescanned to interrogate its speckle pattern and recompute the signature. The signature is then used to find the product in the database, whereby the originally specified performance attribute is retrieved. The fraud is then detectable. This method can be used to test products returned under a warranty claim, for example.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,INGENIA HOLDINGS (U.K.) LIMITED (2007-02-20);;INGENIA HOLDINGS LIMITED (2009-08-14),https://lens.org/045-721-601-778-903,Patent Application,yes,97,28,6,6,0,G01R31/2896;;G01R31/31718;;G01R31/31719;;H01L23/544;;H01L23/573;;H01L2223/54406;;H01L2223/54413;;H01L2223/54473;;H01L2223/54486;;H01L2924/0002;;G01R31/311;;G01R31/31719;;H01L2223/54473;;H01L23/573;;H01L2223/54486;;H01L2223/54406;;G01R31/31718;;G01R31/2896;;H01L23/544;;H01L2223/54413;;H01L2924/0002,G01R31/28,324/158.1,0,0,,,,DISCONTINUED
100,WO,A1,WO 2007/012816 A1,123-028-236-329-991,2007-02-01,2007,GB 2006002689 W,2006-07-19,GB 0515460 A;;US 70273205 P,2005-07-27,VERIFICATION OF AUTHENTICITY,"An article identification method can comprise: determining a signature from an article based upon an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method can also comprise splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/123-028-236-329-991,Patent Application,yes,3,12,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,G07D7/12;;G06V10/28;;G06V10/40;;G06V10/42;;G07D7/20,,1,1,046-032-889-977-057,10.1016/s0030-4018(97)00546-4,"HAIST T ET AL: ""Optical detection of random features for high security applications"", OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173 - 179, XP004118061, ISSN: 0030-4018",PENDING
101,KR,A,KR 20080043317 A,117-722-812-410-396,2008-05-16,2008,KR 20087004721 A,2006-07-19,GB 0515460 A;;US 70273205 P;;GB 2006002689 W,2005-07-27,VERIFICATION OF AUTHENTICITY,"determining a signature from an article based upon an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method can also comprise splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/117-722-812-410-396,Patent Application,no,0,0,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,G06V10/28;;G07D7/20;;G06V10/40;;G06V10/42;;H04L9/00,,0,0,,,,INACTIVE
102,GB,A,GB 2434442 A,014-100-204-348-970,2007-07-25,2007,GB 0600828 A,2006-01-16,GB 0600828 A,2006-01-16,Verification of performance attributes of packaged integrated circuits,"Packaged integrated circuits (ICs) of some types, such as processors, are graded and sold according to a performance scale, such as maximum specified clock speed, set by the manufacturer as a result of testing. As a record of this grading some part of the package, usually the upper surface, is marked with the specified performance attribute. However, criminal activity has developed where the packaging is relabelled to show a higher specification so the ICs can be fraudulently resold at a higher price. To address this problem, the invention envisages that manufacturers maintaining a product database for each packaged IC which logs not only the performance specification, but also a digital signature derived from a speckle pattern obtained horn the packaging. Subsequently, any packaged IC can be rescanned to interrogate its speckle pattern and recompute the signature. The signature is then used to find the product in the database, whereby the originally specified performance attribute is retrieved. The fraud is then detectable. This method can be used to test products returned under a warranty claim, for example.",INGENIA HOLDINGS,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/014-100-204-348-970,Patent Application,no,3,6,6,6,0,G01R31/2896;;G01R31/31718;;G01R31/31719;;H01L23/544;;H01L23/573;;H01L2223/54406;;H01L2223/54413;;H01L2223/54473;;H01L2223/54486;;H01L2924/0002;;G01R31/311;;G01R31/31719;;H01L2223/54473;;H01L23/573;;H01L2223/54486;;H01L2223/54406;;G01R31/31718;;G01R31/2896;;H01L23/544;;H01L2223/54413;;H01L2924/0002,G06K7/10;;G01R31/311,G1A AMHL          MHL;;G1A AR7           MHL;;G1A AT21          MHL;;G1A AT3           MHL;;G4H HJ            HJ,0,0,,,,DISCONTINUED
103,AU,A1,AU 2006/245550 A1,042-584-117-524-576,2006-11-16,2006,AU 2006/245550 A,2006-05-05,GB 0509635 A;;GB 2006001646 W,2005-05-11,Authenticity verification by means of optical scattering,,INGENIA TECH LIMITED,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/042-584-117-524-576,Patent Application,no,0,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B11/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,0,0,,,,DISCONTINUED
104,BR,A2,BR 112012011120 A2,074-019-042-970-465,2016-07-05,2016,BR 112012011120 A,2010-11-04,GB 2010051844 W;;GB 0919664 A;;US 25994609 P,2009-11-10,"método para implementar um sistema para autenticação de um artigo, e, sistema para autenticação de um artigo","""método para implementar um sistema para autenticação de um artigo, e, sistema para autenticação de um artigo"" é descrito um método para implementar um sistema para autenticação de um artigo com base na assinatura gerada a partir de um conjunto compreendendo grupos de pontos de dados coletados quando uma pluralidade de regiões de uma estrutura de superfície intrínseca de um artigo são sequencialmente submetidas a luz coerente e a luz dispersa pela estrutura de superfície intrínseca é coletada. para uma dada implementação de sistema, o método compreende: determinar um conjunto de parâmetros que influência o desempenho do sistema; determinar uma definição de desempenho do sistema que pode ser afetada pelo conjunto de parâmetros; produzir uma população inicial de conjunto de valores de parâmetro, cada conjunto de parâmetro incluindo um valor para cada parâmetro a ser usado em alcançar um desempenho desejado do sistema; determinar para cada conjunto de valores de parâmetros um valor de conveniência em termos da definição de desempenho do sistema; identificar pares correspondentes da população de acordo com as conveniências determinadas; produzindo uma nova população cruzando os pares correspondentes; repetindo a determinação de um valor de conveniência para cada conjunto de valores de parâmetro, identificando os pares correspondentes e produzindo uma nova população até um critério final ser satisfeito; e configurar o sistema de acordo com um selecionado um dos conjuntos de parâmetros a partir da população final. e por meio disso, uma abordagem flixível e apropriada para implementação de sistema pode se seguida que fornece alta eficiência em termos da introdução do tempo humano e que fornece valores de parâmetro de configuraçaõ de alta qualidade confiáveis para permitir resultar em uma implementação de sistema eficiente e confiável.",INGENIA HOLDINGS LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN PAUL RUSSELL,INGENIA HOLDINGS LIMITED (VG) (2017-05-30),https://lens.org/074-019-042-970-465,Patent Application,no,0,0,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G06Q10/00;;G06V10/70;;G07D7/20,,0,0,,,,DISCONTINUED
105,WO,A2,WO 2007/012814 A2,079-795-128-512-928,2007-02-01,2007,GB 2006002686 W,2006-07-19,GB 0515465 A;;US 70289705 P,2005-07-27,ACCESS,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/079-795-128-512-928,Patent Application,yes,0,5,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;G06F21/33;;G06F21/34;;G06K19/14;;G06V10/42;;G06V20/80;;G07D7/12,,0,0,,,,PENDING
106,EP,A1,EP 1907963 A1,100-646-717-834-909,2008-04-09,2008,EP 06765038 A,2006-07-20,GB 2006002708 W;;GB 0515464 A;;US 70274605 P,2005-07-27,PRESCRIPTION AUTHENTICATION USING SPECKLE PATTERNS,,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2010-03-24),https://lens.org/100-646-717-834-909,Patent Application,yes,2,0,7,11,0,G06Q10/10;;G16H10/60;;G16H40/63;;G16H40/67;;G16H20/13;;G06V20/80;;G06Q10/10;;G16H10/60;;G16H20/13;;G16H40/63;;G16H40/67;;G06V20/80,G06Q10/10;;G16H20/13;;G16H40/63;;G16H40/67,,5,0,,,"COWBURN; RUSSELL: ""Nanotechnology- Security and Brand Protection Applications 01"", SMART BRAND AND PRODUCT PROTECTION CONFERENCE 2005, 8 April 2005 (2005-04-08) - 9 April 2005 (2005-04-09), London, UK, pages 1 - 4, XP007904742;;VAN RENESSE R.L.: ""Optical inspection techniques for security instrumentation"", PROC SPIE INT SOC OPT ENG; PROCEEDINGS OF SPIE - THE INTERNATIONAL SOCIETY FOR OPTICAL ENGINEERING, vol. 2659, March 1996 (1996-03-01), pages 159 - 167;;ANONYMOUS: ""Discs and paper get biometric identifiers"", IEE REVIEW, vol. 50, no. 12, December 2004 (2004-12-01), pages 23 - 23;;WILKES; SALLY: ""FIGHTING FRAUD: DOCUMENT BIOMETRICS"", MATERIALS WORLD, vol. 12, no. 12, December 2004 (2004-12-01), pages 29 - 30, XP009073167;;See also references of WO 2007012820A1",DISCONTINUED
107,AR,A1,AR 059011 A1,104-883-464-292-762,2008-03-05,2008,AR P070100162 A,2007-01-15,GB 0600828 A,2006-01-16,VERIFICACION DE ATRIBUTOS DE DESEMPENO DE CIRCUITOS INTEGRADOS EMPAQUETADOS,"Los circuitos integrados empaquetados (ICs) de algunos tipos, como ser procesadores, se clasifican y venden de acuerdo con una escala de desempeno, como ser la velocidad de reloj especificada máxima, que establece el fabricante como resultado de una prueba. Como registro de esta clasificacion algunas partes del envase, frecuentemente la superficie superior, se marca con un atributo de desempeno especificado. Sin embargo la actividad criminal desarrollo el lugar donde el envase se reetiqueta con el fin de mostrar una especificacion superior de modo tal que los ICs pueden revenderse fraudulentamente a un precio mayor. Con el fin de tratar este problema, la presente prevé que los fabricantes mantengan una base de datos de producto para cada IC empaquetado donde se registre no solo la especificacion de desempeno, sino también una firma digital que deriva de un diseno granulado que se obtiene del envase. Posteriormente, cualquier lC empaquetado se puede reescanear con el fin de interrogar su diseno granulado y recomputar la firma. Luego, la firma se utiliza para encontrar el producto en la base de datos, a través de lo cual, se recupera el atributo de desempeno especificado originariamente. Luego, se puede detectar el fraude. Este método se puede utilizar con el fin de probar los productos que se devuelven, por ejemplo, tras un reclamo por garantía.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/104-883-464-292-762,Patent Application,no,0,0,6,6,0,G01R31/2896;;G01R31/31718;;G01R31/31719;;H01L23/544;;H01L23/573;;H01L2223/54406;;H01L2223/54413;;H01L2223/54473;;H01L2223/54486;;H01L2924/0002;;G01R31/311;;G01R31/31719;;H01L2223/54473;;H01L23/573;;H01L2223/54486;;H01L2223/54406;;G01R31/31718;;G01R31/2896;;H01L23/544;;H01L2223/54413;;H01L2924/0002,,,0,0,,,,DISCONTINUED
108,GB,B,GB 2428846 B,154-183-205-601-344,2008-08-13,2008,GB 0515464 A,2005-07-27,GB 0515464 A,2005-07-27,Prescription Authentication,,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/154-183-205-601-344,Granted Patent,no,4,0,4,11,0,G06K19/14;;G16H20/13;;G16H20/13,G06K19/14;;G06F19/00,,0,0,,,,INACTIVE
109,CN,A,CN 101258528 A,187-955-467-925-378,2008-09-03,2008,CN 200680032538 A,2006-07-19,GB 2006002689 W;;GB 0515460 A;;US 70273205 P,2005-07-27,Authenticity verification,"An article identification method can comprise: determining a signature from an article based upon an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method can also comprise splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA TECHNOLOGY LTD,RALPH BUCHANAN JAMES DAVID;;PAUL COWBURN RUSSELL,"ENGENYA HOLDINGS CO., LTD. (2010-04-13)",https://lens.org/187-955-467-925-378,Patent Application,no,0,2,7,22,0,G07D7/004;;G06K7/10;;G06K19/10,G07D7/12;;G07D7/20,,0,0,,,,INACTIVE
110,WO,A3,WO 2007/012813 A3,024-174-394-719-473,2007-05-31,2007,GB 2006002685 W,2006-07-19,GB 0515463 A;;US 70274205 P,2005-07-27,CRYPTOGRAPHIC KEY DISTRIBUTION,"A key distribution system can comprise a key packaging unit operable to package a key using a signature based upon an intrinsic property of a security token, a channel operable to have the packaged key transmitted therethrough; and a key unpacking unit operable to unpack the key using a signature based upon the intrinsic property of the security token. Thereby the key can be transmitted via a non-secure channel to a recipient for use thereby, without it being possible for a third party to obtain a copy of the key by monitoring the channel.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/024-174-394-719-473,Search Report,yes,1,0,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,G07F7/10;;H04L9/08,,3,1,013-750-169-137-892,16049465;;10.1038/436475a,"BUCHANAN, RP COWBURN, AV JAUSOVEC, D PETIT, P SEEM, G XIONG, D ATKINSON, K FENTON, D A ALLWOOD, M T BRYAN: ""'Fingerprinting' documents and packaging"", NATURE, vol. 436, 28 July 2005 (2005-07-28), pages 475, XP002422977;;J R SMITH, A V SUTHERLAND: ""Microstructure Based Indicia"", LABORATORIES ESCHER GROUP, 1999, Cambridge, MA 02142, USA, pages 1 - 5, XP002422978, Retrieved from the Internet <URL:http://web.media.mit.edu/~jrs/jrs_microstructure.pdf> [retrieved on 20070301];;R S PAPPU: ""Physical One-Way Functions"", RSA LABORATORIES, CRYPTOBYTES, vol. 6, no. 2, August 2003 (2003-08-01), pages 21 - 32, XP002422979",PENDING
111,GB,B,GB 2429097 B,030-922-869-524-02X,2008-10-29,2008,GB 0515462 A,2005-07-27,GB 0515462 A,2005-07-27,Verification,,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/030-922-869-524-02X,Granted Patent,no,3,0,5,12,0,G06K19/14;;G07D7/004,G06K19/14,,0,0,,,,INACTIVE
112,TW,A,TW 200723145 A,156-830-443-242-018,2007-06-16,2007,TW 95127165 A,2006-07-25,GB 0515464 A;;US 70274605 P,2005-07-27,Prescription authentication,"The invention relates to a system 100 for verifying the authenticity of medicament entitlement tokens, such as prescriptions 102, used to control the dispensing of medicaments. The system comprises a network 104 connecting at least one token provider terminal 106, a system server 120 and a verification terminal 130. The token provider terminal 106 is operable to provide a signature from a speckle pattern derived from a medicament entitlement token that can be stored by the server system 120. The verification terminal 130 can then be operated remotely to recreate the signature in order to verify the authenticity of the medicament entitlement token by comparing it to stored signatures. The system 100 relies upon the intrinsic physical properties of the medicament entitlement token to generate a unique signature for each token that is produced. This makes the medicament entitlement tokens themselves very difficult to forge. Moreover, the signatures transmitted over the network do not need to contain any details relating to the content of the medicament entitlement tokens, such as patient data, hence signature data stored by the system can be made privacy neutral so that even if it were to be intercepted or copied this would not compromise confidentiality.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/156-830-443-242-018,Patent of Addition,no,0,0,7,11,0,G06Q10/10;;G16H10/60;;G16H40/63;;G16H40/67;;G16H20/13;;G06V20/80;;G06Q10/10;;G16H10/60;;G16H20/13;;G16H40/63;;G16H40/67;;G06V20/80,G06Q10/00;;G06K19/00;;G06Q10/10;;G06Q50/00;;G16H20/13;;G16H40/63;;G16H40/67;;H04L9/00,,0,0,,,,PENDING
113,EP,A2,EP 1908212 A2,159-534-770-574-047,2008-04-09,2008,EP 06765020 A,2006-07-19,GB 2006002685 W;;GB 0515463 A;;US 70274205 P,2005-07-27,KEYS,,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES D R;;COWBURN RUSSELL P,,https://lens.org/159-534-770-574-047,Patent Application,yes,0,0,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,H04L9/08,,1,0,,,See references of WO 2007012813A3,DISCONTINUED
114,WO,A1,WO 2007/080375 A1,002-013-168-482-943,2007-07-19,2007,GB 2007000015 W,2007-01-03,GB 0600828 A;;US 76187006 P,2006-01-16,VERIFICATION OF PERFORMANCE ATTRIBUTES OF PACKAGED INTEGRATED CIRCUITS,"Packaged integrated circuits (ICs) of some types, such as processors, are graded and sold according to a performance scale, such as maximum specified clock speed, set by the manufacturer as a result of testing. As a record of this grading some part of the package, usually the upper surface, is marked with the specified performance attribute. However, criminal activity has developed where the packaging is relabelled to show a higher specification so the ICs can be fraudulently resold at a higher price. To address this problem, the invention envisages that manufacturers maintaining a product database for each packaged IC which logs not only the performance specification, but also a digital signature derived from a speckle pattern obtained from the packaging. Subsequently, any packaged IC can be rescanned to interrogate its speckle pattern and recompute the signature. The signature is then used to find the product in the database, whereby the originally specified performance attribute is retrieved. The fraud is then detectable. This method can be used to test products returned under a warranty claim, for example.",INGENIA HOLDINGS UK LTD;;COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/002-013-168-482-943,Patent Application,yes,5,6,6,6,0,G01R31/2896;;G01R31/31718;;G01R31/31719;;H01L23/544;;H01L23/573;;H01L2223/54406;;H01L2223/54413;;H01L2223/54473;;H01L2223/54486;;H01L2924/0002;;G01R31/311;;G01R31/31719;;H01L2223/54473;;H01L23/573;;H01L2223/54486;;H01L2223/54406;;G01R31/31718;;G01R31/2896;;H01L23/544;;H01L2223/54413;;H01L2924/0002,H01L23/544,,0,0,,,,PENDING
115,MY,A,MY 142697 A,011-084-422-582-38X,2010-12-30,2010,MY PI20063533 A,2006-07-25,GB 0515463 A;;US 70274205 P,2005-07-27,KEYS,"KEYS 5 A KEY DISTRIBUTION SYSTEM CAN COMPRISE A KEY PACKAGING UNIT OPERABLE TO PACKAGE A KEY USING A SIGNATURE BASED UPON AN INTRINSIC PROPERTY OF A SECURITV TOKEN, A CHANNEL OPERABLE TO HAVE THE PACKAGED KEY TRANSMITTED THERETHIOUGH; AND A KEY UNPACKING UNIT OPERABLE TO UNPACK THE KEY USING A SIGNATURE BASED UPON THE INTRINSIC PROPERTY OF THE SECURITY TOKEN. THEREBY THE KEY CAN BE TRANSMITTED VIA A NON-SECURE 10 CHANNEL TO A RECIPIENT FOR USE THEREBY, WITHOUT IT BEING POSSIBLE FOR A THIRD PARTY TO OBTAIN A COPY OF THE KEY BY MONITORING THE CHANNEL. C_ 1,00(JS 33 @CQIO 6",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;RALPH BUCHANAN JAMES DAVID,,https://lens.org/011-084-422-582-38X,Granted Patent,no,0,0,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,H04L9/08,,0,0,,,,ACTIVE
116,EP,A3,EP 2110776 A3,122-789-413-171-663,2010-04-07,2010,EP 09165454 A,2006-12-22,EP 06831458 A;;GB 0526662 A;;GB 0526422 A;;GB 0607867 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. The apparatus can utilise a camera to ensure that article alignment within the reading volume is such as to provide for reliable signature generation for comparison purposes.
",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL PAUL;;SEEM PETER;;BUCHANAN JAMES,INGENIA HOLDINGS LIMITED (2012-10-24),https://lens.org/122-789-413-171-663,Search Report,yes,3,0,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G03G21/04;;G06V10/141;;G06V10/147;;G06V10/42;;G07D7/12,,2,2,013-750-169-137-892;;046-032-889-977-057,16049465;;10.1038/436475a;;10.1016/s0030-4018(97)00546-4,"BUCHANAN J D R ET AL: ""'Fingerprinting' documents and packaging"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 436, 28 July 2005 (2005-07-28), pages 475, XP002405507, ISSN: 0028-0836;;HAIST T ET AL: ""Optical detection of random features for high security applications"", OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173 - 179, XP004118061, ISSN: 0030-4018",ACTIVE
117,GB,B,GB 2429095 B,137-436-044-798-460,2008-08-13,2008,GB 0515460 A,2005-07-27,GB 0515460 A,2005-07-27,Verification of authenticity,"An article identification method comprises: determining a signature from an article based upon an intrinsic characteristic of the article comparing the determined signature to a stored signature, splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/137-436-044-798-460,Granted Patent,no,3,0,7,22,0,G07D7/004;;G06K7/10;;G06K19/10,G06K19/10;;G06K7/10,,0,0,,,,INACTIVE
118,MY,A,MY 141899 A,021-731-044-847-803,2010-07-16,2010,MY PI20063567 A,2006-07-26,GB 0515461 A;;US 70294605 P,2005-07-27,AUTHENTICITY VERIFICATION,"A METHOD FOR AUTHENTICITY VERIFICATION. THE METHOD CAN COMPRISE CONDUCTING A TRANSACTION BETWEEN FIRST AND SECOND PARTIES, THE PARTIES BEING RESPECTIVELY LOCATED AT FIRS AND SECOND LOCATIONS REMOTE ONE-ANOTHER, THE OUTCOME OF THE TRANSACTION BEING THE TRANSFER OF TITLE TO GOODS AND/OR SERVICES FROM THE FIRST PARTY TO THE SECOND PARTY. DATA DESCRIBING A VALUE ENTITLEMENT TOKEN OF THE SECOND PARTY CAN BE CAPTURED TO CREATE A SIGNATURE FOR THE VALUE ENTITLEMENT TOKEN, THE SIGNATURE BEING BASED UPON AN INTRINSIC PROPERTY OF THE VALUE ENTITLEMENT TOKEN. THE SIGNATURE CAN BE TRANSMITTED FROM THE SECOND PARTY TO A THIRD PARTY WHICH CAN COMPARE THE SIGNATURE TO A DATABASE OF STORED SIGNATURE! (204). A VALIDATION RESULT INDICATING WHETHER THE VALUE ENTITLEMENT TOKEN CORRESPONDS TO A VALUE ENTITLEMENT TOKEN SIGNATURE IN THE DATABASE (204) CAN BE TRANSMITTED FROM THE THIN PARTY TO THE FIRST PARTY.",INGENIA HOLDINGS LTD,COWBURN RUSSELL P;;RALPH BUCHANAN JAMES DAVID,,https://lens.org/021-731-044-847-803,Granted Patent,no,0,0,7,11,0,G06Q20/04;;G06Q20/042;;G06Q20/3674;;G06Q20/40;;G06Q20/4014;;G06V20/80;;G06Q20/04;;G06Q20/042;;G06Q20/4014;;G06Q20/40;;G06Q20/3674;;G06V20/80,G06K19/14,,0,0,,,,ACTIVE
119,GB,A,GB 2428846 A,032-410-943-183-096,2007-02-07,2007,GB 0515464 A,2005-07-27,GB 0515464 A,2005-07-27,Prescription authentication utilising networked system,"The invention relates to a system 100 for verifying the authenticity of medicament entitlement tokens, such as prescriptions 102, used to control the dispensing of medicaments. The system comprises a network 104 connecting at least one token provider terminal 106, a system server 120 and a verification terminal 130. The token provider terminal 106 is operable to provide a signature from a speckle pattern derived from a medicament entitlement token that can be stored by the server system 120. The verification terminal 130 can then be operated remotely to recreate the signature in order to verify the authenticity of the medicament entitlement token by comparing it to stored signatures. The system 100 relies upon the intrinsic physical properties of the medicament entitlement token to generate a unique signature for each token that is produced. This makes the medicament entitlement tokens themselves very difficult to forge. Moreover, the signatures transmitted over the network do not need to contain any details relating to the content of the medicament entitlement tokens, such as patient data, hence signature data stored by the system can be made privacy neutral so that even if it were to be intercepted or copied this would not compromise confidentiality.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/032-410-943-183-096,Patent Application,no,4,5,4,11,0,G06K19/14;;G16H20/13;;G16H20/13,G06K19/14;;G06F19/00,G4M MB4           MCA;;G4M MCA           MCA;;NOT CLASSIFIED    NONE,0,0,,,,INACTIVE
120,CN,B,CN 101263530 B,054-049-129-189-980,2011-01-12,2011,CN 200680033084 A,2006-07-20,GB 2006002716 W;;GB 0515462 A;;US 70435405 P,2005-07-27,Verification of the an article,"An article verification system can comprise a first scanner operable to scan an article to create a signature based upon an intrinsic characteristic of the article and a comparator operable to compare the created signature to a plurality of stored signatures created from previous scans of a plurality of articles. More than one stored signature can be associated with each article, each signature for each article being associated with a respective different portion of each article to the other signatures for that article. Thus the system provides for an article to be checked against multiple records of that article. In some examples, a single match between the later scan and a stored record can be used to positively verify the article.",INGENIA HOLDINGS LTD,COWBURN RUSSELL P;;RALPH BUCHANAN JAMES DAVID,"ENGENYA HOLDINGS CO., LTD. (2010-04-13)",https://lens.org/054-049-129-189-980,Granted Patent,no,0,0,5,12,0,G06K19/14;;G07D7/004,G07D7/12,,0,0,,,,INACTIVE
121,MY,A,MY 148622 A,026-206-288-706-982,2013-05-15,2013,MY PI20063530 A,2006-07-25,GB 0515462 A;;US 70435405 P,2005-07-27,VERIFICATION,"AN ARTICLE VERIFICATION SYSTEM CAN COMPRISE A FIRST SCANNER OPERABLE TO SCAN AN ARTICLE TO CREATE A SIGNATURE BASED UPON AN INTRINSIC CHARACTERISTIC OF THE ARTICLE AND A COMPARATOR OPERABLE TO COMPARE THE CREATED SIGNATURE TO A PLURALITY OF STORED SIGNATURES CREATED FROM PREVIOUS SCANS OF A PLURALITY OF ARTICLES (62). MORE THAN ONE STORED SIGNATURE CAN BE ASSOCIATED WITH EACH ARTICLE, EACH SIGNATURE FOR EACH ARTICLE BEING ASSOCIATED WITH A RESPECTIVE DIFFERENT PORTION OF EACH ARTICLE TO THE OTHER SIGNATURES FOR THAT ARTICLE. THUS THE SYSTEM PROVIDES FOR AN ARTICLE TO BE CHECKED AGAINST MULTIPLE RECORDS OF THAT ARTICLE. IN SOME EXAMPLES, A SINGLE MATCH BETWEEN THE LATER SCAN AND A STORED RECORD CAN BE USED TO POSITIVELY VERIFY THE ARTICLE.",INGENIA HOLDINGS LTD,COWBURN RUSSELL P;;RALPH BUCHANAN JAMES DAVID,,https://lens.org/026-206-288-706-982,Granted Patent,no,0,0,7,12,0,G07D7/121;;G07D7/003;;G06V20/80;;G06V10/145;;G06V10/42;;G07D7/121;;G07D7/003;;G06V10/42;;G06V10/145;;G06V20/80,G06K19/14;;G06V10/145;;G06V10/42,,0,0,,,,ACTIVE
122,CN,A,CN 102770889 A,067-338-745-688-591,2012-11-07,2012,CN 201080057837 A,2010-11-04,GB 2010051844 W;;GB 0919664 A;;US 25994609 P,2009-11-10,Optimisation,"There is described a method for implementing a system for authentication of an article based upon a signature generated from a set comprising groups of data points collected when a plurality of regions of an intrinsic surface structure of an article are sequentially subjected to coherent light and the light scattered by the intrinsic surface structure is collected. For a given system implementation, the method comprises: determining a set of parameters which influence the performance of the system; determining a definition of system performance which can be affected by the set of parameters; producing an initial population of parameter value sets, each parameter set including a value for each parameter to be used in achieving a desired system performance; determining for each parameter value set a fitness value in terms of the system performance definition; identifying mating pairs of the population in accordance with the determined fitnesses; producing a new population by crossing the mating pairs; repeating the determining of a fitness value for each parameter value set, identifying of mating pairs and producing a new population until an end criterion is satisfied; and configuring the system in accordance with a selected one of the parameter sets from the final population. Thereby, a flexible and appropriate approach to system implementation can be followed which provides high efficiency in terms of the human time input and which provides high quality reliable setup parameter values to enable a reliable and efficient system implementation to result.",INGENIA HOLDINGS LTD,PAUL COWBURN RUSSELL;;RALPH BUCHANAN JAMES DAVID,,https://lens.org/067-338-745-688-591,Patent Application,no,3,1,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G07D7/20;;G06V10/70,,0,0,,,,DISCONTINUED
123,TW,A,TW 200718145 A,113-530-259-689-851,2007-05-01,2007,TW 95127167 A,2006-07-25,GB 0515463 A;;US 70274205 P,2005-07-27,Keys,"A key distribution system can comprise a key packaging unit operable to package a key using a signature based upon an intrinsic property of a security token, a channel operable to have the packaged key transmitted therethrough; and a key unpacking unit operable to unpack the key using a signature based upon the intrinsic property of the security token. Thereby the key can be transmitted via a non-secure channel to a recipient for use thereby, without it being possible for a third party to obtain a copy of the key by monitoring the channel.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/113-530-259-689-851,Patent of Addition,no,0,1,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,H04L9/08;;H04L9/28,,0,0,,,,PENDING
124,US,A1,US 2007/0027819 A1,039-484-275-797-880,2007-02-01,2007,US 46054406 A,2006-07-27,US 46054406 A;;GB 0515461 A;;US 70294605 P,2005-07-27,Authenticity Verification,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the transfer of title to goods and/or services from the first party to the second party. Data describing a value entitlement token of the second party can be captured to create a signature for the value entitlement token, the signature being based upon an intrinsic property of the value entitlement token. The signature can be transmitted from the second party to a third party which can compare the signature to a database of stored signatures. A validation result indicating whether the value entitlement token corresponds to a value entitlement token signature in the database can be transmitted from the third party to the first party.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,INGENIA HOLDINGS (UK) LIMITED (2006-11-11);;INGENIA HOLDINGS LIMITED (2009-08-14);;INGENIA TECHNOLOGY LIMITED (2008-08-06),https://lens.org/039-484-275-797-880,Patent Application,yes,57,51,7,11,0,G06Q20/04;;G06Q20/042;;G06Q20/3674;;G06Q20/40;;G06Q20/4014;;G06V20/80;;G06Q20/04;;G06Q20/042;;G06Q20/4014;;G06Q20/40;;G06Q20/3674;;G06V20/80,G06Q99/00,705/67,0,0,,,,DISCONTINUED
125,GB,B,GB 2428948 B,027-755-105-520-682,2007-09-05,2007,GB 0515463 A,2005-07-27,GB 0515463 A,2005-07-27,Keys,,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/027-755-105-520-682,Granted Patent,no,5,0,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,H04L9/08,,0,0,,,,INACTIVE
126,EP,A2,EP 2110776 A2,044-532-801-187-367,2009-10-21,2009,EP 09165454 A,2006-12-22,EP 06831458 A;;GB 0526662 A;;GB 0526422 A;;GB 0607867 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. The apparatus can utilise a camera to ensure that article alignment within the reading volume is such as to provide for reliable signature generation for comparison purposes.
",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL PAUL;;SEEM PETER;;BUCHANAN JAMES,INGENIA HOLDINGS LIMITED (2012-10-24),https://lens.org/044-532-801-187-367,Patent Application,yes,6,2,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G03G21/04;;G06V10/141;;G06V10/147;;G06V10/42;;G07D7/12,,3,1,013-750-169-137-892,16049465;;10.1038/436475a,"R ANDERSON: ""Plastic tag makes foolproof ID"", TECHNOLOGY RESEARCH NEWS, 2 October 2002 (2002-10-02);;R ANDERSON: ""Security Engineering: a guide to building dependable distributed systems"", 2001, WILEY, pages: 251 - 252;;JAMES D. R. BUCHANAN ET AL.: ""Forgery: 'Fingerprinting' documents and packaging"", NATURE, vol. 436, 28 July 2005 (2005-07-28), pages 475 - 475",ACTIVE
127,GB,B,GB 2429096 B,065-717-951-299-084,2008-11-05,2008,GB 0515461 A,2005-07-27,GB 0515461 A,2005-07-27,Authenticity verification,,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/065-717-951-299-084,Granted Patent,no,6,0,4,11,0,G06K19/14;;G06Q20/4014;;G06Q20/02;;G06Q20/12;;G07C9/24,G06K19/14;;G06Q20/00;;G07C9/00,,0,0,,,,INACTIVE
128,WO,A1,WO 2007/012815 A1,076-224-045-249-564,2007-02-01,2007,GB 2006002688 W,2006-07-19,GB 0515461 A;;US 70294605 P,2005-07-27,AUTHENTICITY VERIFICATION,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the transfer of title to goods and/or services from the first party to the second party. Data describing a value entitlement token of the second party can be captured to create a signature for the value entitlement token, the signature being based upon an intrinsic property of the value entitlement token. The signature can be transmitted from the second party to a third party which can compare the signature to a database of stored signatures. A validation result indicating whether the value entitlement token corresponds to a value entitlement token signature in the database can be transmitted from the third party to the first party.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/076-224-045-249-564,Patent Application,yes,4,3,7,11,0,G06Q20/04;;G06Q20/042;;G06Q20/3674;;G06Q20/40;;G06Q20/4014;;G06V20/80;;G06Q20/04;;G06Q20/042;;G06Q20/4014;;G06Q20/40;;G06Q20/3674;;G06V20/80,G07D7/12;;G07F7/08,,1,0,,,See also references of EP 1908028A1,PENDING
129,TW,A,TW 200737015 A,087-536-027-612-202,2007-10-01,2007,TW 95127170 A,2006-07-25,GB 0515460 A;;US 70273205 P,2005-07-27,Verification of authenticity,"An article identification method can comprise: determining a signature from an article based upon an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method can also comprise splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/087-536-027-612-202,Patent of Addition,no,0,1,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,G01B11/24;;G06K5/00;;G06K17/00;;G06K19/14;;G06V10/28;;G06V10/40;;G06V10/42;;G07D7/20;;G07F7/12,,0,0,,,,PENDING
130,US,A1,US 2012/0246159 A1,087-974-153-946-158,2012-09-27,2012,US 201013505424 A,2010-11-04,US 201013505424 A;;GB 0919664 A;;US 25994609 P;;GB 2010051844 W,2009-11-10,OPTIMISATION,"There is described a method for implementing a system for authentication of an article based upon a signature generated from a set comprising groups of data points collected when a plurality of regions of an intrinsic surface structure of an article are sequentially subjected to coherent light and the light scattered by the intrinsic surface structure is collected. For a given system implementation, the method comprises: determining a set of parameters which influence the performance of the system; determining a definition of system performance which can be affected by the set of parameters; producing an initial population of parameter value sets, each parameter set including a value for each parameter to be used in achieving a desired system performance; determining for each parameter value set a fitness value in terms of the system performance definition; identifying mating pairs of the population in accordance with the determined fitnesses; producing a new population by crossing the mating pairs; repeating the determining of a fitness value for each parameter value set, identifying of mating pairs and producing a new population until an end criterion is satisfied; and configuring the system in accordance with a selected one of the parameter sets from the final population. Thereby, a flexible and appropriate approach to system implementation can be followed which provides high efficiency in terms of the human time input and which provides high quality reliable setup parameter values to enable a reliable and efficient system implementation to result.",COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2012-05-30),https://lens.org/087-974-153-946-158,Patent Application,yes,1,1,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G06F17/30;;G06V10/70,707/736;;X707E17005,0,0,,,,INACTIVE
131,GB,A,GB 2429096 A,146-181-918-801-46X,2007-02-14,2007,GB 0515461 A,2005-07-27,GB 0515461 A,2005-07-27,Online authenticity verification utilising third party,"A method for conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the transfer of title to goods and/or services from the first party to the second party. Data describing a value entitlement token of the second party can be captured to create a signature for the value entitlement token, the signature being based upon an intrinsic property of the value entitlement token. The signature can be transmitted from the second party to a third party which can compare the signature to a database of stored signatures. A validation result indicating whether the value entitlement token corresponds to a value entitlement token signature in the database can be transmitted from the third party to the first party.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/146-181-918-801-46X,Patent Application,no,5,5,4,11,0,G06K19/14;;G06Q20/4014;;G06Q20/02;;G06Q20/12;;G07C9/24,G06K19/14;;G06Q20/00;;G07C9/00,G4M MB4           MCA;;G4M MCA           MCA;;NOT CLASSIFIED    NONE,0,0,,,,INACTIVE
132,JP,A,JP 2013012227 A,018-643-389-943-472,2013-01-17,2013,JP 2012191136 A,2012-08-31,GB 0515460 A;;US 70273205 P,2005-07-27,VERIFICATION OF AUTHENTICITY,"PROBLEM TO BE SOLVED: To realize higher level subdivision in verifying an article.SOLUTION: A method comprises the steps of: determining a signature from an article on the basis of an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method also comprises the steps of: splitting the determined signature into blocks of contiguous data; performing a comparison operation between each block and respective blocks of the stored signature; and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to calculate a compensation value for use in determining a comparison result. The method further comprises the step of determining a similarity result between the determined signature and the stored signature by using the compensation value to adjust the determined signature. An article damaged by stretching or shrinking can be identified, and a non-linear signature determination can be accommodated without losing identification accuracy.",ENGINEER TECHNOLOGY UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/018-643-389-943-472,Patent Application,no,10,1,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,G06K7/00;;G06K17/00;;G06V10/28;;G06V10/40;;G06V10/42,,0,0,,,,INACTIVE
133,WO,A2,WO 2007/012813 A2,022-931-134-636-017,2007-02-01,2007,GB 2006002685 W,2006-07-19,GB 0515463 A;;US 70274205 P,2005-07-27,KEYS,"A key distribution system can comprise a key packaging unit operable to package a key using a signature based upon an intrinsic property of a security token, a channel operable to have the packaged key transmitted therethrough; and a key unpacking unit operable to unpack the key using a signature based upon the intrinsic property of the security token. Thereby the key can be transmitted via a non-secure channel to a recipient for use thereby, without it being possible for a third party to obtain a copy of the key by monitoring the channel.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/022-931-134-636-017,Patent Application,yes,0,1,12,12,0,H04L9/0816;;H04L9/3247;;H04L9/3247;;H04K1/00;;H04K1/00;;H04L9/0825;;H04L9/0825;;H04L9/3231;;H04L9/3231;;H04L9/3234;;H04L9/3234;;H04L2209/34;;H04L2209/34,H04L9/08,,0,0,,,,PENDING
134,GB,A,GB 2429092 A,043-869-583-405-916,2007-02-14,2007,GB 0515465 A,2005-07-27,GB 0515465 A,2005-07-27,Access to data using a token with intrinsic signature,"Access to data is provided via a system which comprises a data record associated with a stored access token signature, and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property eg surface features giving rise to scatter of coherent radiation, of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record. A compensation valve may be determined between compared signatures to account for damage to the taken or variations in the signature generation. Rapid comparison may be effected by comparing thumbnails of signatures instead of complete signatures. Access may be effected over a network, including encrypting the signature prior to transmission.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/043-869-583-405-916,Patent Application,no,7,10,5,16,0,G06F21/35,G06F1/00;;G07C9/00,G4H HTG           TG;;G4H H14A          TG;;G4H H2P           TG,0,0,,,,INACTIVE
135,EP,A3,EP 2175396 A3,101-464-869-464-248,2010-08-11,2010,EP 10150648 A,2006-12-22,EP 06831458 A;;GB 0526662 A;;GB 0526422 A;;GB 0607867 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.
",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES;;SEEM PETER,,https://lens.org/101-464-869-464-248,Search Report,yes,0,0,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G03G21/04;;G06F17/30;;G06V10/141;;G06V10/147;;G06V10/42;;G07D7/12,,1,0,,,No Search,DISCONTINUED
136,US,A1,US 2023/0341489 A1,106-837-339-384-567,2023-10-26,2023,US 202217724667 A,2022-04-20,US 202217724667 A,2022-04-20,PET TRANSMISSION SOURCE BASED ON CONTINUOUS BED MOTION,"A method for generating transmission information in a time-of-flight positron emission tomography (PET) scanner having a patient tunnel and a plurality of PET detector rings. The PET scanner uses continuous bed motion to move a patient bed and patient through the patient tunnel. The patient receives a positron-emitting radioisotope dose prior to undergoing a PET scan. The method includes storing a positron-emitting radioisotope in a radiation shielded container. The method also includes moving the radioisotope into a stationary vessel located adjacent to the PET detectors and within a field of view of the PET scanner at substantially the same time that the patient receives the radioisotope dose to form a stationary transmission source wherein transmission information is generated while the bed undergoes continuous bed motion. Further, the method includes withdrawing the radioisotope from the vessel when the PET scan is complete and storing the radioisotope in the container.",SIEMENS MEDICAL SOLUTIONS USA INC,HAMILL JAMES;;TEIMOORISICHANI MOHAMMADREZA;;BUCHANAN CHARLES RUSSELL,SIEMENS MEDICAL SOLUTIONS USA INC (2022-04-14),https://lens.org/106-837-339-384-567,Patent Application,yes,6,0,1,1,0,G06T11/003;;G01R33/481;;G01T1/2985;;A61B6/4417;;A61B6/037;;A61B6/032;;A61B6/08;;A61B6/5235;;A61B6/035;;G01T1/1611;;G01R33/481;;A61B6/037;;A61B6/4417;;G06T11/003;;G06T2207/10088;;A61B6/0407;;G06T2207/10104;;A61B6/481;;G01R33/4812;;G01T1/2985;;A61B6/5235,G01R33/48;;A61B6/00;;A61B6/03;;A61B6/04;;G06T11/00,,2,0,,,"Mollet, Pieter, et al. ""Improvement of attenuation correction in time-of-flight PET/MR imaging with a positron-emitting source."" Journal of Nuclear Medicine 55.2 (2014): 329-336. (Year: 2014);;Mollet, Pieter, et al. ""Simultaneous MR-compatible emission and transmission imaging for PET using time-of-flight information."" IEEE transactions on medical imaging 31.9 (2012): 1734-1742. (Year: 2012)",PENDING
137,US,A1,US 2007/0028107 A1,114-255-755-183-57X,2007-02-01,2007,US 46054006 A,2006-07-27,US 46054006 A;;GB 0515464 A;;US 70274605 P,2005-07-27,Prescription Authentication,"The invention relates to a system 100 for verifying the authenticity of medicament entitlement tokens, such as prescriptions 102 , used to control the dispensing of medicaments. The system comprises a network 104 connecting at least one token provider terminal 106 , a system server 120 and a verification terminal 130 . The token provider terminal 106 is operable to provide a signature from a speckle pattern derived from a medicament entitlement token that can be stored by the server system 120 . The verification terminal 130 can then be operated remotely to recreate the signature in order to verify the authenticity of the medicament entitlement token by comparing it to stored signatures. The system 100 relies upon the intrinsic physical properties of the medicament entitlement token to generate a unique signature for each token that is produced. This makes the medicament entitlement tokens themselves very difficult to forge. Moreover, the signatures transmitted over the network do not need to contain any details relating to the content of the medicament entitlement tokens, such as patient data, hence signature data stored by the system can be made privacy neutral so that even if it were to be intercepted or copied this would not compromise confidentiality.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (2006-11-11);;INGENIA HOLDINGS (UK) LIMITED (2006-11-11);;INGENIA HOLDINGS LIMITED (2009-08-14);;INGENIA TECHNOLOGY LIMITED (2006-11-20),https://lens.org/114-255-755-183-57X,Patent Application,yes,46,42,7,11,0,G06Q10/10;;G16H10/60;;G16H40/63;;G16H40/67;;G16H20/13;;G06V20/80;;G06Q10/10;;G16H10/60;;G16H20/13;;G16H40/63;;G16H40/67;;G06V20/80,G06Q10/10;;G16H20/13;;G16H40/63;;G16H40/67;;H04L9/00,713/172;;705/2;;713/176,0,0,,,,DISCONTINUED
138,MX,A,MX 2007014105 A,155-923-920-301-76X,2008-02-05,2008,MX 2007014105 A,2006-05-05,GB 0509635 A;;GB 2006001646 W,2005-05-11,AUTHENTICITY VERIFICATION BY MEANS OF OPTICAL SCATTERING.,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the provision by the first party to the second party of the right to an entitlement token. Following the transaction outcome, data describing a written format for the entitlement token can be transmitted from the first party to the second party. The entitlement token can be written at the second location using the data describing the written format. The method can further comprise creating a first signature for the written entitlement token at the second location, the signature being based upon an intrinsic property of the written entitlement token, and storing the first signature in a signature database. Further, the method can comprise creating a second signature for the written entitlement token at a third location remote from the second location, the second signature being based upon the intrinsic property of the written entitlement token; and comparing attributes of the second signature with attributes of the first stored in the database to verify the authenticity of the written entitlement token.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/155-923-920-301-76X,Patent Application,no,0,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B11/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,0,0,,,,PENDING
139,ZA,B,ZA 200709628 B,004-259-177-326-718,2010-04-28,2010,ZA 200709628 A,2007-11-08,GB 0509635 A,2005-05-11,Authenticity verification by means of optical scattering,,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/004-259-177-326-718,Granted Patent,no,0,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,0,0,,,,ACTIVE
140,GB,A8,GB 2429092 A8,116-390-223-561-191,2007-02-28,2007,GB 0515465 A,2005-07-27,GB 0515465 A,2005-07-27,Access to data using a token with intrinsic signature,,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/116-390-223-561-191,Patent Application,no,0,0,5,16,0,G06F21/35,,G4H HTG           TG;;G4H H14A          TG;;G4H H2P           TG;;NOT CLASSIFIED    NONE,0,0,,,,INACTIVE
141,CA,A1,CA 2608063 A1,135-866-735-613-434,2006-11-16,2006,CA 2608063 A,2006-05-05,GB 0509635 A;;GB 2006001646 W,2005-05-11,AUTHENTICITY VERIFICATION BY MEANS OF OPTICAL SCATTERING,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the provision by the first party to the second party of th e right to an entitlement token. Following the transaction outcome, data describing a written format for the entitlement token can be transmitted fro m the first party to the second party. The entitlement token can be written at the second location using the data describing the written format. The method can further comprise creating a first signature for the written entitlement token at the second location, the signature being based upon an intrinsic property of the written entitlement token, and storing the first signature i n a signature database. Further, the method can comprise creating a second signature for the written entitlement token at a third location remote from the second location, the second signature being based upon the intrinsic property of the written entitlement token; and comparing attributes of the second signature with attributes of the first stored in the database to veri fy the authenticity of the written entitlement token.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/135-866-735-613-434,Patent Application,no,0,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B11/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,0,0,,,,DISCONTINUED
142,US,A1,US 2007/0028108 A1,173-966-647-975-490,2007-02-01,2007,US 46054606 A,2006-07-27,US 46054606 A;;GB 0515465 A;;US 70289705 P,2005-07-27,Access,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,INGENIA HOLDINGS LIMITED (2009-08-14);;INGENIA TECHNOLOGY LIMITED (2006-11-20),https://lens.org/173-966-647-975-490,Patent Application,yes,10,69,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;H04L9/00;;G06F21/33;;G06F21/34;;G06V10/42;;G06V20/80,713/172;;713/176,0,0,,,,DISCONTINUED
143,MY,A,MY 141526 A,183-738-591-831-428,2010-05-14,2010,MY PI20063532 A,2006-07-25,GB 0515464 A;;US 70274605 P,2005-07-27,PRESCRIPTION AUTHENTICATION,"THE INVENTION RELATES TO A SYSTEM 100 FOR VERIFYING THE AUTHENTICITY OF MEDICAMENT ENTITLEMENT TOKENS, SUCH AS PRESCRIPTIONS 102, USED TO CONTROL THE DISPENSING OF 5 MEDICAMENTS. THE SYSTEM COMPRISES A NETWORK 104 CONNECTING AT LEAST ONE TOKEN PROVIDER TERMINAL 106, A SYSTEM SERVER 120 AND A VERIFICATION TERMINAL 130. THE TOKEN PROVIDER TERMINAL 106 IS OPERABLE TO PROVIDE A SIGNATURE FROM A SPECKLE PATTERN DERIVED FROM A MEDICAMENT ENTITLEMENT TOKEN THAT CAN BE STORED BY THE SERVER SYSTERN 120. THE VERIFICATION TERMINAL 130 CAN THEN BE OPERATED REMOTELY TO RECREATE THE SIGNATURE IN TO ORDER TO VERIFY THE AUTHENTICITY OF THE MEDICAMENT ENTITLEMENT TOKEN BY COMPAR-ING IT TO STORED SIGNATURES. THE SYSTEM 100 RELIES UPON THE INTRINSIC PHYSICAL PROPERTIES OF THE MEDICAMENT ENTITLEMENT TOKEN TO GENERATE A UNIQUE SIGNATURE FOR EACH TOKEN THAT IS PRODUCED. THIS MAKES THE MEDICAMENT ENTITLEMENT TOKENS THEMSELVES VERY DIFFICULT TO FORGE. MOREOVER, THE SIGNATURES TRANSMITTED OVER THE NETWORK DO NOT NEED TO CONTAIN 1 5 ANY DETAILS RELATING TO THE CONTENT OF THE MEDICAMENT ENTITLEMENT TOKENS, SUCH AS PATIENT DATA, HENCE SIGNATURE DATA STORED BY THE SYSTEM CAN BE MADE PRIVACY NEUTRAL SO THAT EVEN IF IT WERE TO BE INTERCEPTED OR COPIED THIS WOULD NOT COMPROMISE CONFIDENTIALITY.",INGENIA HOLDINGS LTD,COWBURN RUSSELL P;;RALPH BUCHANAN JAMES DAVID,,https://lens.org/183-738-591-831-428,Granted Patent,no,0,0,7,11,0,G06Q10/10;;G16H10/60;;G16H40/63;;G16H40/67;;G16H20/13;;G06V20/80;;G06Q10/10;;G16H10/60;;G16H20/13;;G16H40/63;;G16H40/67;;G06V20/80,G06K19/14;;G06Q10/10;;G16H20/13;;G16H40/63;;G16H40/67,,0,0,,,,ACTIVE
144,WO,A1,WO 2006/120398 A1,029-499-811-231-127,2006-11-16,2006,GB 2006001646 W,2006-05-05,GB 0509635 A,2005-05-11,AUTHENTICITY VERIFICATION BY MEANS OF OPTICAL SCATTERING,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the provision by the first party to the second party of the right to an entitlement token. Following the transaction outcome, data describing a written format for the entitlement token can be transmitted from the first party to the second party. The entitlement token can be written at the second location using the data describing the written format. The method can further comprise creating a first signature for the written entitlement token at the second location, the signature being based upon an intrinsic property of the written entitlement token, and storing the first signature in a signature database. Further, the method can comprise creating a second signature for the written entitlement token at a third location remote from the second location, the second signature being based upon the intrinsic property of the written entitlement token; and comparing attributes of the second signature with attributes of the first stored in the database to verify the authenticity of the written entitlement token.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/029-499-811-231-127,Patent Application,yes,3,11,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B11/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,2,0,,,"PATENT ABSTRACTS OF JAPAN vol. 2003, no. 05 12 May 2003 (2003-05-12);;See also references of EP 1880343A1",PENDING
145,CN,A,CN 101218593 A,025-278-475-142-816,2008-07-09,2008,CN 200680022695 A,2006-05-05,GB 0509635 A,2005-05-11,Authenticity verification by means of optical scattering,,INGENIA TECHNOLOGY LTD,PAUL COWBURN RUSSELL;;RALPH BUCHANAN JAMES DAVID,,https://lens.org/025-278-475-142-816,Patent Application,no,0,1,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B11/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,0,0,,,,DISCONTINUED
146,GB,A,GB 2429097 A,039-158-338-058-230,2007-02-14,2007,GB 0515462 A,2005-07-27,GB 0515462 A,2005-07-27,Verification utilising a plurality of signatures,"An article verification system comprises a first scanner operable to scan an article to create a signature based upon an intrinsic characteristic of the article and a comparator operable to compare the created signature to a plurality of stored signatures created from previous scans of a plurality of articles. More than one stored signature can be associated with each article, each signature for each article being associated with a respective different portion of each article to the other signatures for that article. Thus the system provides for an article to be checked against multiple records of that article. A single match between the later scan and a stored record can be used to positively verify the article.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/039-158-338-058-230,Patent Application,no,3,9,5,12,0,G06K19/14;;G07D7/004,G06K19/14,G4M MB4           MCA;;G4M MCA           MCA;;NOT CLASSIFIED    NONE,0,0,,,,INACTIVE
147,EP,A1,EP 1908027 A1,054-599-861-312-691,2008-04-09,2008,EP 06765023 A,2006-07-19,GB 2006002689 W;;GB 0515460 A;;US 70273205 P,2005-07-27,VERIFICATION OF AUTHENTICITY,,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2012-10-24),https://lens.org/054-599-861-312-691,Patent Application,yes,0,1,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,G06V10/28;;G07D7/12;;G06V10/40;;G06V10/42;;G07D7/20,,0,0,,,,INACTIVE
148,EP,B1,EP 1908027 B1,062-804-145-733-241,2010-09-29,2010,EP 06765023 A,2006-07-19,GB 2006002689 W;;GB 0515460 A;;US 70273205 P,2005-07-27,VERIFICATION OF AUTHENTICITY,,INGENIA HOLDINGS LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2012-10-24),https://lens.org/062-804-145-733-241,Granted Patent,yes,3,0,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,G06Q10/02;;G06V10/28;;G06V10/40;;G06V10/42;;G07D7/12;;G07D7/20,,1,0,,,"HAIST T ET AL: ""Optical detection of random features for high security applications"" OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173-179, XP004118061 ISSN: 0030-4018",INACTIVE
149,GB,B,GB 2476226 B,175-407-766-836-76X,2012-03-28,2012,GB 0919664 A,2009-11-10,GB 0919664 A,2009-11-10,Optimisation,,INGENIA HOLDINGS LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/175-407-766-836-76X,Granted Patent,no,1,0,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G06K7/10;;G06K7/14;;G06K19/00;;G06V10/70;;G07D7/20,,2,1,053-958-092-328-407,10.1109/icsmc.2000.884411,"W S Wijesoma et al., ""Selecting optimal personalized features for on-line signature verification using GA"", 2000, IEEE;;A Khan et al, ""Optimizing perceptual shaping of a digital watermark using genetic programming"".",INACTIVE
150,EP,B1,EP 2110776 B1,004-277-950-760-685,2012-10-31,2012,EP 09165454 A,2006-12-22,EP 06831458 A;;GB 0526662 A;;GB 0526422 A;;GB 0607867 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,,INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;SEEM PETER;;BUCHANAN JAMES,INGENIA HOLDINGS LIMITED (2012-10-24),https://lens.org/004-277-950-760-685,Granted Patent,yes,3,0,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G03G21/04;;G06V10/141;;G06V10/147;;G06V10/42;;G07D7/12,,2,0,,,"BUCHANAN J D R ET AL: ""'Fingerprinting' documents and packaging"" NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 436, 28 July 2005 (2005-07-28), page 475, XP002405507 ISSN: 0028-0836;;HAIST T ET AL: ""Optical detection of random features for high security applications"" OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173-179, XP004118061 ISSN: 0030-4018",ACTIVE
151,IN,A,IN 3897DEN2012 A,005-910-081-627-790,2015-09-04,2015,IN 3897DEN2012 A,2012-05-03,GB 0919664 A;;US 25994609 P;;GB 2010051844 W,2009-11-10,"""OPTIMISATION""","There is described a method for implementing a system for authentication of an article based upon a signature generated from a set comprising groups of data points collected when a plurality of regions of an intrinsic surface structure of an article are sequentially subjected to coherent light and the light scattered by the intrinsic surface structure is collected. For a given system implementation, the method comprises: determining a set of parameters which influence the performance of the system; determining a definition of system performance which can be affected by the set of parameters; producing an initial population of parameter value sets, each parameter set including a value for each parameter to be used in achieving a desired system performance; determining for each parameter value set a fitness value in terms of the system performance definition; identifying mating pairs of the population in accordance with the determined fitnesses; producing a new population by crossing the mating pairs; repeating the determining of a fitness value for each parameter value set, identifying of mating pairs and producing a new population until an end criterion is satisfied; and configuring the system in accordance with a selected one of the parameter sets from the final population. Thereby, a flexible and appropriate approach to system implementation can be followed which provides high efficiency in terms of the human time input and which provides high quality reliable setup parameter values to enable a reliable and efficient system implementation to result.",INGENIA HOLDINGS LTD,PAUL RUSSELL COWBURN;;JAMES DAVID RALPH BUCHANAN,,https://lens.org/005-910-081-627-790,Patent Application,no,0,0,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G07D7/20;;G06V10/70,,0,0,,,,PENDING
152,KR,A,KR 20080008417 A,033-885-210-477-535,2008-01-23,2008,KR 20077028851 A,2007-12-10,GB 0509635 A,2005-05-11,AUTHENTICITY VERIFICATION BY MEANS OF OPTICAL SCATTERING,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the provision by the first party to the second party of the right to an entitlement token. Following the transaction outcome, data describing a written format for the entitlement token can be transmitted from the first party to the second party. The entitlement token can be written at the second location using the data describing the written format. The method can further comprise creating a first signature for the written entitlement token at the second location, the signature being based upon an intrinsic property of the written entitlement token, and storing the first signature in a signature database. Further, the method can comprise creating a second signature for the written entitlement token at a third location remote from the second location, the second signature being based upon the intrinsic property of the written entitlement token; and comparing attributes of the second signature with attributes of the first stored in the database to verify the authenticity of the written entitlement token.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/033-885-210-477-535,Patent Application,no,0,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G07B11/00;;G06F21/64;;G06V20/80;;G07B1/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,0,0,,,,DISCONTINUED
153,EP,B1,EP 2499618 B1,075-464-817-726-284,2014-01-29,2014,EP 10779031 A,2010-11-04,GB 0919664 A;;US 25994609 P;;GB 2010051844 W,2009-11-10,OPTIMISATION,,INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2014-01-22),https://lens.org/075-464-817-726-284,Granted Patent,yes,3,0,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G06V10/70;;G07D7/20,,0,0,,,,ACTIVE
154,EP,A1,EP 2499618 A1,071-587-448-634-468,2012-09-19,2012,EP 10779031 A,2010-11-04,GB 0919664 A;;US 25994609 P;;GB 2010051844 W,2009-11-10,OPTIMISATION,,INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,INGENIA HOLDINGS LIMITED (2014-01-22),https://lens.org/071-587-448-634-468,Patent Application,yes,0,0,14,14,0,G07D7/2075;;G06V20/80;;G06V10/70;;G06F18/21;;G06K7/10544;;G06K7/14;;G06K19/10;;G07D7/2075;;G06V20/69;;G06V10/42;;G06V20/80;;G06F18/21;;G06F2218/10;;G06F2218/14;;G06V10/70;;G07D7/2075,G06V10/70;;G07D7/20,,0,0,,,,ACTIVE
155,US,A1,US 2007/0028093 A1,079-867-884-145-131,2007-02-01,2007,US 46055806 A,2006-07-27,US 46055806 A;;GB 0515460 A;;US 70273205 P,2005-07-27,Verification of Authenticity,"An article identification method can comprise: determining a signature from an article based upon an intrinsic characteristic of the article; and comparing the determined signature to a stored signature. The method can also comprise splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,INGENIA HOLDINGS LIMITED (2011-06-15),https://lens.org/079-867-884-145-131,Patent Application,yes,98,48,15,22,0,G06Q10/02;;G07D7/003;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G06V20/80;;G06V10/28;;G06V10/40;;G06V10/42;;G06Q10/02;;G07D7/003;;G06V10/42;;G06V10/28;;G06V10/40;;G06V20/80,G06V10/28;;H04L9/00;;G06V10/40;;G06V10/42,713/155,0,0,,,,INACTIVE
156,TW,A,TW 200729049 A,076-792-535-685-428,2007-08-01,2007,TW 95127162 A,2006-07-25,GB 0515462 A;;US 70435405 P,2005-07-27,Verification,"An article verification system can comprise a first scanner operable to scan an article to create a signature based upon an intrinsic characteristic of the article and a comparator operable to compare the created signature to a plurality of stored signatures created from previous scans of a plurality of articles. More than one stored signature can be associated with each article, each signature for each article being associated with a respective different portion of each article to the other signatures for that article. Thus the system provides for an article to be checked against multiple records of that article. In some examples, a single match between the later scan and a stored record can be used to positively verify the article.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/076-792-535-685-428,Patent of Addition,no,0,0,7,12,0,G07D7/121;;G07D7/003;;G06V20/80;;G06V10/145;;G06V10/42;;G07D7/121;;G07D7/003;;G06V10/42;;G06V10/145;;G06V20/80,G06V10/145;;G06V10/42,,0,0,,,,PENDING
157,WO,A1,WO 2007/012820 A1,088-353-756-176-505,2007-02-01,2007,GB 2006002708 W,2006-07-20,GB 0515464 A;;US 70274605 P,2005-07-27,PRESCRIPTION AUTHENTICATION USING SPECKLE PATTERNS,"The invention relates to a system (100) for verifying the authenticity of medicament entitlement tokens, such as prescriptions (102), used to control the dispensing of medicaments. The system comprises a network (104) connecting at least one token provider terminal (106), a system server (120) and a verification terminal (130). The token provider terminal 106 is operable to provide a signature from a speckle pattern derived from a medicament entitlement token that can be stored by the server system (120). The verification terminal (130) can then be operated remotely to recreate the signature in order to verify the authenticity of the medicament entitlement token by comparing it to stored signatures. The system (100) relies upon the intrinsic physical properties of the medicament entitlement token to generate a unique signature for each token that is produced. This makes the medicament entitlement tokens themselves very difficult to forge. Moreover, the signatures transmitted over the network do not need to contain any details relating to the content of the medicament entitlement tokens, such as patient data, hence signature data stored by the system can be made privacy neutral so that even if it were to be intercepted or copied this would not compromise confidentiality.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/088-353-756-176-505,Patent Application,yes,6,1,7,11,0,G06Q10/10;;G16H10/60;;G16H40/63;;G16H40/67;;G16H20/13;;G06V20/80;;G06Q10/10;;G16H10/60;;G16H20/13;;G16H40/63;;G16H40/67;;G06V20/80,G06Q10/10;;G16H20/13;;G16H40/63;;G16H40/67,,2,1,014-283-534-008-99X,10.1126/science.1074376;;12242435,"PAPPU R ET AL: ""Physical one-way functions"", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 297, no. 5589, September 2002 (2002-09-01), pages 2026 - 2030, XP002285061, ISSN: 0036-8075;;See also references of EP 1907963A1",PENDING
158,BR,A2,BR PI0608804 A2,192-601-617-609-77X,2016-08-23,2016,BR PI0608804 A,2006-05-05,GB 2006001646 W;;GB 0509635 A,2005-05-11,"método e sistema para verificação de autenticidade, uso do sistema, e, método para autenticar uma licença de acesso",,INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/192-601-617-609-77X,Patent Application,no,0,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B11/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,0,0,,,,DISCONTINUED
159,WO,A3,WO 2007/012814 A3,188-952-021-428-097,2007-04-12,2007,GB 2006002686 W,2006-07-19,GB 0515465 A;;US 70289705 P,2005-07-27,SIGNATURE FOR ACCESS TOKENS,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/188-952-021-428-097,Search Report,yes,3,0,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;G06F21/33;;G06F21/34;;G06K19/14;;G06V10/42;;G06V20/80;;G07D7/12,,3,2,046-032-889-977-057;;014-283-534-008-99X,10.1016/s0030-4018(97)00546-4;;10.1126/science.1074376;;12242435,"WILKES ET AL: ""FIGHTING FRAUD: DOCUMENT BIOMETRICS"", MATERIALS WORLD, INSTITUTE OF METALS, LONDON, GB, vol. 12, no. 12, December 2004 (2004-12-01), pages 29 - 30, XP009073167, ISSN: 0967-8638;;HAIST T ET AL: ""Optical detection of random features for high security applications"", OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173 - 179, XP004118061, ISSN: 0030-4018;;PAPPU R ET AL: ""Physical one-way functions"", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 297, no. 5589, September 2002 (2002-09-01), pages 2026 - 2030, XP002285061, ISSN: 0036-8075",PENDING
160,TW,A,TW 200731146 A,011-686-622-431-381,2007-08-16,2007,TW 95127160 A,2006-07-25,GB 0515465 A;;US 70289705 P,2005-07-27,Access,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/011-686-622-431-381,Patent of Addition,no,0,0,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;G06F21/33;;G06F21/34;;G06V10/42;;G06V20/80;;H04L9/32;;H04L29/00,,0,0,,,,PENDING
161,MY,A,MY 142408 A,105-122-822-668-783,2010-11-30,2010,MY PI20063531 A,2006-07-25,GB 0515465 A;;US 70289705 P,2005-07-27,ACCESS,"A DATA ACCESS SYSTEM CAN BE PROVIDED. THE SYSTEM CAN COMPRISE A DATA RECORD ASSOCIATED WITH A STORED ACCESS TOKEN SIGNATURE (L06) AND A SIGNATURE GENERATOR, OPERABLE TO SCAN AN ACCESS TOKEN TO CREATE A SIGNATURE (306) FOR THE ACCESS TOKEN, THE SIGNATURE (306) BEING BASED UPON AN INTRINSIC PROPERTY OF THE ACCESS TOKEN. THE SYSTEM CAN ALSO COMPRISE A COMPARATOR FOR COMPARING THE CREATED SIGNATURE (306) WITH THE STORED SIGNATURE (L06). THE SYSTEM CAN BE OPERABLE TO MAKE THE DATA RECORD AVAILABLE IN THE EVENT OF A MATCH BETWEEN THE STORED SIGNATURE (L06) AND THE CREATED SIGNATURE (306). THUS SECURE ACCESS TO SENSITIVE OR PRIVATE DATA CAN BE CONTROLLED USING AN ACCESS TOKEN IN THE POSSESSION OF AN INDIVIDUAL OR ENTITY DESCRIBED BY OR IN THE DATA RECORD. THE MOST SUITABLE DRAWING IS",INGENIA HOLDINGS LTD,COWBURN RUSSELL P;;RALPH BUCHANAN JAMES DAVID,,https://lens.org/105-122-822-668-783,Granted Patent,no,0,0,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;G06F21/33;;G06F21/34;;G06V10/42;;G06V20/80,,0,0,,,,ACTIVE
162,US,A1,US 2006/0294583 A1,116-417-990-835-541,2006-12-28,2006,US 38286506 A,2006-05-11,US 38286506 A;;US 67989205 P,2005-05-11,Authenticity Verification,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the provision by the first party to the second party of the right to an entitlement token. Following the transaction outcome, data describing a written format for the entitlement token can be transmitted from the first party to the second party. The entitlement token can be written at the second location using the data describing the written format. The method can further comprise creating a first signature for the written entitlement token at the second location, the signature being based upon an intrinsic property of the written entitlement token, and storing the first signature in a signature database. Further, the method can comprise creating a second signature for the written entitlement token at a third location remote from the second location, the second signature being based upon the intrinsic property of the written entitlement token; and comparing attributes of the second signature with attributes of the first stored in the database to verify the authenticity of the written entitlement token.",INGENIA HOLDINGS U K LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,INGENIA HOLDINGS (U.K.) LIMITED (2006-11-11);;INGENIA HOLDINGS LIMITED (2009-08-14);;INGENIA TECHNOLOGY LIMITED (2006-11-20),https://lens.org/116-417-990-835-541,Patent Application,yes,66,38,1,1,0,G06Q20/3825;;G06Q20/388;;G06Q20/40;;G06Q20/4014;;G07D7/2008;;G07D7/2033;;G06V20/80;;G06Q20/388;;G06Q20/40;;G06Q20/4014;;G07D7/2033;;G07D7/2008;;G06Q20/3825;;G06V20/80,H04L9/32,726/10,0,0,,,,DISCONTINUED
163,TW,A,TW 200731155 A,148-328-357-758-866,2007-08-16,2007,TW 95127171 A,2006-07-25,GB 0515461 A;;US 70294605 P,2005-07-27,Authenticity verification,"A method for authenticity verification. The method can comprise conducting a transaction between first and second parties, the parties being respectively located at first and second locations remote one-another, the outcome of the transaction being the transfer of title to goods and/or services from the first party to the second party. Data describing a value entitlement token of the second party can be captured to create a signature for the value entitlement token, the signature being based upon an intrinsic property of the value entitlement token. The signature can be transmitted from the second party to a third party which can compare the signature to a database of stored signatures. A validation result indicating whether the value entitlement token correspond to a value entitlement token signature in the database can be transmitted from the third party to the first party.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/148-328-357-758-866,Patent of Addition,no,0,0,7,11,0,G06Q20/04;;G06Q20/042;;G06Q20/3674;;G06Q20/40;;G06Q20/4014;;G06V20/80;;G06Q20/04;;G06Q20/042;;G06Q20/4014;;G06Q20/40;;G06Q20/3674;;G06V20/80,G06Q30/00;;H04L9/32;;H04L29/00,,0,0,,,,PENDING
164,EP,A2,EP 1907986 A2,178-401-529-314-054,2008-04-09,2008,EP 06765021 A,2006-07-19,GB 2006002686 W;;GB 0515465 A;;US 70289705 P,2005-07-27,SIGNATURE FOR ACCESS TOKENS,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/178-401-529-314-054,Patent Application,yes,0,0,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;G06F21/33;;G06F21/34;;G06K19/14;;G06V10/42;;G06V20/80;;G07D7/12,,0,0,,,,ACTIVE
165,EP,A2,EP 2175396 A2,014-895-065-516-760,2010-04-14,2010,EP 10150648 A,2006-12-22,EP 06831458 A;;GB 0526662 A;;GB 0526422 A;;GB 0607867 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.
",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES;;SEEM PETER,,https://lens.org/014-895-065-516-760,Patent Application,yes,6,2,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G03G21/04;;G06F17/30;;G06V10/141;;G06V10/147;;G06V10/42;;G07D7/12,,3,1,013-750-169-137-892,16049465;;10.1038/436475a,"R ANDERSON: ""Plastic tag makes foolproof ID"", TECHNOLOGY RESEARCH NEWS, 2 October 2002 (2002-10-02);;R ANDERSON: ""Security Engineering: a guide to building dependable distributed systems"", 2001, WILEY, pages: 251 - 252;;ADDITIONALLY; JAMES D. R. BUCHANAN ET AL.: ""Forgery: 'Fingerprinting' documents and packaging"", NATURE, vol. 436, 28 July 2005 (2005-07-28), pages 475 - 475",DISCONTINUED
166,EP,A1,EP 1880343 A1,020-619-638-375-819,2008-01-23,2008,EP 06727017 A,2006-05-05,GB 2006001646 W;;GB 0509635 A,2005-05-11,AUTHENTICITY VERIFICATION BY MEANS OF OPTICAL SCATTERING,,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/020-619-638-375-819,Patent Application,yes,7,0,16,16,0,G06Q20/045;;G07B15/00;;G07D7/004;;G07F7/08;;G07F7/125;;G07C9/20;;G06V20/80;;G06F18/00;;G07D7/1205;;G06K7/10;;G06K19/14;;G07B1/00;;G07B11/00;;G07C9/20;;G07B11/00;;G07B15/00;;G06F18/00;;G06Q20/045;;G06V20/80,G06F21/33;;G06F21/64;;G06V20/80;;G07B11/00;;G07B15/00;;G07C9/00;;G07D7/20;;G07F7/12,,1,0,,,See also references of WO 2006120398A1,DISCONTINUED
167,EP,B1,EP 1907986 B1,094-818-650-384-810,2008-12-24,2008,EP 06765021 A,2006-07-19,GB 2006002686 W;;GB 0515465 A;;US 70289705 P,2005-07-27,SIGNATURE FOR ACCESS TOKENS,"A data access system can be provided. The system can comprise a data record associated with a stored access token signature and a signature generator, operable to scan an access token to create a signature for the access token, the signature being based upon an intrinsic property of the access token. The system can also comprise a comparator for comparing the created signature with the stored signature. The system can be operable to make the data record available in the event of a match between the stored signature and the created signature. Thus secure access to sensitive or private data can be controlled using an access token in the possession of an individual or entity described by or in the data record.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH,,https://lens.org/094-818-650-384-810,Granted Patent,yes,3,0,11,16,0,G07D7/004;;G07D7/20;;G07D7/12;;G06V20/80;;G06V10/42;;G06F18/00;;G07D7/20;;G07D7/004;;G07D7/12;;G06V10/42;;G06V20/80;;G06F18/00,G06F21/62;;G06F21/33;;G06F21/34;;G06K19/14;;G06V10/42;;G06V20/80;;G07D7/12,,3,0,,,"WILKES ET AL: ""FIGHTING FRAUD: DOCUMENT BIOMETRICS"" MATERIALS WORLD, INSTITUTE OF METALS, LONDON, GB, vol. 12, no. 12, December 2004 (2004-12), pages 29-30, XP009073167 ISSN: 0967-8638;;HAIST T ET AL: ""Optical detection of random features for high security applications"" OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173-179, XP004118061 ISSN: 0030-4018;;PAPPU R ET AL: ""Physical one-way functions"" SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 297, no. 5589, September 2002 (2002-09), pages 2026-2030, XP002285061 ISSN: 0036-8075",ACTIVE
168,US,A1,US 2007/0025619 A1,176-963-988-492-37X,2007-02-01,2007,US 46055206 A,2006-07-27,US 46055206 A;;GB 0515462 A;;US 70435405 P,2005-07-27,Verification,"An article verification system can comprise a first scanner operable to scan an article to create a signature based upon an intrinsic characteristic of the article and a comparator operable to compare the created signature to a plurality of stored signatures created from previous scans of a plurality of articles. More than one stored signature can be associated with each article, each signature for each article being associated with a respective different portion of each article to the other signatures for that article. Thus the system provides for an article to be checked against multiple records of that article. In some examples, a single match between the later scan and a stored record can be used to positively verify the article.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R,IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (2006-11-10);;INGENIA HOLDINGS (UK) LIMITED (2006-11-11);;INGENIA HOLDINGS LIMITED (2009-08-14);;INGENIA TECHNOLOGY LIMITED (2006-11-20),https://lens.org/176-963-988-492-37X,Patent Application,yes,99,36,7,12,0,G07D7/121;;G07D7/003;;G06V20/80;;G06V10/145;;G06V10/42;;G07D7/121;;G07D7/003;;G06V10/42;;G06V10/145;;G06V20/80,G06V10/145;;G06V10/42,382/190,0,0,,,,DISCONTINUED
169,GB,A,GB 2429095 A,193-642-629-985-550,2007-02-14,2007,GB 0515460 A,2005-07-27,GB 0515460 A,2005-07-27,Authenticity verification by comparing blocks of signatures,"An article identification method comprises: determining a signature from an article based upon an intrinsic characteristic of the article comparing the determined signature to a stored signature, splitting the determined signature into blocks of contiguous data, performing a comparison operation between each block and respective blocks of the stored signature, and comparing an attribute of a comparison result from each block comparison to an expected attribute of the block comparison to determine a compensation value for use in determining a comparison result. The method can also comprise determining a similarity result between the determined signature and the stored signature, using the compensation value to adjust the determined signature. Thus an article damaged by stretching or shrinking can be successfully identified. Also, a non-linear signature determination can be accommodated without losing identification accuracy.",INGENIA TECHNOLOGY LTD,BUCHANAN JAMES DAVID RALPH;;COWBURN RUSSELL PAUL,,https://lens.org/193-642-629-985-550,Patent Application,no,3,6,7,22,0,G07D7/004;;G06K7/10;;G06K19/10,G06K19/10;;G06K7/10,G4M MB4           MCA;;G4M MCA           MCA;;NOT CLASSIFIED    NONE,0,0,,,,INACTIVE
170,US,A1,US 2013/0207713 A1,093-195-834-706-517,2013-08-15,2013,US 201313765094 A,2013-02-12,US 201313765094 A;;US 201261597999 P,2012-02-13,Coincident Tracking Turn-On For Mixed Voltage Logic,"A method for dealing with high inrush current when voltage is applied to mixed voltage logic integrated circuits is disclosed. A depletion N-Channel Metal Oxide Semiconductor Field Effect Transistor (MOSFET) or junction Field Effect Transistor (JFET) is added to a linear voltage regulator in mixed voltage logic integrated circuits. The Field Effect Transistor (FET) is utilized to allow the core voltage to come up with Input/Output voltage prior to turn-on of linear voltage regulator. Turn-on state of FET allows the core voltage to rise with Input/Output voltage until the FET threshold is reached across the gate. When threshold is reached, the FET turns off to allow linear voltage regulator turn on and take over supply power.",ELECTRONIC SYSTEMS INTEGRATION INC BAE SYSTEMS INFORMATION AND;;BAE SYS INF & ELECT SYS INTEG,WILLIS SCOTT C;;SINGLETON WILLIAM C;;BUCHANAN RUSSELL,BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC (2013-02-11),https://lens.org/093-195-834-706-517,Patent Application,yes,2,0,2,2,0,H03K17/08104;;H03K17/08104,H03K17/081,327/380,0,0,,,,ACTIVE
171,GB,A,GB 2604903 A,187-320-089-785-355,2022-09-21,2022,GB 202103774 A,2021-03-18,GB 202103774 A,2021-03-18,Detection of Ransomware,"The present invention relates to a computer program product, a computing device and a method of detecting a file encrypted by ransomware by identifying a file write operation for a file on the computing device and determining if a predetermined number of bytes of the file is stored in a memory buffer on the computing device. An entropy value of the predetermined number of bytes in the memory buffer is determined and compared to a first predetermined threshold, wherein if the determined entropy value exceeds the first predetermined threshold the file associated with the file write operation is flagged as being potentially encrypted by ransomware.",THE COURT OF EDINBURGH NAPIER UNIV CONSTITUTED BY THE NAPIER COLLEGE OF COMMERCE AND TECHNOLOGY NO 2,BILL BUCHANAN;;PETER MCLAREN;;GORDON RUSSELL;;ZHIYUAN TAN,,https://lens.org/187-320-089-785-355,Patent Application,no,6,0,4,4,0,G06F21/554;;G06F21/566;;G06F21/6218;;G06F21/55;;G06F21/56;;G06F21/62,G06F21/55;;G06F21/56;;G06F21/62,,0,0,,,,DISCONTINUED
172,EP,A1,EP 4309063 A1,054-899-213-006-076,2024-01-24,2024,EP 22709365 A,2022-03-08,GB 202103774 A;;GB 2022050600 W,2021-03-18,DETECTION OF RANSOMWARE,,THE COURT OF EDINBURGH NAPIER UNIV,BUCHANAN BILL;;MCLAREN PETER;;GORDON RUSSELL;;TAN ZHIYUAN,,https://lens.org/054-899-213-006-076,Patent Application,yes,0,0,4,4,0,G06F21/554;;G06F21/566;;G06F21/6218;;G06F21/55;;G06F21/56;;G06F21/62,G06F21/55;;G06F21/56;;G06F21/62,,0,0,,,,PENDING
173,WO,A1,WO 2022/195254 A1,165-836-709-689-882,2022-09-22,2022,GB 2022050600 W,2022-03-08,GB 202103774 A,2021-03-18,DETECTION OF RANSOMWARE,"The present invention relates to a computer program product, a computing device and a method of detecting a file encrypted by ransomware by identifying a file write operation for a file on the computing device and determining if a predetermined number of bytes of the file is stored in a memory buffer on the computing device. An entropy value of the predetermined number of bytes in the memory buffer is determined and compared to a first predetermined threshold, wherein if the determined entropy value exceeds the first predetermined threshold the file associated with the file write operation is flagged as being potentially encrypted by ransomware.",THE COURT OF EDINBURGH NAPIER UNIV,BUCHANAN BILL;;MCLAREN PETER;;GORDON RUSSELL;;TAN ZHIYUAN,,https://lens.org/165-836-709-689-882,Patent Application,yes,6,0,4,4,0,G06F21/554;;G06F21/566;;G06F21/6218;;G06F21/55;;G06F21/56;;G06F21/62,G06F21/55;;G06F21/56;;G06F21/62,,0,0,,,,PENDING
174,US,B2,US 8994434 B2,164-666-113-799-049,2015-03-31,2015,US 201313765094 A,2013-02-12,US 201313765094 A;;US 201261597999 P,2012-02-13,Coincident tracking turn-on for mixed voltage logic,"A method for dealing with high inrush current when voltage is applied to mixed voltage logic integrated circuits is disclosed. A depletion N-Channel Metal Oxide Semiconductor Field Effect Transistor (MOSFET) or junction Field Effect Transistor (JFET) is added to a linear voltage regulator in mixed voltage logic integrated circuits. The Field Effect Transistor (FET) is utilized to allow the core voltage to come up with Input/Output voltage prior to turn-on of linear voltage regulator. Turn-on state of FET allows the core voltage to rise with Input/Output voltage until the FET threshold is reached across the gate. When threshold is reached, the FET turns off to allow linear voltage regulator turn on and take over supply power.",BAE SYS INF & ELECT SYS INTEG,WILLIS SCOTT C;;SINGLETON WILLIAM C;;BUCHANAN RUSSELL,BAE SYSTEMS INFORMATION AND ELECTRONIC SYSTEMS INTEGRATION INC (2013-02-11),https://lens.org/164-666-113-799-049,Granted Patent,yes,4,0,2,2,0,H03K17/08104;;H03K17/08104,H03L5/00;;H03K5/08;;H03K17/081,327/309;;327/306,0,0,,,,ACTIVE
175,US,A,US 6014048 A,179-460-551-961-449,2000-01-11,2000,US 8550998 A,1998-05-27,US 8550998 A,1998-05-27,Clock generator with multiple feedback paths including a delay locked loop path,The present invention encompasses the use of multiple feedback paths in a clock source for an integrated circuit device to maintain phase lock to an external clock. It is further contemplated by the present invention that feedback paths are provided from the internal clock distribution path and from a matching path that approximates the delay of the clock distribution path. The matching path may comprise a delay locked loop. Feedback from the clock distribution path is used in normal operation and feedback from the matching path is used when the internal clock distribution path is disabled. The clock source of the present invention also may implement power management functions.,ADVANCED MICRO DEVICES INC,TALAGA JR RONALD F;;HERSHBARGER RUSSELL;;BUCHANAN JAMES M,AMD TECHNOLOGIES HOLDINGS INC (2009-03-02);;ADVANCED MICRO DEVICES INC (1998-05-26);;GLOBALFOUNDRIES INC (2009-03-02),https://lens.org/179-460-551-961-449,Granted Patent,yes,3,57,1,1,0,G06F1/10;;G06F1/10;;H03L7/07;;H03L7/07;;H03L7/08;;H03L7/08;;H03L7/081;;H03L7/081;;H03L7/18;;H03L7/18,G06F1/10;;H03L7/07;;H03L7/08;;H03L7/081;;H03L7/18,327/156;;327/292;;327/294,1,0,,,"Weste, et al, Principles of CMOS VLSI Design: A Systems Perspective, 2 nd Ed., pp. 334 336, 356 357 and 364, published by Addison Wesley Publishing Company, 1993.",EXPIRED
176,US,B2,US 11387011 B2,151-677-799-208-320,2022-07-12,2022,US 201816217111 A,2018-12-12,US 201816217111 A;;US 88793310 A,2010-09-22,Compact radioisotope generator,An apparatus for manufacturing a radioisotope comprises a container. The container comprising a portable neutron source and a solution that comprises a particular isotope. The portable neutron source is surrounded by the solution. The solution comprises at least one of copper phthalocyanine or copper salicylaldehyde o-phenylene diamine. The portable neutron source emits neutrons that react with the particular isotope resulting in the transformation of the particular isotope into the radioisotope.,SIEMENS MEDICAL SOLUTIONS USA INC,HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL,SIEMENS MEDICAL SOLUTIONS USA INC (2019-01-02),https://lens.org/151-677-799-208-320,Granted Patent,yes,14,0,6,6,0,G21G2001/0094;;G21G1/06;;G21G2001/0094;;G21G1/06,G21G1/06;;G21G1/00,,18,10,091-140-477-167-859;;046-356-981-621-847;;050-219-273-589-86X;;011-026-620-617-541;;152-516-170-805-67X;;036-789-033-862-289;;028-998-162-085-261;;030-361-786-035-506;;086-977-772-913-467;;137-492-406-327-719,10.1586/erv.09.105;;19863251;;10.1016/s1357-4310(98)01226-x;;9572059;;10.1007/bf02278269;;10.1007/bf02913577;;10.1007/bf02060371;;10.1007/bf02039830;;10.1007/978-94-009-7099-1_93;;10.1016/j.jinorgbio.2004.06.009;;15522415;;10.1080/18811248.1986.9735098;;10.1080/18811248.1974.9730672,"Verma, “Neutron Activation Analysis.” Atomic and Nuclear Analytical Methods: XRF, Mössbauer, XPS, NAA and B63Ion-Beam Spectroscopic Techniques (2007): 243-268. (Year: 2007).;;Sundararao, “Decay Characteristics of Some Shortlived Radionuclides Produced by Activation Using 252Cf Source”, CONF-760436, vol. 2 (1976). (Year: 1976).;;Sen, “Role of heavy water in biological sciences with an emphasis on thermostabilization of vaccines”, Expert review of vaccines 8, No. 11 (2009): 1587-1602. (Year: 2009).;;Lin, “Optimum coolant chemistry in BWRs”, The 4th International Topical Meeting on Nuclear Thermal Hydraulics, Operations and Safety (1994). (Year: 1994).;;Gadalla, “Impacts of Cooling Water Quality on Operational Safety of Water Cooled Reactor”, Eleventh International Water Technology Conference (2007). (Year: 2007).;;Hawthorne, “New horizons for therapy based on the boron neutron capture reaction”, Molecular medicine today 4, No. 4 (1998): 174-181. (Year: 1998).;;Chen, “On the interaction between fuel crud and water chemistry in nuclear power plants” (2000). (Year: 2000).;;Matsuura, “Isotope effect of retention value between64Cu and66Cu in neutron-irradiated copper phthalocyanine”, Journal of Radioanalytical and Nuclear Chemistry 134, No. 2 (1989): 311-316. (Year: 1989).;;Chen, J.H. et al; “Cation Self-Diffusion in Chalcopyrite and Pyrite”; Metallurgical Transactions B; vol. 6B; pp. 331-339.;;Preparation of a Practically Carrier-Free Radioactive Copper Preparation 64Cu with High Activity From Cu Phthalocyanin, Herr et al., 5a 629-630 (1950).;;Measurement of Macrocopic and Microscopic Thermal Neutron Cross Sections of V, Co, Cu, In, Dy and Au Using Neutron Self-Absorption Properties Celenk et al., Journal of Radioanalytrical and Nuclear Chemistry, Articles, vol. 148, No. 2 (1991) 393-401.;;R.J. Batra and A.N. Garg., “Thermal Neutron Activation Analysis of Cu in its Ores by Using AN 2 4 1 Am—Be Neutron Source,” Journal of Radioanalytical and Nuclear Chemistry, Articles, 129(2), pp. 335-342, 1989.;;Rodger C. Martin and Steven E. Kos, “Applications and Availability of Californium-252 Neutron Sources for Waste Characterization,” Presentation at Spectrum 2000 International Conference on Nuclear and Hazardous Waste Management, Chattanooga, Tennessee, Sep. 24-28, 2000.;;Mannhart, “Measurement and evaluation of integral data in the Cf-252 neutron field”, In Nuclear Data for Science and Technology, pp. 429-435, Springer, Dordrecht, 1983. (Year: 1983).;;Smith, “Molecular imaging with copper-64”, Journal of inorganic biochemistry 98, No. 11 (2004): 1874-1901. (Year 2004).;;Sekine, “Application of Nuclear Recoil to Radioisotope Enrichment of Copper-84: Feasibility of Simplified Chemical Processing of Water-Soluble Copper Phthalocyanine”, Journal of Nuclear Science and Technology; No. 12; pp. 1064-1068; 1986.;;Takagi et al; “Preliminary research on isolation and removal of long-lived radionuclides in reactor coolant by ion exchange resin”; Journal of Nuclear Science and Technology 11; No. 8 pp. 326-333; 1974.;;Ex parte James J. Hamill, Stefan B. Siegel, and Charles Russell Buchanan, decision of the Patent Trial and Appeal Board, U.S. Appl. No. 12/887,933, Appeal No. 2017-010160, 8 pages, dated Aug. 14, 2018.",ACTIVE
177,US,B2,US 11315699 B2,192-226-178-310-976,2022-04-26,2022,US 201816217103 A,2018-12-12,US 201816217103 A;;US 88793310 A,2010-09-22,Composition of matter comprising a radioisotope composition,Disclosed are a method and apparatus for making a radioisotope and a composition of matter including the radioisotope. The radioisotope is made by exposing a material to neutrons from a portable neutron source.,SIEMENS MEDICAL SOLUTIONS USA INC,HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL,SIEMENS MEDICAL SOLUTIONS USA INC (2018-12-19),https://lens.org/192-226-178-310-976,Granted Patent,yes,14,0,6,6,0,G21G2001/0094;;G21G1/06;;G21G2001/0094;;G21G1/06,G21G1/06;;G21G1/00,,18,10,028-998-162-085-261;;030-361-786-035-506;;086-977-772-913-467;;137-492-406-327-719;;091-140-477-167-859;;050-219-273-589-86X;;046-356-981-621-847;;011-026-620-617-541;;152-516-170-805-67X;;036-789-033-862-289,10.1007/978-94-009-7099-1_93;;10.1016/j.jinorgbio.2004.06.009;;15522415;;10.1080/18811248.1986.9735098;;10.1080/18811248.1974.9730672;;10.1586/erv.09.105;;19863251;;10.1007/bf02278269;;10.1016/s1357-4310(98)01226-x;;9572059;;10.1007/bf02913577;;10.1007/bf02060371;;10.1007/bf02039830,"Verma, “Neutron Activation Analysis.” Atomic and Nuclear Analytical Methods: XRF, Mössbauer, XPS, NAA and B63Ion-Beam Spectroscopic Techniques (2007): 243-268. (Year: 2007).;;Sundararao, “Decay Characteristics Of Some Shortlived Radionuclides Produced By Activation Using 252Cf Source”, CONF-760436, vol. 2 (1976). (Year: 1976).;;Mannhart, “Measurement and evaluation of integral data in the Cf-252 neutron field”, In Nuclear Data for Science and Technology, pp. 429-435, Springer, Dordrecht, 1983. (Year: 1983).;;Smith, “Molecular imaging with copper-64”, Journal of inorganic biochemistry 98, No. 11 (2004): 1874-1901. (Year: 2004).;;Gadalla, “Impacts of Cooling Water Quality on Operational Safety of Water Cooled Reactor”, Eleventh International Water Technology Conference (2007). (Year: 2007).;;Lin, “Optimum coolant chemistry in BWRs”, The 4th International Topical Meeting on Nuclear Thermal Hydraulics, Operations and Safety (1994). (Year: 1994).;;Chen, “On the interaction between fuel crud and water chemistry in nuclear power plants”, 2000. (Year: 2000).;;Sekine, “Application of Nuclear Recoil to Radioisotope Enrichment of Copper-64: Feasibility of Simplified Chemical Processing of Water-Soluble Copper Phthalocyanine”, journal of nuclear science and technology 23, No. 12 (1986): 1064-1068. (Year: 1986).;;Takagi, “Preliminary research on isolation and removal of long-lived radionuclides in reactor coolant by ion exchange resin”, Journal of Nuclear Science and Technology 11, No. 8 (1974): 326-333. (Year: 1974).;;Sen, “Role of heavy water in biological sciences with an emphasis on thermostabilization of vaccines”, Expert review of vaccines 8, No. 11 (2009): 1587-1602. (Year: 2009).;;Matsuura : “Isotope effect of retention value between64Cu and66Cu in neutron-irradiated copper phthalocyanine”; Journal of Radioanalytical and Nuclear Chemistry 134; No. 2; 1989: pp. 311-316.;;Hawthorne: “New horizons for therapy based on the boron neutron capture reaction”; Molecular medicine today 4; No. 4 (1998); pp. 174-181.;;Ex parte James J. Hamill, Stefan B. Siegel, and Charles Russell Buchanan, decision of the Patent Trial and Appeal Board, U.S. Appl. No. 12/887,933, Appeal No. 2017-010160, 8 pages, dated Aug. 14, 2018.;;Chen, J.H. et al; “Cation Self-Diffusion in Chalcopyrite and Pyrite”; Metallurgical Transactions B; vol. 6B; pp. 331-339, Jun. 1975.;;Preparation of a Practically Carrier-Free Radioactive Copper Preparation 64Cu with High Activity From Cu Phthalocyanin, Herr et al., 5a 629-630 (1950).;;Measurement of Macrocopic and Microscopic Thermal Neutron Cross Sections of V, Co, Cu, In, Dy and Au Using Neutron Self-Absorption Properties Celenk et al., Journal of Radioanalytrical and Nuclear Chemistry, Articles, vol. 148, No. 2 (1991) 393-401.;;R.J. Batra and A.N. Garg., “Thermal Neutron Activation Analysis of Cu In Its Ores by Using AN 2 4 1 Am—Be Neutron Source,” Journal of Radioanalytical and Nuclear Chemistry, Articles, 129(2), pp. 335-342, 1989.;;Rodger C. Martin and Steven E. Kos, “Applications and Availability of Californium-252 Neutron Sources for Waste Characterization,” Presentation at Spectrum 2000 International Conference on Nuclear and Hazardous Waste Management, Chattanooga, Tennessee, Sep. 24-28, 2000.",ACTIVE
178,US,A,US 1749987 A,166-674-186-655-065,1930-03-11,1930,US 29214328 A,1928-07-12,US 29214328 A,1928-07-12,Broom or the like,,SHAKESPEARE PRODUCTS CO,RUSSELL SAMUEL G;;BUCHANAN ERNEST L;;POTTER ROSSITER R,,https://lens.org/166-674-186-655-065,Granted Patent,no,0,1,1,1,0,A46B3/08;;A46B3/08,A46B3/08,,0,0,,,,EXPIRED
179,US,A1,US 2012/0069946 A1,159-468-936-863-373,2012-03-22,2012,US 88793310 A,2010-09-22,US 88793310 A,2010-09-22,Compact Radioisotope Generator,Disclosed are a method and apparatus for making a radioisotope and a composition of matter including the radioisotope. The radioisotope is made by exposing a material to neutrons from a portable neutron source.,HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL;;SIEMENS MEDICAL SOLUTIONS,HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL,SIEMENS MEDICAL SOLUTIONS USA INC (2010-09-20),https://lens.org/159-468-936-863-373,Patent Application,yes,4,18,6,6,0,G21G2001/0094;;G21G1/06;;G21G2001/0094;;G21G1/06,G21G1/06,376/182;;376/189;;376/158;;376/170,3,2,152-516-170-805-67X;;011-026-620-617-541,10.1007/bf02060371;;10.1007/bf02913577,"Celenk et al., ""Measurment of Macroscope and Microscopic Thermal Neutron Cross Sections of V, Co, Cu, In, Dy, and Au, Using Neutron Self-Absorption Properties."" J. Rad. Nuc. Chem. Vol. 148 No. 2 (1991) pp. 393-401.;;Herr et al., ""Preparation of a Practically Carrier-Free Radioactive Copper Preparation 64Cu With High Activity From Cu Phthalocyanin."" Z. Naturforschg. 5a 629-630 (1950);;Cation Sel-Diffusion in Chalcopyrite and Pyrite, Chen et al. Met. Trans. B v. 6B June 1975.",ACTIVE
180,US,A1,US 2005/0121193 A1,127-401-254-111-601,2005-06-09,2005,US 72745403 A,2003-12-04,US 72745403 A,2003-12-04,Method of optimizing production of gas from subterranean formations,"The present invention relates generally to subterranean well construction, and more particularly, to improved methods for producing gas from subterranean formations that include coal seams. The method according to the present invention includes the steps of drilling at least one substantially vertical well bore intersecting the coal seam, drilling at least one substantially horizontal well bore disposed substantially within the coal seam and exiting from the at least one substantially vertical well bore, and fracturing the coal seam along the at least one substantially horizontal well bore using a hydrajetting tool to produce a plurality of fractures. The plurality of fractures is spaced to maximize interference between the fractures and enhances the production of gas from the coal seam of the subterranean formation. A plurality of substantially horizontal well bores can also be drilled. The plurality of substantially horizontal well bores can be spaced to maximize interference between the substantially horizontal well bores.",BUCHANAN LARRY J.;;WEIDA S. D.;;RUSSELL DON P.,BUCHANAN LARRY J;;WEIDA S D;;RUSSELL DON P,HALLIBURTON ENERGY SERVICES INC (2004-01-22),https://lens.org/127-401-254-111-601,Patent Application,yes,12,25,2,2,0,E21B43/305;;E21B43/305;;E21B43/006;;E21B43/006,E21B43/00;;E21B43/30,166/281;;166/308.1,0,0,,,,EXPIRED
181,US,A1,US 2020/0027620 A1,008-097-549-250-950,2020-01-23,2020,US 201816217111 A,2018-12-12,US 201816217111 A;;US 88793310 A,2010-09-22,Compact Radioisotope Generator,Disclosed are a method and apparatus for making a radioisotope and a composition of matter including the radioisotope. The radioisotope is made by exposing a material to neutrons from a portable neutron source.,SIEMENS MEDICAL SOLUTIONS USA INC,HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL,SIEMENS MEDICAL SOLUTIONS USA INC (2019-01-02),https://lens.org/008-097-549-250-950,Patent Application,yes,0,0,6,6,0,G21G2001/0094;;G21G1/06;;G21G2001/0094;;G21G1/06,G21G1/06,,0,0,,,,ACTIVE
182,US,A1,US 2020/0027619 A1,090-527-874-405-208,2020-01-23,2020,US 201816217103 A,2018-12-12,US 201816217103 A;;US 88793310 A,2010-09-22,Compact Radioisotope Generator,Disclosed are a method and apparatus for making a radioisotope and a composition of matter including the radioisotope. The radioisotope is made by exposing a material to neutrons from a portable neutron source.,SIEMENS MEDICAL SOLUTIONS USA INC,HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL,SIEMENS MEDICAL SOLUTIONS USA INC (2018-12-19),https://lens.org/090-527-874-405-208,Patent Application,yes,0,0,6,6,0,G21G2001/0094;;G21G1/06;;G21G2001/0094;;G21G1/06,G21G1/06,,0,0,,,,ACTIVE
183,US,B2,US 10186337 B2,168-837-622-556-351,2019-01-22,2019,US 88793310 A,2010-09-22,US 88793310 A,2010-09-22,Compact radioisotope generator,"A method and apparatus for making a radioisotope and a composition of matter including the radioisotope. The radioisotope is made by exposing a material to neutrons from a portable neutron source. More specifically, a solution includes a particular isotope. The neutron source is completely surrounded by the solution. The solution is exposed to the neutrons. Generated radioisotopes are extracted from the solution.",HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL;;SIEMENS MEDICAL SOLUTIONS USA INC,HAMILL JAMES J;;SIEGEL STEFAN B;;BUCHANAN CHARLES RUSSELL,SIEMENS MEDICAL SOLUTIONS USA INC (2010-09-20),https://lens.org/168-837-622-556-351,Granted Patent,yes,5,1,6,6,0,G21G2001/0094;;G21G1/06;;G21G2001/0094;;G21G1/06,G21G1/06;;G21G1/00,,5,3,152-516-170-805-67X;;011-026-620-617-541;;036-789-033-862-289,10.1007/bf02060371;;10.1007/bf02913577;;10.1007/bf02039830,"Celenk et al., “Measurment of Macroscope and Microscopic Thermal Neutron Cross Sections of V, Co, Cu, in, Dy, and Au, Using Neutron Self-Absorption Properties.” J. Rad. Nuc. Chem. vol. 148 No. 2 (1991) pp. 393-401.;;Herr et al., “Preparation of a Practically Carrier-Free Radioactive Copper Preparation 64Cu With High Activity From Cu Phthalocyanin.” Z. Naturforschg. 5a 629-630 (1950).;;Cation Sel-Diffusion in Chalcopyrite and Pyrite, Chen et al. Met. Trans. B v. 6B Jun. 1975.;;R.J. Batra and A.N. Garg., “Thermal Neutron Activation Analysis of Cu in its Ores by Using AN 2 4 1 Am—Be Neutron Source,” Journal of Radioanalytical and Nuclear Chemistry, Articles, 129(2), pp. 335-342, 1989.;;Rodger C. Martin and Steven E. Kos, “Applications and Availability of Californium-252 Neutron Sources for Waste Characterization,” Presentation at Spectrum 2000 International Conference on Nuclear and Hazardous Waste Management, Chattanooga, Tennessee, Sep. 24-28, 2000.",ACTIVE
184,US,B2,US 7104320 B2,040-984-417-549-185,2006-09-12,2006,US 72745403 A,2003-12-04,US 72745403 A,2003-12-04,Method of optimizing production of gas from subterranean formations,"The present invention relates generally to subterranean well construction, and more particularly, to improved methods for producing gas from subterranean formations that include coal seams. The method according to the present invention includes the steps of drilling at least one substantially vertical well bore intersecting the coal seam, drilling at least one substantially horizontal well bore disposed substantially within the coal seam and exiting from the at least one substantially vertical well bore, and fracturing the coal seam along the at least one substantially horizontal well bore using a hydrajetting tool to produce a plurality of fractures. The plurality of fractures is spaced to maximize interference between the fractures and enhances the production of gas from the coal seam of the subterranean formation. A plurality of substantially horizontal well bores can also be drilled. The plurality of substantially horizontal well bores can be spaced to maximize interference between the substantially horizontal well bores.",HALLIBURTON ENERGY SERV INC,BUCHANAN LARRY J;;WEIDA S DANA;;RUSSELL DON P,HALLIBURTON ENERGY SERVICES INC (2004-01-22),https://lens.org/040-984-417-549-185,Granted Patent,yes,12,27,2,2,0,E21B43/305;;E21B43/305;;E21B43/006;;E21B43/006,E21B43/26;;E21B43/00;;E21B43/30;;E21B49/00,166/245;;166/250.01;;166/250.1;;166/308.1;;175/62,0,0,,,,INACTIVE
185,AR,A1,AR 058729 A1,016-343-379-112-045,2008-02-20,2008,AR P060105771 A,2006-12-26,GB 0526422 A;;GB 0526662 A;;GB 0607867 A;;US 75363305 P;;US 74525706 P,2005-12-23,AUTENTICACION OPTICA,"Se puede proveer un aparato para determinar una firma de un artículo en un volumen de lectura del aparato. El aparato puede comprender una fuente que se puede operar para generar un rayo coherente y un elemento que dirige un rayo que se puede operar para dirigir el rayo coherente al volumen de lectura. El aparato también puede comprender una configuracion del detector para recoger senales creadas por dispersion del rayo coherente dentro del volumen de lectura, en donde senales diferentes están relacionadas con la dispersion de diferentes partes del volumen de lectura, teniendo la configuracion del detector una apertura numérica mayor que un mínimo predeterminado y un procesador que se puede operar para determinar una firma para un artículo en el volumen de lectura de las senales recogidas. El uso de tal aparto puede ser repetido siempre que se requiera para probar la autenticidad del artículo. Usando este sistema, se ha descubierto que no tiene sentido el esfuerzo y los costos necesarios para realizar tokens preparados especialmente, ya que las características unicas se pueden medir de una manera directa de una amplia variedad de artículos diarios.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,,https://lens.org/016-343-379-112-045,Patent Application,no,0,0,4,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/20;;G06F16/00;;G06V20/80;;G06V10/95;;G06V10/42;;G07D7/121;;G03G21/046;;G06V10/42;;G06V10/95;;G06V20/80,G06V10/42,,0,0,,,,PENDING
186,WO,A1,WO 2007/144598 A1,088-336-073-326-346,2007-12-21,2007,GB 2007002173 W,2007-06-12,GB 0611618 A;;US 80453706 P,2006-06-12,SCANNER AUTHENTICATION,"A method of creating a signature for an article can be provided. The method can comprise illuminating regions of the article sequentially by light at non-normal incidence and detecting light reflected from the surface of each region of the article. The method can further comprise processing signals representative of the reflected light from each region, the signals being indicative of a surface roughness of the region, to determine a signature for the article.",INGENIA TECHNOLOGY LTD;;COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,,https://lens.org/088-336-073-326-346,Patent Application,yes,6,44,5,5,0,G06K19/086;;G07D7/2033;;G06V20/80;;G06V10/10;;G06V40/12;;G06K19/086;;G07D7/2033;;G06V10/10;;G06V20/80,G06V10/10;;G07D7/00,,2,2,013-750-169-137-892;;046-032-889-977-057,16049465;;10.1038/436475a;;10.1016/s0030-4018(97)00546-4,"BUCHANAN J D R ET AL: ""'Fingerprinting' documents and packaging"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 436, 28 July 2005 (2005-07-28), pages 475, XP002422977, ISSN: 0028-0836;;HAIST T ET AL: ""Optical detection of random features for high security applications"", OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173 - 179, XP004118061, ISSN: 0030-4018",PENDING
187,JP,A,JP 2011023015 A,161-614-366-810-468,2011-02-03,2011,JP 2010175324 A,2010-08-04,GB 0526422 A;;US 75363305 P;;GB 0526662 A;;GB 0607867 A;;US 74525706 P,2005-12-23,OPTICAL AUTHENTICATION,"<P>PROBLEM TO BE SOLVED: To provide an apparatus for determining a signature from an article in a reading volume of the apparatus. <P>SOLUTION: The apparatus includes a source light operable so as to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also include a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable so as to determine a signature for an article in the reading volume from the collected signals. Use of such an apparatus can be repeated whenever required to test authenticity of the article. Using this system, it is understood that it is essentially pointless to take the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a simple manner from various everyday articles. <P>COPYRIGHT: (C)2011,JPO&INPIT",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,,https://lens.org/161-614-366-810-468,Patent Application,no,5,6,4,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/20;;G06F16/00;;G06V20/80;;G06V10/95;;G06V10/42;;G07D7/121;;G03G21/046;;G06V10/42;;G06V10/95;;G06V20/80,G06K7/10;;G06V10/42;;H04N1/387,,0,0,,,,INACTIVE
188,US,A1,US 2007/0165208 A1,054-386-074-982-988,2007-07-19,2007,US 61558106 A,2006-12-22,US 61558106 A;;GB 0526422 A;;GB 0607867 A;;GB 0526662 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R;;SEEM PETER R,INGENIA HOLDINGS LIMITED (2011-01-20),https://lens.org/054-386-074-982-988,Patent Application,yes,59,124,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G06V10/141;;G06V10/147;;G06V10/42,356/71,0,0,,,,INACTIVE
189,TW,A,TW 200816061 A,169-421-897-657-802,2008-04-01,2008,TW 96121225 A,2007-06-12,GB 0611618 A;;US 80453706 P,2006-06-12,Scanner authentication,"A method of creating a signature for an article can be provided. The method can comprise illuminating regions of the article sequentially by light at non-normal incidence and detecting light reflected from the surface of each region of the article. The method can further comprise processing signals representative of the reflected light from each region, the signals being indicative of a surface roughness of the region, to determine a signature for the article.",INGENIA TECHNOLOGY LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,,https://lens.org/169-421-897-657-802,Patent of Addition,no,0,0,5,5,0,G06K19/086;;G07D7/2033;;G06V20/80;;G06V10/10;;G06V40/12;;G06K19/086;;G07D7/2033;;G06V10/10;;G06V20/80,G06V10/10;;G07D7/00,,0,0,,,,PENDING
190,CN,A,CN 101385037 A,098-596-902-460-723,2009-03-11,2009,CN 200680053240 A,2006-12-22,GB 0526422 A,2005-12-23,Optical authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;RALPH BUCHANAN JAMES DAVID;;ROBERT SEEM PETER,"ENGENYA HOLDINGS CO., LTD. (2010-04-14)",https://lens.org/098-596-902-460-723,Patent Application,no,0,7,2,30,0,,G06K9/52;;G03G21/04;;G07D7/12,,0,0,,,,DISCONTINUED
191,US,B2,US 7812935 B2,128-453-209-023-048,2010-10-12,2010,US 61558106 A,2006-12-22,US 61558106 A;;GB 0526422 A;;GB 0607867 A;;GB 0526662 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,"An apparatus for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.",INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,INGENIA HOLDINGS LIMITED (2011-01-20),https://lens.org/128-453-209-023-048,Granted Patent,yes,101,47,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G06V10/141;;G06V10/147;;G06V10/42,356/71;;356/341;;356/343,32,10,046-032-889-977-057;;013-750-169-137-892;;117-746-395-397-755;;102-840-775-673-316;;121-035-460-007-543;;041-551-127-916-12X;;014-283-534-008-99X;;010-885-886-851-721;;139-509-297-460-756;;136-658-407-268-598,10.1016/s0030-4018(97)00546-4;;16049465;;10.1038/436475a;;10.1016/s0923-5965(02)00084-x;;10.1006/cviu.2001.0922;;10.1145/1120680.1120685;;10.1145/988772.988797;;10.1126/science.1074376;;12242435;;10.1109/nrsc.2007.371365;;10.1109/tc.2006.138;;10.1016/j.optcom.2004.09.060,"Haist et al., ""Optical detection of random features for high security applications,"" Optics Communications, 147:173-179 (1998).;;Buchanan, James, ""Fingerprinting Documents and Packaging,"" Nature 436, Jul. 28, 2005, p. 475.;;International Search Report for Great Britain patent application No. GB0607867.9, Aug. 2006.;;Kravolec, ""Plastic Tag Makes Foolproof ID,"" Technology Research News, Oct. 2, 2002.;;Anderson, R., ""Security Engineering: A Guide to Building Dependable Distributed Systems,"" Wiley 2001, pp. 251-252.;;Zhang, D., ""Shape-Based Image Retrieval Using Generic Fourier Descriptor,"" Signal Processing. Image Communication, Ellsevier Science Publishers, Amsterdam, NL, Nov. 2002.;;Derrode, S., ""Robust and Efficient Fourier-Mellin Transform Approximations for Gray-Level Image Reconstruction and Complete Invariant Description,"" Computer Vision and Image Understanding, Academic Press, San Diego, CA, Jul. 2001.;;Ravikanth, P, ""Physical One-Way Functions,"" Thesis at the Massachusetts Institute of Technology, pp. 1-154, Mar. 2001.;;Chen, Y., ""Certifying Authenticity via Fiber-Infused Paper,"" Apr. 2005.;;Kirovski, D., ""Toward an Automated Verification of Certificates of Authentication,"" 2004.;;Smalley, ""Plastic Tag Makes Foolproof ID,"" TRN, 2 pages.;;Written Opinion for PCT/GB2007/000015 dated May 4, 2007.;;International Search Report for PCT/GB2009/001702 dated Oct. 23, 2009.;;UK Search Report for GB0812772.2 dated Nov. 6, 2008.;;UK Search Report for GB0812773 dated Mar. 2009.;;UK Search Report for GB0812773 dated Nov. 2008.;;International Search Report for PCT/GB2007/002173 dated Sep. 19, 2007.;;Search Report for GB0720673.3 dated Mar. 28, 2008.;;G.J. Simmons, A survey of information authentication, In Contemporary Cryptology, The Science of Information Integrity , pp. 379-419 IEEE Press (1992).;;International Search Report for PCT/GB2005/0009222 dated Jun. 10, 2005.;;Pappu et al., ""Physical one-way functions,"" Science, American Association for the Advancement of Science, vol. 297, No. 5589, pp. 2026-2030 (2002).;;Cowburn, Russell, ""Nanotechnology-Security and Brand Protection Applications 01,"" Smart Brand and Product Protection Conference 2005, Apr. 8, 2005 to Apr. 9, 2005, pp. 1-4, London, UK.;;Van Renesse R.L., ""Optical inspection techniques for security instrumentation,"" Proceedings of SPIE-The International Society for Optical Engineering, Vo. 2659, pp. 159-167 (Mar. 1996).;;Anonymous, ""Discs and paper get biometric identifiers,"" IEEE Review, vol. 50, No. 12, p. 23, (Dec. 2004).;;Wilkes, Sally, ""Fighting Fraud: Document Biometrics,"" Materials World, vol. 12, No. 12, pp. 29-30 (Dec. 2004).;;Smith et al., ""Microstructure Based Indicia,"" Laboratories Escher Group, pp. 1 -5 (1999).;;El-Khamy S. E. et al., ""The FBG stream cipher,"" Proceedings of the 24th Radio National Science Conference (NRSC 2007) IEEE Cairo, Egypt, pp. 1-8 (Mar. 2007).;;Hao F. et al., ""Combining crypto with biometrics effectively,"" IEEE Transactions on Computers IEEE USA, 55(9):1081-1088 (Sep. 2006).;;International Search Report for Great Britain Patent Application No. GB0711461.4 dated Sep. 21, 2007.;;International Search Report and Written Opinion for PCT/GB2008/002020 dated Jun. 16, 2009.;;Huss G. et al., ""Spatial filtering efficiency of single-mode optical fibers for stellar interferometry applications: phenomenological and numerical study,"" Optics Communications, North-Holland Publishing Co., Amsterdam, NL, 244:209-217 (Sep. 23, 2004).;;Kvasnik et al., ""Image recognition using surface scattered light in a coherent optical processor,"" Image Processing and its Applications, University of Manchester Institute of Science and Technology UK, pp. 361-364 (1992).",INACTIVE
192,US,A,US 3431150 A,160-925-788-011-481,1969-03-04,1969,US 3431150D A,1966-10-07,US 58600166 A,1966-10-07,PROCESS FOR IMPLANTING GRIDS IN SEMICONDUCTOR DEVICES,,US AIR FORCE,DOLAN RUSSELL P JR;;BUCHANAN BOBBY L;;ROOSILD SVEN A,,https://lens.org/160-925-788-011-481,Granted Patent,no,3,19,1,1,0,H01L21/00;;H01L21/00;;H01J37/3171;;H01J37/3171;;H01L21/266;;H01L21/266;;H01L29/00;;H01L29/00;;Y10S257/919;;Y10S257/919,H01J37/317;;H01L21/00;;H01L21/266;;H01L29/00,148/1.5,0,0,,,,EXPIRED
193,US,A1,US 2008/0044096 A1,189-329-471-529-006,2008-02-21,2008,US 76124107 A,2007-06-11,US 76124107 A;;GB 0611618 A;;US 80453706 P,2006-06-12,Scanner Authentication,"A method of creating a signature for an article can be provided. The method can comprise illuminating regions of the article sequentially by light at non-normal incidence and detecting light reflected from the surface of each region of the article. The method can further comprise processing signals representative of the reflected light from each region, the signals being indicative of a surface roughness of the region, to determine a signature for the article.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES D R;;SEEM PETER R,INGENIA HOLDINGS LIMITED (2009-08-14);;INGENIA TECHNOLOGY LIMITED (2007-11-20),https://lens.org/189-329-471-529-006,Patent Application,yes,55,45,5,5,0,G06K19/086;;G07D7/2033;;G06V20/80;;G06V10/10;;G06V40/12;;G06K19/086;;G07D7/2033;;G06V10/10;;G06V20/80,G06V10/10,382/238,0,0,,,,DISCONTINUED
194,US,A,US 5232300 A,114-061-723-240-183,1993-08-03,1993,US 82247392 A,1992-01-17,US 82247392 A,1992-01-17,Brush decontamination kit,"A squeezeable container for holding and dispensing decontaminating powder is disclosed. The squeezeable container comprises a brush assembly and gripping means. The brush assembly is attached to the top section of the container in a screw-like manner, and comprises a brush formed of bristles which have a portion that is heat set so as to be held together in a semi-rigid manner. The bristles are arranged to form a reservoir within the brush assembly. The reservoir has an exit section closed off by the semi-rigid bristles, and an entrance section closed off by a plug member. The gripping means has a first end attached to the plug member and a second end extending out of the semi-rigid bristles. The pulling of the gripping means removes the plug from the dispenser and opens the brush reservoir. A squeezing action of the container puffs the powder within the container into the brush reservoir, and movement of brush dispenses the powder over any designed contaminated area.",PACO PHARMACEUTICAL SERVICES I,BUCHANAN JAMES G;;HAINE JR WALTER A;;HAINES RUSSELL R,PACO PHARMACEUTICAL SERVICES INC (1992-01-15),https://lens.org/114-061-723-240-183,Granted Patent,yes,9,1,1,1,0,A46B17/04;;A46B17/04;;A46B11/0041;;A46B11/0041;;A46B11/0079;;A46B11/0079;;A46B2200/20;;A46B2200/20;;B65D23/04;;B65D23/04;;B65D39/16;;B65D39/16;;B65D47/42;;B65D47/42,A46B11/00;;A46B17/04;;B65D23/04;;B65D39/16;;B65D47/42,401/268;;401/4;;401/186;;401/269;;401/288,1,0,,,Advertisement of the Oneshot roller of the Diagraph Corporation given on p. 4 of the Diagraph Corporation s 1992 catalog.,EXPIRED
195,GB,A,GB 2440386 A,191-211-295-921-073,2008-01-30,2008,GB 0611618 A,2006-06-12,GB 0611618 A,2006-06-12,Scanner authentication,A method of creating a signature for an article such as a sheet of paper comprises: illuminating 12 regions of the article with illumination at a non normal angle relative to detection means 20. The method detects signals indicative of the roughness of the surface of the article and may be used to generate a unique signature. The scanning means may comprise a standard flatbed scanner or photocopier arranged to measure at high contrast. The detection means may be used for authenticating articles against databases of signatures.,INGENIA TECHNOLOGY LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,,https://lens.org/191-211-295-921-073,Patent Application,no,7,10,5,5,0,G06K19/086;;G07D7/2033;;G06V20/80;;G06V10/10;;G06V40/12;;G06K19/086;;G07D7/2033;;G06V10/10;;G06V20/80,G06K7/10;;G06V10/10,,0,0,,,,DISCONTINUED
196,US,B2,US 8497983 B2,194-444-159-285-451,2013-07-30,2013,US 85905310 A,2010-08-18,US 85905310 A;;GB 0526422 A;;GB 0526662 A;;GB 0607867 A;;US 61558106 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.",COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT;;INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,INGENIA HOLDINGS LIMITED (2011-09-09),https://lens.org/194-444-159-285-451,Granted Patent,yes,108,27,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G06V10/141;;G06V10/147;;G06V10/42,356/71;;356/341;;356/400,35,10,014-283-534-008-99X;;010-885-886-851-721;;139-509-297-460-756;;136-658-407-268-598;;041-551-127-916-12X;;121-035-460-007-543;;046-032-889-977-057;;013-750-169-137-892;;117-746-395-397-755;;102-840-775-673-316,10.1126/science.1074376;;12242435;;10.1109/nrsc.2007.371365;;10.1109/tc.2006.138;;10.1016/j.optcom.2004.09.060;;10.1145/988772.988797;;10.1145/1120680.1120685;;10.1016/s0030-4018(97)00546-4;;16049465;;10.1038/436475a;;10.1016/s0923-5965(02)00084-x;;10.1006/cviu.2001.0922,"Search Report for GB0720673.3 dated Mar. 28, 2008.;;G.J. Simmons, A survey of information authentication, in Contemporary Cryptology, The Science of Information Integrity , pp. 379-419 IEEE Press (1992).;;International Search Report for PCT/GB2005/0009222 dated Jun. 10, 2005.;;Pappu et al., ""Physical one-way functions,"" Science, American Association for the Advancement of Science, vol. 297, No. 5589, pp. 2026-2030 (2002).;;Cowburn, Russell, ""Nanotechnology-Security and Brand Protection Applications 01,"" Smart Brand and Product Protection Conference 2005, Apr. 8, 2005 to Apr. 9, 2005, pp. 1-4, London, UK.;;Van Renesse R.L., ""Optical inspection techniques for security instrumentation,"" Proceedings of SPIE-The International Society for Optical Engineering, Vo. 2659, pp. 159-167 (Mar. 1996).;;Anonymous, ""Discs and paper get biometric identifiers,"" IEEE Review, vol. 50, No. 12, p. 23, (Dec. 2004).;;Wilkes, Sally, ""Fighting Fraud: Document Biometrics,"" Materials World, vol. 12, No. 12, pp. 29-30 (Dec. 2004).;;Smith et al., ""Microstructure Based Indicia,"" Laboratories Escher Group, pp. 1-5 (1999).;;Schneier B., ""Applied Cryptography. Protocols, Algorithms, and Source Code in C, Passage,"" Applied Cryptography, 2nd Ed., John Wiley & Sons, Inc., New York, p. 197 (1996).;;El-Khamy S. E. et al., ""The FBG stream cipher,"" Proceedings of the 24th Radio National Science Conference (NRSC 2007) IEEE Cairo, Egypt, pp. 1-8 (Mar. 2007).;;Hao F. et al., ""Combining crypto with biometrics effectively,"" IEEE Transactions on Computers IEEE USA, 55 (9):1081-1088 (Sep. 2006).;;International Search Report for Great Britain Patent Application No. GB0711461.4 dated Sep. 21, 2007.;;International Search Report and Written Opinion for PCT/GB2008/002020 dated Jun. 16, 2009.;;Written Opinion for PCT/GB2007/000015 dated May 4, 2007.;;International Search Report for PCT/GB2009/001702 dated Oct. 23, 2009.;;UK Search Report for GB0812772.2 dated Nov. 6, 2008.;;UK Search Report for GB0812773 dated Mar. 2009.;;UK Search Report for GB0812773 dated Nov. 2008.;;International Search Report for PCT/GB2007/002173 dated Sep. 19, 2007.;;Huss G. et al., ""Spatial filtering efficiency of single-mode optical fibers for stellar interferometry applications: phenomenological and numerical study,"" Optics Communications, North-Holland Publishing Co., Amsterdam, NL, 244:209-217 (Sep. 23, 2004).;;Kvasnik et al., ""Image recognition using surface scattered light in a coherent optical processor,"" Image Processing and its Applications, University of Manchester Institute of Science and Technology UK, pp. 361-364 (1992).;;Kirovski, Darko, ""Toward an Automated Verification of Certificates of Authenticity,"" pp. 160-169 (2004).;;Chen, Yuqun et al., ""Certifying Authenticity via Fiber-Infused Paper,"" ACM SIG ecom Exchanges, 5(3):29-37 (2005).;;Haist et al., ""Optical detection of random features for high security applications,"" Optics Communications, 147:173-179 (1998).;;Buchanan, James, ""Fingerprinting Documents and Packaging,"" Nature, 436:475 (Jul. 28, 2005).;;International Search Report issued by UK Intellectual Property Office for GB0607867.9 dated Aug. 22, 2006.;;Kravolec, ""Plastic Tag Makes Foolproof ID,"" Technology Research News, Oct. 2, 2002.;;Anderson, R., ""Security Engineering: A Guide to Building Dependable Distributed Systems,"" Wiley 2001, pp. 251-252.;;Zhang D et al., ""Shape-based image retrieval using generic Fourier descriptor,"" Signal Processing. Image Communication, Ellsevier Science Publishers, Amsterdam, NL 17(10):825-848 (Nov. 2002).;;Derrode S et al., ""Robust and Efficient Fourier-Mellin Transform Approximations for Gray-Level Image Reconstruction and Complete Invariant Description,"" Computer Vision and Image Understanding, Academic Press, San Diego, CA, 83(1):57-78 (Jul. 2001).;;Ravikanth, Pappu Srinivasa. ""Physical One-Way Functions,"" Thesis at the Massachusetts Institute of Technology, pp. 1-154, Mar. 2001.;;d'Agraives et al., ""Surface Topography. A Remarkable Method for the Identification of Seals of Structures in General,"" Commission of the European Communities Joint Research Centre, Ispra Establishment 1-21020 Ispra (Va), Italy, pp. 403-309 (1981).;;Zwick/Roell-Zwick Materials Testing-the new direction in extension measurement-optiXtens, pp. 1-11 (2003).;;Smalley, Eric, ""Plastic tag makes foolproof ID,"" Technology Research News, Technology Research News LLC, Oct. 2, 2002 (2 pages).",INACTIVE
197,US,A,US 3430113 A,141-577-890-360-875,1969-02-25,1969,US 3430113D A,1965-10-04,US 49295465 A,1965-10-04,CURRENT MODULATED FIELD EFFECT TRANSISTOR,,US AIR FORCE,ROOSILD SVEN A;;BUCHANAN BOBBY L;;DOLAN RUSSELL P JR,,https://lens.org/141-577-890-360-875,Granted Patent,no,9,3,1,1,0,H01L29/739;;H01L29/739;;H01L27/00;;H01L27/00;;H01L29/00;;H01L29/00,H01L27/00;;H01L29/00;;H01L29/739,317/235,0,0,,,,EXPIRED
198,EP,A1,EP 1969525 A1,162-877-951-993-286,2008-09-17,2008,EP 06831458 A,2006-12-22,GB 2006004900 W;;GB 0526422 A;;US 75363305 P;;GB 0526662 A;;GB 0607867 A;;US 74525706 P,2005-12-23,OPTICAL AUTHENTICATION,,INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,INGENIA HOLDINGS LIMITED (2010-04-07),https://lens.org/162-877-951-993-286,Patent Application,yes,0,1,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G03G21/04;;G06V10/141;;G06V10/147;;G06V10/42;;G07D7/12,,0,0,,,,DISCONTINUED
199,WO,A1,WO 2007/072044 A1,130-718-776-193-484,2007-06-28,2007,GB 2006004900 W,2006-12-22,GB 0526422 A;;US 75363305 P;;GB 0526662 A;;GB 0607867 A;;US 74525706 P,2005-12-23,OPTICAL AUTHENTICATION,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.",INGENIA HOLDINGS UK LTD;;COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,,https://lens.org/130-718-776-193-484,Patent Application,yes,3,17,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G03G21/04;;G06V10/141;;G06V10/147;;G06V10/42;;G07D7/12,,2,2,013-750-169-137-892;;046-032-889-977-057,16049465;;10.1038/436475a;;10.1016/s0030-4018(97)00546-4,"BUCHANAN J D R ET AL: ""'Fingerprinting' documents and packaging"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 436, 28 July 2005 (2005-07-28), pages 475, XP002405507, ISSN: 0028-0836;;HAIST T ET AL: ""Optical detection of random features for high security applications"", OPTICS COMMUNICATIONS, NORTH-HOLLAND PUBLISHING CO. AMSTERDAM, NL, vol. 147, no. 1-3, 1 February 1998 (1998-02-01), pages 173 - 179, XP004118061, ISSN: 0030-4018",PENDING
200,AU,A,AU 1986/065245 A,031-935-531-257-445,1987-05-05,1987,AU 1986/065245 A,1986-10-15,US 78839685 A,1985-10-17,SPIRAL COIN-QUEUEING HEAD FOR HIGH-SPEED COIN-SORTING AND COUNTING APPARATUS,,CHILDERS CORP,CHILDERS ROGER K;;BUCHANAN KENNETH L;;DARMOUR CHARLES RUSSELL II,,https://lens.org/031-935-531-257-445,Patent Application,no,0,0,10,10,0,G07D3/128;;G07D9/008;;G07D5/00;;G07D9/008;;G07D3/128,G07D3/12;;G07D3/16;;G07D9/00,,0,0,,,,DISCONTINUED
201,US,A1,US 2010/0316251 A1,005-631-321-792-129,2010-12-16,2010,US 85905310 A,2010-08-18,US 85905310 A;;GB 0526422 A;;GB 0526662 A;;GB 0607867 A;;US 61558106 A;;US 75363305 P;;US 74525706 P,2005-12-23,Optical Authentication,"An apparatus may be provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different parts of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.",INGENIA HOLDINGS LTD,COWBURN RUSSELL PAUL;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,INGENIA HOLDINGS LIMITED (2011-09-09),https://lens.org/005-631-321-792-129,Patent Application,yes,100,40,20,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/128;;G07D7/20;;G06F16/00;;G09C1/00;;G09C5/00;;G06V20/80;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/42;;G06V10/7515;;G06K7/10;;G07D7/12;;G06F16/24561;;G06F16/3331;;G06T7/40;;G07D7/121;;G03G21/046;;G07D7/128;;G07D7/121;;G07D7/004;;G07D7/20;;G09C1/00;;G06F16/00;;G09C5/00;;G06V10/42;;G06V10/95;;G06V10/141;;G06V10/147;;G06V10/431;;G06V10/7515;;G06V20/80,G06V10/141;;G06V10/147;;G06V10/42,382/100,0,0,,,,INACTIVE
202,TW,A,TW 200734200 A,042-843-434-106-435,2007-09-16,2007,TW 95148839 A,2006-12-25,GB 0526422 A;;US 75363305 P;;GB 0526662 A;;GB 0607867 A;;US 74525706 P,2005-12-23,Iptical authentication,"An apparatus maybe provided for determining a signature from an article in a reading volume of the apparatus. The apparatus can comprise a source operable to generate a coherent beam and a beam directing member operable to direct the coherent beam into the reading volume. The apparatus may also comprise a detector arrangement for collecting signals created by scatter of the coherent beam within the reading volume, wherein different ones of the signals relate to scatter from different of the reading volume, the detector arrangement having a numerical aperture greater than a predetermined minimum and a processor operable to determine a signature for an article in the reading volume from the collected signals. Use of such apparatus can be repeated whenever required to test authenticity of the article. Using this system, it has been is discovered that it is essentially pointless to go to the effort and expense of making specially prepared tokens, since unique characteristics are measurable in a straightforward manner from a wide variety of every day articles.",INGENIA HOLDINGS UK LTD,COWBURN RUSSELL P;;BUCHANAN JAMES DAVID RALPH;;SEEM PETER ROBERT,,https://lens.org/042-843-434-106-435,Patent of Addition,no,0,7,4,30,0,G03G21/046;;G07D7/004;;G07D7/121;;G07D7/20;;G06F16/00;;G06V20/80;;G06V10/95;;G06V10/42;;G07D7/121;;G03G21/046;;G06V10/42;;G06V10/95;;G06V20/80,G06V10/42,,0,0,,,,PENDING
203,BR,A,BR 8606929 A,183-841-288-657-514,1987-11-03,1987,BR 8606929 A,1986-10-15,US 78839685 A;;US 8602174 W,1985-10-17,CABECA DE ENFILEIRAMENTO DE MOEDA ESPIRAL PARA APARELHO DE SEPARACAO E CONTAGEM DE MOEDA DE ALTA VELOCIDADE,,CHILDERS CORP,CHILDERS ROGER K;;BUCHANAN KENNETH L;;DARMOUR CHARLES RUSSELL II,,https://lens.org/183-841-288-657-514,Patent Application,no,0,1,10,10,0,G07D3/128;;G07D9/008;;G07D5/00;;G07D9/008;;G07D3/128,G07D3/12;;G07D3/16;;G07D9/00,,0,0,,,,DISCONTINUED
204,US,A,US 1181429 A,170-817-972-837-341,1916-05-02,1916,US 4199915 A,1915-07-26,US 4199915 A,1915-07-26,CORN-HEADING KNIFE.,,BUCHANAN LEMUEL O;;MADDOX JOHN S;;RUSSELL JAMES P;;SPEERS ALBERT,BUCHANAN LEMUEL O;;MADDOX JOHN S;;RUSSELL JAMES P;;SPEERS ALBERT,,https://lens.org/170-817-972-837-341,Granted Patent,no,0,0,1,1,0,B26B27/007;;B26B27/007,,,0,0,,,,EXPIRED
205,US,S,US D0554907 S,066-816-008-380-359,2007-11-13,2007,US 25395806 F,2006-02-15,US 25395806 F,2006-02-15,Store wall fixture,,BAKERS FOOTWEAR GROUP INC,EDISON PETER A;;VANDER PLUYM JOSEPH R;;OBATA KIKU;;BUCHANAN JR RUSSELL,BAKERS FOOTWEAR GROUP INC (2006-03-24);;BAKERS 2013 LLC (2013-02-28),https://lens.org/066-816-008-380-359,Design Right,no,0,21,1,1,0,,,0604;;D 6478;;D6/479,0,0,,,,EXPIRED
206,US,S,US D0553878 S,056-974-006-214-833,2007-10-30,2007,US 25408406 F,2006-02-16,US 25408406 F,2006-02-16,Store counter display and backdrop area,,BAKERS FOOTWEAR GROUP INC,EDISON PETER A;;VANDER PLUYM JOSEPH R;;OBATA KIKU;;BUCHANAN JR RUSSELL,BAKERS FOOTWEAR GROUP INC (2006-03-24);;BAKERS 2013 LLC (2013-02-28),https://lens.org/056-974-006-214-833,Design Right,no,0,2,1,1,0,,,0604;;D 6436;;D6/396,0,0,,,,EXPIRED
207,US,A,US 3895738 A,112-183-257-228-066,1975-07-22,1975,US 39884173 A,1973-09-20,US 39884173 A,1973-09-20,Gasoline dispensing system,"An improved system for dispensing of gasoline and the like which utilizes electronic computational and control devices to meter selected grades of gasoline while accurately computing the money price of dispensed gasoline. The system utilizes meters controlling the flow of multiple grades of gasoline in such manner that gasoline may be dispensed in any of a plurality of separate grades or blended grades, and associated computational equipment driven in response to such metering outputs accurately compute the gallonage delivered for each grade as well as the proportional unit price for the particular selected grade or blend of grades dispensed. The equipment utilizes a plurality of dispensing meters which provide an electronic pulse output for subsequent processing through a multiplexer to derive pulse count for gallonage dispensed from all meters; thereafter, the multiplexed pulse output is utilized in computational equipment to provide count output and display of both gallons dispensed per grade or blend and the price for such dispensing. Central totalizing equipment provides continual count of all gallonage dispensed for each grade from any or all associated dispensers while also providing totalization of the money value of the gallons dispensed.",BUCHANAN GEORGE E;;KRONE DONALD R;;KRONE RUSSELL R;;NOYES JAMES E,BUCHANAN GEORGE E;;KRONE DONALD R;;KRONE RUSSELL R;;NOYES JAMES E,,https://lens.org/112-183-257-228-066,Granted Patent,no,3,27,1,1,0,B67D7/228;;G06Q50/06;;G07F13/025;;B67D7/228;;G06Q50/06;;G07F13/025,B67D7/22;;G07F13/02,222/26,0,0,,,,EXPIRED
208,US,S,US D0549012 S,170-436-969-175-675,2007-08-21,2007,US 25397006 F,2006-02-15,US 25397006 F,2006-02-15,Pedestal display table,,BAKERS FOOTWEAR GROUP INC,EDISON PETER A;;VANDER PLUYM JOSEPH R;;OBATA KIKU;;BUCHANAN JR RUSSELL,BAKERS FOOTWEAR GROUP INC (2006-03-24);;BAKERS 2013 LLC (2013-02-28),https://lens.org/170-436-969-175-675,Design Right,no,0,8,1,1,0,,,0603;;D 6486;;D6/495,0,0,,,,EXPIRED
209,WO,A3,WO 2008/067045 A3,074-466-120-668-97X,2008-10-30,2008,US 2007/0080991 W,2007-10-10,US 82950606 P,2006-10-13,CRYSTALS AND STRUCTURES OF RON KINASE,"The present invention provides machine readable media embedded with the three- dimensional molecular structure coordinates of RONKD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of RONKD or RONKD crystals and compounds and compositions that affect RON activity.",SGX PHARMACEUTICALS INC;;LOUIE GORDON V;;BUCHANAN SEAN GRANT;;RUSSELL MARIJANE;;ADAMS JASON;;ROMERO RICHARD,LOUIE GORDON V;;BUCHANAN SEAN GRANT;;RUSSELL MARIJANE;;ADAMS JASON;;ROMERO RICHARD,,https://lens.org/074-466-120-668-97X,Search Report,yes,1,0,2,2,0,C12N9/12;;C07K2299/00,C12N9/12;;A61K45/00;;G06F17/50,,15,15,065-509-465-274-600;;005-827-225-132-168;;051-509-608-666-145;;025-760-309-469-78X;;078-693-761-098-570;;132-814-004-003-989;;099-644-743-069-910;;053-880-350-666-162;;066-782-625-682-376;;040-847-392-778-764;;009-096-178-362-516;;068-084-785-084-230;;074-242-724-019-45X;;002-960-475-608-054;;081-543-055-861-537,pmc231551;;8816464;;10.1128/mcb.16.10.5518;;10.1038/sj.onc.1205783;;12214279;;pmc395256;;10.1002/j.1460-2075.1994.tb06659.x;;8062829;;10.1073/pnas.1734128100;;10.2210/pdb1r0p/pdb;;14559966;;pmc240673;;10959094;;10.1002/1098-2264(2000)9999:9999<::aid-gcc1015>3.0.co;2-n;;10.1002/1098-2264(2000)9999:9999<::aid-gcc1015>3.3.co;2-e;;10.2174/1568009033333745;;12570659;;15827676;;10.1245/aso.2005.08.013;;11593422;;10.1038/sj.onc.1204836;;10.1158/0008-5472.can-06-0283;;16982759;;10.3998/ark.5550190.0007.805;;12833670;;11790605;;10.1016/s1359-6446(01)02091-8;;10.2174/157016306776637564;;16712463;;15031492;;10.1126/science.1095920;;15993809;;10.1016/s1359-6446(05)03484-7,"COLLESI CHIARA ET AL: ""A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype"", MOLECULAR AND CELLULAR BIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, vol. 16, no. 10, 1 January 1996 (1996-01-01), pages 5518 - 5526, XP002411431, ISSN: 0270-7306;;CHEN YI-QING ET AL: ""Targeted expression of the receptor tyrosine kinase RON in distal lung epithelial cells results in multiple tumor formation: oncogenic potential of RON in vivo."", ONCOGENE 12 SEP 2002, vol. 21, no. 41, 12 September 2002 (2002-09-12), pages 6382 - 6386, XP002491940, ISSN: 0950-9232;;GAUDINO G ET AL: ""RON IS A HETERODIMERIC TYROSINE KINASE RECEPTOR ACTIVATED BY THE HGF HOMOLOGUE MSP"", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 13, no. 15, 1 January 1994 (1994-01-01), pages 3524 - 3532, XP002036128, ISSN: 0261-4189;;SCHIERING NIKOLAUS ET AL: ""Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a."", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 28 OCT 2003, vol. 100, no. 22, 28 October 2003 (2003-10-28), pages 12654 - 12659, XP002491742, ISSN: 0027-8424;;ANGELONI D ET AL: ""Gene structure of the human receptor tyrosine kinase RON and mutation analysis in lung cancer samples."", GENES, CHROMOSOMES & CANCER OCT 2000, vol. 29, no. 2, October 2000 (2000-10-01), pages 147 - 156, XP002491741, ISSN: 1045-2257;;DANILKOVITCH-MIAGKOVA ALLA: ""Oncogenic signaling pathways activated by RON receptor tyrosine kinase."", CURRENT CANCER DRUG TARGETS FEB 2003, vol. 3, no. 1, February 2003 (2003-02-01), pages 31 - 40, XP009104463, ISSN: 1568-0096;;RAMSAY CAMP E ET AL: ""RON, a Tyrosine Kinase Receptor Involved in Tumor Progression and Metastasis"", ANNALS OF SURGICAL ONCOLOGY, SPRINGER-VERLAG, NE, vol. 12, no. 4, 1 April 2005 (2005-04-01), pages 273 - 281, XP019369668, ISSN: 1534-4681;;PEACE BELINDA E ET AL: ""Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis"", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 20, no. 43, 27 September 2001 (2001-09-27), pages 6142 - 6151, XP009102370, ISSN: 0950-9232;;O'TOOLE JENNIFER M ET AL: ""Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member"", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, vol. 66, no. 18, 15 September 2006 (2006-09-15), pages 9162 - 9170, XP009102372, ISSN: 0008-5472;;MORETTI L., TCHERNIN L. , SCAPOZZA L.: ""Tyrosine Kinase drug discovery: what can be learned from solved crystal structures?"", ARKIVOC, vol. viii, 16 May 2006 (2006-05-16), http://www.arkat-usa.org/arkivoc-journal/browse-arkivoc/2006/8/, pages 38 - 49, XP002491744;;LANGER T ET AL: ""CHEMICAL FEATURE-BASED PHARMACOPHORES AND VIRTUAL LIBRARY SCREENING FOR DISCOVERY OF NEW LEADS"", CURRENT OPINION IN DRUG DISCOVERY AND DEVELOPMENT, CURRENT DRUGS, LONDON, GB, vol. 6, no. 3, 1 May 2003 (2003-05-01), pages 370 - 376, XP008056088, ISSN: 1367-6733;;SCHNEIDER G ET AL: ""VIRTUAL SCREENING AND FAST AUTOMATED DOCKING METHODS"", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 7, no. 1, 1 January 2002 (2002-01-01), pages 64, XP009069134, ISSN: 1359-6446;;BALAKIN KONSTANTIN V ET AL: ""Rational design approaches to chemical libraries for hit identification."", CURRENT DRUG DISCOVERY TECHNOLOGIES MAR 2006, vol. 3, no. 1, March 2006 (2006-03-01), pages 49 - 65, XP009104569, ISSN: 1570-1638;;NOBLE MARTIN E M ET AL: ""Protein kinase inhibitors: insights into drug design from structure."", SCIENCE (NEW YORK, N.Y.) 19 MAR 2004, vol. 303, no. 5665, 19 March 2004 (2004-03-19), pages 1800 - 1805, XP002492249, ISSN: 1095-9203;;CONGREVE M ET AL: ""Keynote review: Structural biology and drug discovery"", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 10, no. 13, 1 July 2005 (2005-07-01), pages 895 - 907, XP004966896, ISSN: 1359-6446",PENDING
210,WO,A2,WO 2008/067045 A2,170-785-773-731-540,2008-06-05,2008,US 2007/0080991 W,2007-10-10,US 82950606 P,2006-10-13,CRYSTALS AND STRUCTURES OF RON KINASE,"The present invention provides machine readable media embedded with the three- dimensional molecular structure coordinates of RONKD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of RONKD or RONKD crystals and compounds and compositions that affect RON activity.",STRUCTURAL GENOMIX INC;;LOUIE GORDON V;;BUCHANAN SEAN GRANT;;RUSSELL MARIJANE;;ADAMS JASON;;ROMERO RICHARD,LOUIE GORDON V;;BUCHANAN SEAN GRANT;;RUSSELL MARIJANE;;ADAMS JASON;;ROMERO RICHARD,,https://lens.org/170-785-773-731-540,Patent Application,yes,0,0,2,2,0,C12N9/12;;C07K2299/00,C12N9/00,,0,0,,,,PENDING
211,US,S,US D0543383 S,032-165-323-189-597,2007-05-29,2007,US 25399306 F,2006-02-15,US 25399306 F,2006-02-15,Store window display fixture with stripe,,BAKERS FOOTWEAR GROUP INC,EDISON PETER A;;VANDER PLUYM JOSEPH R;;OBATA KIKU;;BUCHANAN JR RUSSELL,BAKERS FOOTWEAR GROUP INC (2006-03-26);;BAKERS 2013 LLC (2013-02-28),https://lens.org/032-165-323-189-597,Design Right,no,0,11,1,1,0,,,0601;;D 6474,0,0,,,,EXPIRED
212,US,S,US D0556489 S,136-801-571-875-452,2007-12-04,2007,US 25399206 F,2006-02-15,US 25399206 F,2006-02-15,Accessory wall panel,,BAKERS FOOTWEAR GROUP INC,EDISON PETER A;;VANDER PLUYM JOSEPH R;;OBATA KIKU;;BUCHANAN JR RUSSELL,BAKERS FOOTWEAR GROUP INC (2006-03-24);;BAKERS 2013 LLC (2013-02-28),https://lens.org/136-801-571-875-452,Design Right,no,0,0,1,1,0,,,0604;;D 6571,0,0,,,,EXPIRED
213,US,S,US D0554908 S,163-720-440-851-260,2007-11-13,2007,US 25407706 F,2006-02-16,US 25407706 F,2006-02-16,Store wall fixture,,BAKERS FOOTWEAR GROUP INC,EDISON PETER A;;VANDER PLUYM JOSEPH R;;OBATA KIKU;;BUCHANAN JR RUSSELL,BAKERS FOOTWEAR GROUP INC (2006-03-24);;BAKERS 2013 LLC (2013-02-28),https://lens.org/163-720-440-851-260,Design Right,no,0,21,1,1,0,,,0604;;D 6478;;D6/479,0,0,,,,EXPIRED
214,US,S,US D0539564 S,041-193-393-023-319,2007-04-03,2007,US 25394106 F,2006-02-15,US 25394106 F,2006-02-15,Display table,,BAKERS FOOTWEAR GROUP INC,EDISON PETER A;;VANDER PLUYM JOSEPH R;;OBATA KIKU;;BUCHANAN JR RUSSELL,BAKERS FOOTWEAR GROUP INC (2006-03-24);;BAKERS 2013 LLC (2013-02-28),https://lens.org/041-193-393-023-319,Design Right,no,0,0,1,1,0,,,0604;;D 6474,0,0,,,,EXPIRED
215,US,A1,US 2004/0258615 A1,078-698-790-994-49X,2004-12-23,2004,US 82799104 A,2004-04-20,US 82799104 A;;US 46442403 P,2003-04-22,System and method for synthesis of molecular imaging probes including FDG,"
   The invention provides a method and apparatus for preparation of radiochemicals wherein the reaction that couples the radioactive isotope to the reactive precursor to form a positron-emitting molecular imaging probe is performed in a microfluidic environment. The method comprises providing a micro reactor, providing a precursor solution and introducing the precursor solution into the micro reactor, wherein the precursor solution comprises a reactive precursor adapted for reaction with a radioactive isotope and dissolved in an organic solvent, providing a radioactive solution and introducing the radioactive solution into the micro reactor, wherein the radioactive solution comprises a radioactive isotope dissolved in an organic solvent, and uniting the precursor solution with the radioactive solution in a microchannel of the micro reactor enabling the reactive precursor to react with the radioactive isotope as the precursor solution and radioactive solution flow in the microchannel to form a radiochemical in solution. 
",MOLECULAR TECHNOLOGIES INC,BUCHANAN CHARLES RUSSELL;;PADGETT HENRY C;;COLLIER THOMAS LEE;;MATTEO JOSEPH C;;ALVORD CHARLES W,MOLECULAR TECHNOLOGIES INC (2004-08-10),https://lens.org/078-698-790-994-49X,Patent Application,yes,3,51,10,10,0,A61K51/0491;;A61K51/0491;;A61K51/0402;;A61K51/0402;;A61K51/0453;;A61K51/0453;;A61K51/0455;;A61K51/0455;;A61K51/0459;;A61K51/0459;;B01J19/0093;;B01J19/0093;;B01J2219/00873;;B01J2219/00873;;B01J2219/00889;;B01J2219/00889;;B01J2219/00891;;B01J2219/00891;;B01J2219/0095;;B01J2219/0095;;G21G1/0005;;G21G1/0005;;G21G4/08;;G21G4/08;;G21H5/02;;G21H5/02,A61B/;;A61K51/00;;B01D57/02;;B01D59/42;;B01D59/50;;B01L3/00;;C02F1/40;;C02F11/00;;C25B11/00;;C25B13/00;;G01J1/42;;G01N25/20;;G01N27/26;;G01N27/27;;G01T/;;G21G4/08;;G21H5/02;;H01L27/00,424/1.11,0,0,,,,DISCONTINUED
216,US,A1,US 2004/0262158 A1,108-718-390-901-997,2004-12-30,2004,US 82884404 A,2004-04-21,US 82884404 A;;US 46442403 P,2003-04-22,Solid-state beta detector for microfluidic devices,"
   A beta detector assembly for use in the synthesis and analysis of radiopharmaceuticals, such as in microfluidic radiochromatography. The beta detector assembly includes a base, preferably fabricated from glass so as to take advantage of electroosmotic flow, that serves as the body of the beta detector assembly. A microfluidic channel passes through the length of the base. A solid-state charge particle detector, for detecting beta particles, is provided and is positioned with respect to the base so as to receive beta particles. A portion of the base is disposed between the microfluidic channel and the solid-state charge particle detector and has a thickness that is selected to substantially allow transmission of beta particles there thru for detection by the charge particle detector. In one embodiment, the base is fabricated of glass. In another embodiment, the base is fabricated of silicon such that the base and the solid-state charge particle detector are integral. 
",MOLECULAR TECHNOLOGIES INC,ALVORD CHARLES W;;BUCHANAN CHARLES RUSSELL;;MATTEO JOSEPH C;;PADGETT HENRY CLIFTON;;COLLIER THOMAS LEE,MOLECULAR TEHNOLOGIES INC (2004-08-10),https://lens.org/108-718-390-901-997,Patent Application,yes,4,5,10,10,0,A61K51/0491;;A61K51/0491;;A61K51/0402;;A61K51/0402;;A61K51/0453;;A61K51/0453;;A61K51/0455;;A61K51/0455;;A61K51/0459;;A61K51/0459;;B01J19/0093;;B01J19/0093;;B01J2219/00873;;B01J2219/00873;;B01J2219/00889;;B01J2219/00889;;B01J2219/00891;;B01J2219/00891;;B01J2219/0095;;B01J2219/0095;;G21G1/0005;;G21G1/0005;;G21G4/08;;G21G4/08;;G21H5/02;;G21H5/02,A61B/;;A61K51/00;;B01D57/02;;B01D59/42;;B01D59/50;;B01L3/00;;C02F1/40;;C02F11/00;;C25B11/00;;C25B13/00;;G01J1/42;;G01N25/20;;G01N27/26;;G01N27/27;;G01T/;;G21G4/08;;G21H5/02;;H01L27/00,2044,0,0,,,,DISCONTINUED
217,EP,A4,EP 1583827 A4,102-408-388-699-556,2006-07-12,2006,EP 03814310 A,2003-12-18,US 0340935 W;;US 43547602 P;;US 73857503 A,2002-12-20,CRYSTALS AND STRUCTURES OF SPLEEN TYROSINE KINASE SYKKD,,STRUCTURAL GENOMIX INC,ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,,https://lens.org/102-408-388-699-556,Search Report,no,3,0,7,7,0,C07K14/705;;C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00;;C07K14/705,C07K14/705;;C12N9/12,,6,6,095-285-822-151-982;;008-153-296-969-345;;071-270-829-313-494;;028-464-934-618-27X;;032-040-871-883-695;;046-476-323-617-375,9698567;;10.1006/jmbi.1998.1964;;10.1016/s0021-9258(17)32717-5;;8163536;;10.1038/372746a0;;7997262;;0007997262;;10.2174/1389450003349074;;11467076;;11676469;;10.1006/bbrc.2001.5788;;10.1093/oxfordjournals.jbchem.a002970;;11481033,"FUTTERER K ET AL: ""Structural basis for syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide"", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 281, no. 3, 21 August 1998 (1998-08-21), pages 523 - 537, XP004462386, ISSN: 0022-2836;;LAW CHE-LEUNG ET AL: ""Molecular cloning of human syk: A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex"", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 269, no. 16, 22 April 1994 (1994-04-22), pages 12310 - 12319, XP002200453, ISSN: 0021-9258;;HUBBARD S R ET AL: ""CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN RECEPTOR"", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 372, 22 December 1994 (1994-12-22), pages 746 - 754, XP002061072, ISSN: 0028-0836;;BROADBRIDGE R J ET AL: ""The Src homology-2 domains (SH2 domains) of the protein tyrosine kinase p56lck: structure, mechanism and drug design."", CURRENT DRUG TARGETS. DEC 2000, vol. 1, no. 4, December 2000 (2000-12-01), pages 365 - 386, XP002382016, ISSN: 1389-4501;;YANAGI S ET AL: ""Syk expression and novel function in a wide variety of tissues."", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2 NOV 2001, vol. 288, no. 3, 2 November 2001 (2001-11-02), pages 495 - 498, XP002382017, ISSN: 0006-291X;;SADA K ET AL: ""Structure and function of Syk protein-tyrosine kinase."", JOURNAL OF BIOCHEMISTRY. AUG 2001, vol. 130, no. 2, August 2001 (2001-08-01), pages 177 - 186, XP009066874, ISSN: 0021-924X",DISCONTINUED
218,AU,A1,AU 2003/301227 A1,166-480-907-875-020,2004-07-22,2004,AU 2003/301227 A,2003-12-18,US 73857503 A;;US 43547602 P;;US 0340935 W,2002-12-20,CRYSTALS AND STRUCTURES OF SPLEEN TYROSINE KINASE SYKKD,,STRUCTURAL GENOMIX INC,ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,,https://lens.org/166-480-907-875-020,Patent Application,no,0,0,7,7,0,C07K14/705;;C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00;;C07K14/705,C07K14/705;;C12N9/12,,0,0,,,,DISCONTINUED
219,WO,A3,WO 2004/058177 A3,064-834-588-890-086,2005-05-26,2005,US 0340935 W,2003-12-18,US 43547602 P;;US 73857503 A,2002-12-20,CRYSTALS AND STRUCTURES OF SPLEEN TYROSINE KINASE SYKKD,"The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of SYKKD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of SYKKD, and compounds and compositions that affect SYK activity.",STRUCTURAL GENOMIX INC;;ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,,https://lens.org/064-834-588-890-086,Search Report,yes,3,0,7,7,0,C07K14/705;;C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00;;C07K14/705,C07K14/705;;C12N9/12,,3,3,008-596-021-979-272;;082-764-722-496-277;;057-481-734-602-851,1703531;;10.1016/s0021-9258(18)52281-x;;11494125;;10.1038/sj.onc.1204515;;12668002;;10.1016/s0960-894x(03)00163-x,"LITWIN C.M. ET AL: ""Purification and Characterization of a pp60c-src-related Tyrosine Kinase that Effectively Phosphorylates a Synthetic Peptide Derived from p34cdc2"", J. BIOL. CHEM., vol. 266, no. 4, 5 February 1991 (1991-02-05), pages 2557 - 2566, XP002985456;;GOODMAN P.A. ET AL: ""Spleen Tyrosine Kinase (Syk) Deficiency in Childhood pro-B Cell Acute Lymphoblastic Leukemia"", ONCOGENE, vol. 20, no. 30, 5 July 2001 (2001-07-05), pages 3969 - 3978, XP002985457;;CYWIN C.Y. ET AL: ""Discovery and SAR of Novel [1,6]Naphthyridines as Potent Inhibitors of Spleen Tyrosine Kinase (SYK)"", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 8, 17 April 2003 (2003-04-17), pages 1415 - 1418, XP002985458",PENDING
220,US,A1,US 2004/0253178 A1,061-582-612-477-367,2004-12-16,2004,US 73857503 A,2003-12-17,US 73857503 A;;US 43547602 P,2002-12-20,Crystals and structures of spleen tyrosine kinase SYKKD,"
   The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of SYKKD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of SYKKD, and compounds and compositions that affect SYK activity. 
",ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J.,ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,SGX PHARMACEUTICALS INC (2005-08-30);;STRUCTURAL GENOMIX (2004-04-02),https://lens.org/061-582-612-477-367,Patent Application,yes,2,7,7,7,13,C07K14/705;;C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00;;C07K14/705,C07K14/705;;C12N9/12,424/1.69;;X53035;;702/19,0,0,,,,DISCONTINUED
221,DE,D1,DE 69030130 D1,191-828-368-048-413,1997-04-17,1997,DE 69030130 T,1990-04-24,US 34398189 A,1989-04-26,Photographisches Material und Verfahren,,EASTMAN KODAK CO,BUCHANAN JOHN MICHAEL;;COOK EWELL RUSSELL;;MOOBERRY JARED BEN;;PROEHL GARY STEPHEN;;SINGER STEPHEN PAUL;;WASHBURN WILLIAM NAVIE,,https://lens.org/191-828-368-048-413,Granted Patent,no,0,0,9,9,0,G03C7/30511;;G03C7/30511;;Y10S430/156;;Y10S430/156;;Y10S430/157;;Y10S430/157;;Y10S430/158;;Y10S430/158;;Y10S430/159;;Y10S430/159;;Y10S430/16;;Y10S430/16;;Y10S430/161;;Y10S430/161,G03C1/06;;G03C1/43;;G03C7/305;;G03C7/392,,0,0,,,,EXPIRED
222,WO,A2,WO 2004/058177 A2,083-145-415-004-387,2004-07-15,2004,US 0340935 W,2003-12-18,US 43547602 P;;US 73857503 A,2002-12-20,CRYSTALS AND STRUCTURES OF SPLEEN TYROSINE KINASE SYKKD,"The present invention provides machine readable media embedded with the three-dimensional molecular structure coordinates of SYKKD and subsets thereof, including binding pockets, methods of using the structure to identify and design affecters, including inhibitors and activator, mutants of SYKKD, and compounds and compositions that affect SYK activity.",STRUCTURAL GENOMIX INC;;ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,,https://lens.org/083-145-415-004-387,Patent Application,yes,0,0,7,7,0,C07K14/705;;C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00;;C07K14/705,C07K14/705;;C12N9/12,,0,0,,,,PENDING
223,EP,A2,EP 1583827 A2,070-641-693-826-883,2005-10-12,2005,EP 03814310 A,2003-12-18,US 0340935 W;;US 43547602 P;;US 73857503 A,2002-12-20,CRYSTALS AND STRUCTURES OF SPLEEN TYROSINE KINASE SYKKD,,STRUCTURAL GENOMIX INC,ATWELL SHANE;;HENDLE JORG;;BUCHANAN SEAN GRANT;;FEIL INGEBORG;;RUSSELL MARIJANE;;BADGER JOHN;;TOMIMOTO MASAKI;;SAUDER MICHAEL J,,https://lens.org/070-641-693-826-883,Patent Application,yes,0,0,7,7,13,C07K14/705;;C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00;;C07K14/705,C07K14/705;;C12N9/12,,0,0,,,,DISCONTINUED
224,EP,B1,EP 0394974 B1,079-605-235-646-956,1997-03-12,1997,EP 90107789 A,1990-04-24,US 34398189 A,1989-04-26,Photographic material and process,,EASTMAN KODAK CO,BUCHANAN JOHN MICHAEL;;COOK EWELL RUSSELL;;MOOBERRY JARED BEN;;PROEHL GARY STEPHEN;;SINGER STEPHEN PAUL;;WASHBURN WILLIAM NAVIE,,https://lens.org/079-605-235-646-956,Granted Patent,yes,3,0,9,9,0,G03C7/30511;;G03C7/30511;;Y10S430/156;;Y10S430/156;;Y10S430/157;;Y10S430/157;;Y10S430/158;;Y10S430/158;;Y10S430/159;;Y10S430/159;;Y10S430/16;;Y10S430/16;;Y10S430/161;;Y10S430/161,G03C1/06;;G03C1/43;;G03C7/305;;G03C7/392,,0,0,,,,EXPIRED
225,AU,A8,AU 2003/301227 A8,039-810-627-145-298,2004-07-22,2004,AU 2003/301227 A,2003-12-18,US 73857503 A;;US 43547602 P;;US 0340935 W,2002-12-20,Crystals and structures of spleen tyrosine kinase sykkd,,STRUCTURAL GENOMIX INC,BUCHANAN SEAN GRANT;;SAUDER MICHAEL J;;BADGER JOHN;;RUSSELL MARIJANE;;FEIL INGEBORG;;TOMIMOTO MASAKI;;HENDLE JORG;;ATWELL SHANE,,https://lens.org/039-810-627-145-298,Patent Application,no,0,0,7,7,0,C07K14/705;;C07K2299/00;;C12N9/1205;;C12N9/1205;;C07K2299/00;;C07K14/705,C07K14/705;;C12N9/12,,0,0,,,,DISCONTINUED
226,DE,T2,DE 69030130 T2,059-930-605-765-383,1997-10-09,1997,DE 69030130 T,1990-04-24,US 34398189 A,1989-04-26,Photographisches Material und Verfahren,,EASTMAN KODAK CO,BUCHANAN JOHN MICHAEL;;COOK EWELL RUSSELL;;MOOBERRY JARED BEN;;PROEHL GARY STEPHEN;;SINGER STEPHEN PAUL;;WASHBURN WILLIAM NAVIE,,https://lens.org/059-930-605-765-383,Granted Patent,no,0,0,9,9,0,G03C7/30511;;G03C7/30511;;Y10S430/156;;Y10S430/156;;Y10S430/157;;Y10S430/157;;Y10S430/158;;Y10S430/158;;Y10S430/159;;Y10S430/159;;Y10S430/16;;Y10S430/16;;Y10S430/161;;Y10S430/161,G03C1/06;;G03C1/43;;G03C7/305;;G03C7/392,,0,0,,,,EXPIRED
227,US,A1,US 2004/0153840 A1,130-579-746-490-35X,2004-08-05,2004,US 31580702 A,2002-12-10,US 31580702 A,2002-12-10,Method and system for detection and correction of entrance into an improper MBR state in a computer system,"
   Aspects for detection and correction of entrance into an improper master boot record (MBR) state in a computer system are described. The aspects include providing a proxy MBR at a predetermined location on a storage device of a computer system to provide a proxy MBR. The proxy MBR is then utilized during a restart operation. An original MBR maintained at an original location on the storage device is then utilized during a reboot operation when the utilization of the proxy MBR is unsuccessful. 
",IBM,BUCHANAN WILLIAM W;;CHU SIMON C;;DONOVAN PETER THOMAS;;GRIMES BENJAMIN RUSSELL;;PRUETT GREGORY BRIAN;;RHOADES DAVID B;;TIPPET PAUL BRIAN,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-12-09);;TREND MICRO INCORPORATED (2010-03-31),https://lens.org/130-579-746-490-35X,Patent Application,yes,20,22,2,2,0,G06F11/1417;;G06F11/1417,H04B1/74,714/42,0,0,,,,EXPIRED
228,US,B2,US 7194659 B2,107-391-519-746-943,2007-03-20,2007,US 31580702 A,2002-12-10,US 31580702 A,2002-12-10,Method and system for detection and correction of entrance into an improper MBR state in a computer system,Aspects for detection and correction of entrance into an improper master boot record (MBR) state in a computer system are described. The aspects include providing a proxy MBR at a predetermined location on a storage device of a computer system to provide a proxy MBR. The proxy MBR is then utilized during a restart operation. An original MBR maintained at an original location on the storage device is then utilized during a reboot operation when the utilization of the proxy MBR is unsuccessful.,IBM,BUCHANAN JR WILLIAM W;;CHU SIMON C;;DONOVAN PETER THOMAS;;GRIMES BENJAMIN RUSSELL;;PRUETT GREGORY BRIAN;;RHOADES DAVID B;;TIPPET PAUL BRIAN,INTERNATIONAL BUSINESS MACHINES CORPORATION (2002-12-09);;TREND MICRO INCORPORATED (2010-03-31),https://lens.org/107-391-519-746-943,Granted Patent,yes,20,20,2,2,0,G06F11/1417;;G06F11/1417,G06F11/00;;H04B1/74,714/36,2,0,,,"IBM Research Disclosure, vol. 42, No. 419, Article 41997, ""Backup Master Boot Record for virus recovery,"" Mar. 1999.;;IBM Technical Disclosure Bulletin, vol. 36, No. 6B, pp. 295-298, ""Auto-Bios Image Configurator,"" Jun. 1993.",ACTIVE
229,BR,B1,BR 0106832 B1,044-030-993-194-376,2009-08-11,2009,BR 0106832 A,2001-10-18,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,"sistema de bombeamento integrado, sistema para mover um fluido subterráneo, processo de bombeamento de um fluido e sistema para bombeamento de um fluido.",,,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/044-030-993-194-376,Granted Patent,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,F04B23/04;;E21B43/12;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
230,CA,A1,CA 2623365 A1,158-005-076-369-49X,2002-04-18,2002,CA 2623365 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A;;CA 2359458 A,2000-10-18,INTEGRATED PUMPING SYSTEM FOR USE IN PUMPING A VARIETY OF FLUIDS,,SCHLUMBERGER CA LTD,ZIMMERMAN THOMAS H;;RUSSELL W KEITH;;VENERUSO ANTHONY F;;LEE LAWRENCE C;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;ARAUZ GRIGORY L;;BUCHANAN STEVEN E,,https://lens.org/158-005-076-369-49X,Patent Application,no,0,1,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,F04D13/08;;E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/00;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
231,CA,A1,CA 2721550 A1,176-185-051-241-813,2002-04-18,2002,CA 2721550 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A;;CA 2623365 A,2000-10-18,INTEGRATED PUMPING SYSTEM FOR USE IN PUMPING A VARIETY OF FLUIDS,"An integrated pumping system for use in environments, such as subterranean environments, to move a desired fluid from one location to another. The integrated pumping system comprises one or more stages that each have an integrated pump and motor. A controller may be utilized to individually control the one or more integrated pumps and motors.",SCHLUMBERGER CA LTD,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/176-185-051-241-813,Patent Application,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,F04D13/08;;E21B43/12;;F04B23/04;;F04B47/06;;F04B49/06;;F04C13/00;;F04D13/12;;F04D13/14;;F04D15/00;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
232,BR,A,BR 0106832 A,195-907-522-891-988,2002-10-29,2002,BR 0106832 A,2001-10-18,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,"Sistema de bombeamento, sistema de bombeamento integrado, sistema para mover um fluido subterr neo, processo de bombeamento de um fluido, sistema para bombeamento de um fluido e sistema para mover um fluido","""SISTEMA DE BOMBEAMENTO, SISTEMA DE BOMBEAMENTO INTEGRADO, SISTEMA PARA MOVER UM FLUIDO SUBTERR NEO, PROCESSO DE BOMBEAMENTO DE UM FLUIDO, SISTEMA PARA BOMBEAMENTO DE UM FLUIDO E SISTEMA PARA MOVER UM FLUIDO"". Sistema integrado de bombeamento para uso em ambientes, tais como ambientes subterrâneos, para mover um fluido desejado desde uma localização para outra. O sistema integrado de bombeamento compreende um ou mais estágios onde cada um possui uma bomba e motor integrados. Um controlador pode ser utilizado para controlar individualmente o único ou mais bombas e motores integrados.",SCHLUMBERGER SURENCO SA,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/195-907-522-891-988,Patent Application,no,0,1,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
233,NO,B1,NO 333344 B1,025-015-250-481-783,2013-05-13,2013,NO 20015046 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,Integrert pumpeutstyr for bruk ved pumping av flere forskjellige fluider,"Integrert pumpeutstyr for bruk i slike omgivelser, som underjordiske forhold for å bevege et ønsket fluid fra et sted til et annet. Det integrerte pumpeutstyr omfatter ett eller flere drivtrinn som hvert har integrert pumpe og motor. En regulator kan anvendes for å styre en eller flere av de integrerte pumpe- og motorenheter hver for seg.",SCHLUMBERGER TECHNOLOGY BV,RUSSELL W KEITH;;BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/025-015-250-481-783,Granted Patent,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
234,CA,C,CA 2623365 C,097-028-353-689-098,2011-01-25,2011,CA 2623365 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A;;CA 2359458 A,2000-10-18,INTEGRATED PUMPING SYSTEM FOR USE IN PUMPING A VARIETY OF FLUIDS,"An integrated pumping system for use in environments, such as subterranean environments, to move a desired fluid from one location to another. The integrated pumping system comprises one or more stages that each have an integrated pump and motor. A controller may be utilized to individually control the one or more integrated pumps and motors.",SCHLUMBERGER CA LTD,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/097-028-353-689-098,Granted Patent,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,F04D13/08;;E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/00;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
235,NO,D0,NO 20015046 D0,033-727-217-338-067,2001-10-17,2001,NO 20015046 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,Integrert pumpesystem for anvendelse ved pumping av et mangfold fluider,,SCHLUMBERGER TECHNOLOGY BV,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/033-727-217-338-067,Patent Application,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
236,US,A1,US 2002/0066568 A1,116-671-473-130-934,2002-06-06,2002,US 97033701 A,2001-10-03,US 97033701 A;;US 24145300 P;;US 30531201 P,2000-10-18,Integrated pumping system for use in pumping a variety of fluids,"
   An integrated pumping system for use in environments, such as subterranean environments, to move a desired fluid from one location to another. The integrated pumping system comprises one or more stages that each have an integrated pump and motor. A controller may be utilized to individually control the one or more integrated pumps and motors. 
",BUCHANAN STEVEN E.;;ARAUZ GRIGORY L.;;HAVLINEK KENNETH L.;;KISHINO ASHLEY;;LEE LAWRENCE C.;;RUSSELL W. KEITH;;ZIMMERMAN THOMAS H.;;VENERUSO ANTHONY F.,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,SCHLUMBERGER TECHNOLOGY CORPORATION (2001-09-24),https://lens.org/116-671-473-130-934,Patent Application,yes,0,73,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,166/313;;166/369;;166/105;;166/106;;417/244;;417/321,0,0,,,,EXPIRED
237,NO,L,NO 20015046 L,147-402-079-414-110,2002-04-19,2002,NO 20015046 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,Integrert pumpeutstyr for bruk ved pumping av flere forskjellige fluider,,SCHLUMBERGER TECHNOLOGY BV,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/147-402-079-414-110,Abstract,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
238,US,B2,US 6811382 B2,106-226-932-198-172,2004-11-02,2004,US 97033701 A,2001-10-03,US 97033701 A;;US 24145300 P;;US 30531201 P,2000-10-18,Integrated pumping system for use in pumping a variety of fluids,"
    An integrated pumping system for use in environments, such as subterranean environments, to move a desired fluid from one location to another. The integrated pumping system comprises one or more stages that each have an integrated pump and motor. A controller may be utilized to individually control the one or more integrated pumps and motors. 
",SCHLUMBERGER TECHNOLOGY CORP,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,SCHLUMBERGER TECHNOLOGY CORPORATION (2001-09-24),https://lens.org/106-226-932-198-172,Granted Patent,yes,4,65,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,417/244;;417/423.5;;417/426;;417/63;;415/199.1,0,0,,,,EXPIRED
239,CA,C,CA 2721550 C,052-095-337-764-905,2012-06-26,2012,CA 2721550 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A;;CA 2623365 A,2000-10-18,INTEGRATED PUMPING SYSTEM FOR USE IN PUMPING A VARIETY OF FLUIDS,"An integrated pumping system for use in environments, such as subterranean environments, to move a desired fluid from one location to another. The integrated pumping system comprises one or more stages that each have an integrated pump and motor. A controller may be utilized to individually control the one or more integrated pumps and motors.",SCHLUMBERGER CA LTD,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY F,,https://lens.org/052-095-337-764-905,Granted Patent,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,F04D13/08;;E21B43/12;;F04B23/04;;F04B47/06;;F04B49/06;;F04C13/00;;F04D13/12;;F04D13/14;;F04D15/00;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
240,CA,C,CA 2359458 C,002-926-714-307-568,2008-08-19,2008,CA 2359458 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,INTEGRATED PUMPING SYSTEM FOR USE IN PUMPING A VARIETY OF FLUIDS,"An integrated pumping system for use in environments, such as subterranean environments, to move a desired fluid from one location to another. The integrated pumping system comprises one or more stages that each have an integrated pump and motor. A controller may be utilized to individually control the one or more integrated pumps and motors.",SCHLUMBERGER CA LTD,ZIMMERMAN THOMAS H;;RUSSELL W KEITH;;ARAUZ GRIGORY L;;BUCHANAN STEVEN E;;VENERUSO ANTHONY F;;LEE LAWRENCE C;;HAVLINEK KENNETH L;;KISHINO ASHLEY,,https://lens.org/002-926-714-307-568,Granted Patent,no,0,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,F04D13/08;;E21B43/12;;F04B23/04;;F04B49/06;;F04C13/00;;F04D13/12;;F04D13/14;;F04D15/00;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
241,CA,A1,CA 2359458 A1,144-892-761-344-923,2002-04-18,2002,CA 2359458 A,2001-10-17,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,INTEGRATED PUMPING SYSTEM FOR USE IN PUMPING A VARIETY OF FLUIDS,"An integrated pumping system for use in environments, such as subterranean environments, to move a desired fluid from one location to another. The integrated pumping system comprises one or more stages that each have an integrated pump and motor. A controller may be utilized to individually control the one or more integrated pumps and motors.",SCHLUMBERGER CA LTD,HAVLINEK KENNETH L;;KISHINO ASHLEY;;BUCHANAN STEVEN E;;LEE LAWRENCE C;;RUSSELL W KEITH;;VENERUSO ANTHONY F;;ZIMMERMAN THOMAS H;;ARAUZ GRIGORY L,,https://lens.org/144-892-761-344-923,Patent Application,no,0,2,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,,0,0,,,,EXPIRED
242,GB,B,GB 2369862 B,111-715-840-253-371,2003-07-23,2003,GB 0124239 A,2001-10-10,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,Integrated pumping system for use in pumping a variety of fluids,,SCHLUMBERGER HOLDINGS,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY C;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY FRANK,,https://lens.org/111-715-840-253-371,Granted Patent,no,5,0,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,F1C C101          CBA;;F1C C101          CFWB;;F1C C103          CBA;;F1C C103          CFWB;;F1C C501          CBA;;F1C C502          CBA;;F1C C503          CBA;;F1C C504          CBA;;F1C C505          CBA;;F1C C601          CBA;;F1C C601          CFWB,0,0,,,,EXPIRED
243,GB,A,GB 2369862 A,049-689-266-379-267,2002-06-12,2002,GB 0124239 A,2001-10-10,US 24145300 P;;US 30531201 P;;US 97033701 A,2000-10-18,Multi-stage pumping system,"A multi-stage pumping system 10 comprises a number of stages 40, each of which includes an impeller, a diffuser and a motor. The system 10 may include a fluid intake 26 though which fluid can be drawn from a wellbore 20 a delivered to a holding tank at the surface 28. Each stage 40 may include an identifier ( 81 figure 9a) to check its operation, and the system 10 may include sensors to monitor temperature, speed, vibration, pressure and flow rate. The stages 40 may be independently controlled by a controller 83 to operate at different speeds or in different directions, and each stage 40 may be used as a flow control valve. The system 10 may include electrical quick-connects (77 figure 8 ) which allow the rapid connection and disconnection of adjacent stages 40.",SCHLUMBERGER HOLDINGS,BUCHANAN STEVEN E;;ARAUZ GRIGORY L;;HAVLINEK KENNETH L;;KISHINO ASHLEY C;;LEE LAWRENCE C;;RUSSELL W KEITH;;ZIMMERMAN THOMAS H;;VENERUSO ANTHONY FRANK,,https://lens.org/049-689-266-379-267,Patent Application,no,5,3,16,16,0,E21B43/128;;F04C13/008;;F04D13/14;;F04D15/029;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/103;;H02K21/24;;F04D1/066;;H02K21/24;;H02K5/132;;H02K19/103;;F04C13/008;;H02K16/00;;F04D15/029;;E21B43/128;;F04D13/14;;H02K7/14,E21B43/12;;F04B23/04;;F04C13/00;;F04D13/14;;F04D15/02;;H02K5/132;;H02K7/14;;H02K16/00;;H02K19/10;;H02K21/24,F1C C101          CBA;;F1C C101          CFWB;;F1C C103          CBA;;F1C C103          CFWB;;F1C C501          CBA;;F1C C502          CBA;;F1C C503          CBA;;F1C C504          CBA;;F1C C505          CBA;;F1C C601          CBA;;F1C C601          CFWB,0,0,,,,EXPIRED
244,EP,A2,EP 0394974 A2,109-997-701-044-04X,1990-10-31,1990,EP 90107789 A,1990-04-24,US 34398189 A,1989-04-26,Photographic material and process.,"A novel blocked photographically useful compound comprises a new blocking group that (a) comprises two electrophilic groups, the least electrophilic of which is bonded directly or through a timing group to the photographically useful group (PUG) of the compound, (b) is capable of reacting with a dinucleophile reagent, and (c) has the two electrophilic groups separated from each other by a bond or unsubstituted atom that enables nucleophilic displacement to occur with release of PUG when the compound is reacted with a dinucleophile reagent. Such a blocked photographically useful compound is useful in a photographic material and process to provide increased stability and enable more rapid release of the photographically useful group upon reaction with a dinucleophile reagent.  ",EASTMAN KODAK CO,BUCHANAN JOHN MICHAEL C O EAST;;COOK EWELL RUSSELL C O EASTMAN;;MOOBERRY JARED BEN C O EASTMAN;;PROEHL GARY STEPHEN C O EASTMA;;SINGER STEPHEN PAUL C O EASTMA;;WASHBURN WILLIAM NAVIE C O EAS,,https://lens.org/109-997-701-044-04X,Patent Application,yes,0,12,9,9,0,G03C7/30511;;G03C7/30511;;Y10S430/156;;Y10S430/156;;Y10S430/157;;Y10S430/157;;Y10S430/158;;Y10S430/158;;Y10S430/159;;Y10S430/159;;Y10S430/16;;Y10S430/16;;Y10S430/161;;Y10S430/161,G03C1/06;;G03C1/43;;G03C7/305;;G03C7/392,,0,0,,,,EXPIRED
245,NO,L,NO 20063693 L,110-038-056-215-695,2006-10-23,2006,NO 20063693 A,2006-08-17,US 53869104 P;;US 2005/0002326 W,2004-01-23,Forbindelse og metode for anvendelse,"Utvalgte forbindelser er virksomme i profylakse og behandling av sykdommer, slik som HGF formidlede sykdommer. Oppfinnelsen rommer nye forbindelser, analoger, prodrugs og farmasøytisk akseptable salter derav, farmasøytiske preparater og fremgangsmåter for profylakse og behandling av sykdom og andre lidelser eller tilstander som involverer kreft og lignende. Gjenstand for oppfinnelsen vedrører også prosesser for fremstilling av slike forbindelser så vel som mellomprodukter som er egnet i slike prosesser.",USMASSE CRAIG,BELLON STEVEN;;DIPIETRO LUCIAN V;;KIM JOSEPH L;;KIM TAE-SEONG;;PATEL VINOD F;;TASKER ANDREW;;XI NING;;HARMANGE JEAN-CHRISTOPHE;;BOOKER SHON;;BORG GEORGE;;BUCHANAN JOHN L;;BUCKNER WILLIAM H;;CHAFFEE STUART;;CHENG YUAN;;CHOQUETTE DEBORAH;;GERMAIN JULIE;;GRACEFFA RUSSELL;;HABGOOD GREGORY J;;HODOUS BRIAN L;;LA DANIEL,,https://lens.org/110-038-056-215-695,Abstract,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D217/24;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,DISCONTINUED
246,EP,A3,EP 0394974 A3,160-027-381-429-371,1992-03-18,1992,EP 90107789 A,1990-04-24,US 34398189 A,1989-04-26,PHOTOGRAPHIC MATERIAL AND PROCESS,"A novel blocked photographically useful compound comprises a new blocking group that (a) comprises two electrophilic groups, the least electrophilic of which is bonded directly or through a timing group to the photographically useful group (PUG) of the compound, (b) is capable of reacting with a dinucleophile reagent, and (c) has the two electrophilic groups separated from each other by a bond or unsubstituted atom that enables nucleophilic displacement to occur with release of PUG when the compound is reacted with a dinucleophile reagent. Such a blocked photographically useful compound is useful in a photographic material and process to provide increased stability and enable more rapid release of the photographically useful group upon reaction with a dinucleophile reagent.  ",EASTMAN KODAK COMPANY,"BUCHANAN, JOHN MICHAEL, C/O EASTMAN KODAK COMPANY;;COOK, EWELL RUSSELL, C/O EASTMAN KODAK COMPANY;;MOOBERRY, JARED BEN, C/O EASTMAN KODAK COMPANY;;PROEHL, GARY STEPHEN, C/O EASTMAN KODAK COMPANY;;SINGER, STEPHEN PAUL, C/O EASTMAN KODAK COMPANY;;WASHBURN, WILLIAM NAVIE, C/O EASTMAN KODAK COMPANY",,https://lens.org/160-027-381-429-371,Search Report,yes,3,0,9,9,0,G03C7/30511;;G03C7/30511;;Y10S430/156;;Y10S430/156;;Y10S430/157;;Y10S430/157;;Y10S430/158;;Y10S430/158;;Y10S430/159;;Y10S430/159;;Y10S430/16;;Y10S430/16;;Y10S430/161;;Y10S430/161,G03C1/06;;G03C1/43;;G03C7/305;;G03C7/392,,0,0,,,,EXPIRED
247,US,A1,US 2006/0241115 A1,155-722-182-800-514,2006-10-26,2006,US 4263405 A,2005-01-24,US 4263405 A;;US 53869104 P,2004-01-23,Compounds and methods of use,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A,AMGEN INC (2005-06-14),https://lens.org/155-722-182-800-514,Patent Application,yes,19,36,29,29,2,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/517;;A61K31/4709;;A61K31/498;;A61K31/502;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,514/248;;514/249;;514/266.2;;514/314;;544/237;;544/284;;544/333;;546/167,0,0,,,,ACTIVE
248,US,A1,US 2017/0159290 A1,002-739-960-466-907,2017-06-08,2017,US 201615367411 A,2016-12-02,US 201615367411 A;;US 201562262576 P,2015-12-03,BUILDING FRAMING SYSTEM,"A building framing system includes a floor portion or floor framing system, a wall portion or wall framing system, and a roof portion or roof framing system. Each framing system comprises a plurality of components. Each component defines a connection geometry for connecting one component to another. The connection geometries are such that mechanical or other similar fasteners are not required to hold the various components together; rather, the connection geometries connect the components and hold them in place with respect to one another. Further, the framing systems utilize pre-cut components such that the components of each framing system arrive onsite cut to a needed length and width and with the appropriate connection geometry.",UNIV CLEMSON,ALBRIGHT DUSTIN GRAHAM;;BLOUIN VINCENT YVES-MARIE;;HARDING DANIEL NEVIN;;PASTRE DAVID AARON;;HEINE ULRIKE ANN-SOPHIE;;ERSOY UFUK;;MONKS TY;;WOHLERS ANTHONY;;STONER MICHAEL;;BALOGH ERIC;;SILVERS TYLER;;DIAS CLAIR;;MARTIN ALISON;;PENNINGTON JON;;HAMMER JEFF;;HINKLEY WILL;;HAMRICK JUSTIN;;LATHAM ALEXANDRA;;LESLIE NEELY;;TAYLOR II RODNEY DANIEL;;HERRERO DAVID;;WILSON REBECCA MERCER;;BUCHANAN RUSSELL;;BRACKMANN AMELIA;;MOSHER PAUL;;BECK ALLYSON;;LIBENGOOD ALEX,CLEMSON UNIVERSITY (2018-08-09);;CLEMSON UNIVERSITY RESEARCH FOUNDATION (2018-09-13),https://lens.org/002-739-960-466-907,Patent Application,yes,0,6,2,2,0,E04B1/26;;E04B2/707;;E04B5/14;;E04B2001/262;;E04B2001/2624;;E04B2001/2664;;E04B2001/2672;;E04B2001/2692;;E04B2001/2696;;F16B3/00;;F16B5/07;;F16B7/22;;E04B5/023;;E04B5/023;;E04B1/26;;E04B2/707;;E04B5/14;;E04B2001/262;;E04B2001/2624;;E04B2001/2664;;E04B2001/2672;;E04B2001/2692;;E04B2001/2696;;F16B5/07;;F16B3/00;;F16B7/22,E04B5/02;;E04B1/343;;E04B5/10;;E04B5/12;;E04B7/02;;E04B7/20,,0,0,,,,ACTIVE
249,US,B2,US 10156067 B2,117-171-321-502-706,2018-12-18,2018,US 201615367411 A,2016-12-02,US 201615367411 A;;US 201562262576 P,2015-12-03,Building framing system,"A building framing system includes a floor portion or floor framing system, a wall portion or wall framing system, and a roof portion or roof framing system. Each framing system comprises a plurality of components. Each component defines a connection geometry for connecting one component to another. The connection geometries are such that mechanical or other similar fasteners are not required to hold the various components together; rather, the connection geometries connect the components and hold them in place with respect to one another. Further, the framing systems utilize pre-cut components such that the components of each framing system arrive onsite cut to a needed length and width and with the appropriate connection geometry.",UNIV CLEMSON;;UNIV CLEMSON RES FOUNDATION,ALBRIGHT DUSTIN GRAHAM;;BLOUIN VINCENT YVES-MARIE;;HARDING DANIEL NEVIN;;PASTRE DAVID AARON;;HEINE ULRIKE ANN-SOPHIE;;ERSOY UFUK;;MONKS TY;;WOHLERS ANTHONY;;STONER MICHAEL;;BALOGH ERIC;;SILVERS TYLER;;DIAS CLAIR;;MARTIN ALISON;;PENNINGTON JON;;HAMMER JEFF;;HINKLEY WILL;;HAMRICK JUSTIN;;LATHAM ALEXANDRA;;LESLIE NEELY;;TAYLOR II RODNEY DANIEL;;HERRERO DAVID;;WILSON REBECCA MERCER;;BUCHANAN RUSSELL;;BRACKMANN AMELIA;;MOSHER PAUL;;BECK ALLYSON;;LIBENGOOD ALEX,CLEMSON UNIVERSITY (2018-08-09);;CLEMSON UNIVERSITY RESEARCH FOUNDATION (2018-09-13),https://lens.org/117-171-321-502-706,Granted Patent,yes,27,0,2,2,0,E04B1/26;;E04B2/707;;E04B5/14;;E04B2001/262;;E04B2001/2624;;E04B2001/2664;;E04B2001/2672;;E04B2001/2692;;E04B2001/2696;;F16B3/00;;F16B5/07;;F16B7/22;;E04B5/023;;E04B5/023;;E04B1/26;;E04B2/707;;E04B5/14;;E04B2001/262;;E04B2001/2624;;E04B2001/2664;;E04B2001/2672;;E04B2001/2692;;E04B2001/2696;;F16B5/07;;F16B3/00;;F16B7/22,E04B5/02;;E04B1/26;;E04B2/70;;E04B5/14;;E04B7/02;;E04B7/20,,0,0,,,,ACTIVE
250,CR,A,CR 8531 A,095-233-690-156-444,2007-06-08,2007,CR 8531 A,2006-07-25,US 53869104 P,2004-01-23,COMPUESTOS Y PROCEDIMIENTOS PARA SU USO,"Los compuestos seleccionados son eficaces para la profilaxis y tratamiento de enfermedades, tales como enfermedades mediadas por HGF. La invencion abarca nuevos compuestos, analogos, profarmacos y sales farmaceuticamente aceptables de los mismos, composiciones farmaceuticas y procedimientos para la profilaxis y tratamiento de enfermedades y otros trastornos o afecciones que implican cancer y similares. La presente invencion tambien se refiere a procedimientos para preparar tales compuestos asi como a intermedios utiles en tales procedimientos.",AMGEN INC,MICHELE POTASHMAN;;TAE-SEONG KIM;;STEVEN BELLON;;SHON BOOKER;;YUAN CHENG;;JOSEPH L KIM;;ANDREW TASKER;;NING XI;;SHIMIN XU;;JEAN-CHRISTOPHE HARMANGE;;GEORGE BORG;;MATHEW WEISS;;BRIAN L HODOUS;;RUSSELL GRACEFFA;;WILLIAM H BUCKNER;;CRAIG E MASSE;;DEBORAH CHOQUETTE;;MATHEW MARTIN;;JULIE GERMAIN;;LUCIAN V DIPIETRO;;STUART C CHAFFEE;;JOHN L BUCHANAN;;JOSEPH J NUNES;;GREGORY J HABGOOD;;DAVID C MCGOWAN;;DOUGLAS A WHITTINGTON;;DANIEL LA,,https://lens.org/095-233-690-156-444,Patent Application,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/47;;A61K31/505;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,DISCONTINUED
251,TW,A,TW 200536851 A,055-312-440-535-059,2005-11-16,2005,TW 94102028 A,2005-01-24,US 53869104 P,2004-01-23,Compounds and methods of use,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",AMGEN INC,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A,,https://lens.org/055-312-440-535-059,Patent of Addition,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D417/00;;A61K31/505;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,PENDING
252,GE,B,GE P20084439 B,143-449-331-137-956,2008-07-25,2008,GE AP2005009592 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL USE THEREOF,"The invention encompasses compounds, which are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases (tumors). They also contain novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions.",AMGEN INC,KIM TAE-SEONG;;POTASHMAN MICHELE;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;TASKER ANDREW;;KIM JOSEPH L;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAN H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;LA DANIEL;;PATEL VINOD F,,https://lens.org/143-449-331-137-956,Granted Patent,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/505;;A61K31/47;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
253,AU,B2,AU 2005/206571 B2,031-556-774-113-788,2010-08-12,2010,AU 2005/206571 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,Compounds and methods of use,,AMGEN INC,BORG GEORGE;;BUCHANAN JOHN L;;DIPIETRO LUCIAN V;;KIM JOSEPH L;;WEISS MATTHEW;;XU SHIMIN;;MCGOWAN DAVID C;;LA DANIEL;;WHITTINGTON DOUGLAS A;;POTASHMAN MICHELE;;BOOKER SHON;;TASKER ANDREW;;GRACEFFA RUSSELL;;CHOQUETTE DEBORAH;;GERMAIN JULIE;;BELLON STEVEN;;MARTIN MATTHEW W;;MASSE CRAIG E;;XI NING;;KIM TAE-SEONG;;BUCKNER WILLIAN H;;HABGOOD GREGORY J;;CHENG YUAN;;CHAFFEE STUART C;;HODOUS BRIAN L;;PATEL VINOD F;;HARMANGE JEAN-CHRISTOPHE;;NUNES JOSEPH J,,https://lens.org/031-556-774-113-788,Granted Patent,no,4,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D413/12;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D417/12;;C07D471/04;;C07D487/04,,1,0,,,priority date 16 October 2003 (*WO 2005/037285 A),ACTIVE
254,KR,A,KR 20070026390 A,107-967-378-921-603,2007-03-08,2007,KR 20067016974 A,2006-08-23,US 53869104 P,2004-01-23,COMPOUNDS AND METHODS OF USE,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes. ® KIPO & WIPO 2007",AMGEN INC,POTASHMAN MICHELE;;KIM TAE SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAN H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;PATEL VINOD F;;LA DANIEL,,https://lens.org/107-967-378-921-603,Patent Application,no,0,2,29,29,4,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D217/24;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,DISCONTINUED
255,UA,C2,UA 86614 C2,169-559-042-488-435,2009-05-12,2009,UA A200609287 A,2005-01-24,US 53869104 P,2004-01-23,"COMPOUND HAVING KINASE INGIBITOR ACTIVITY, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF AND USE THEREOF FOR THE PREPARATION OF MEDICINE","Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",AMGEN INC,BELLON STEVEN;;BOOKER SHON;;BORG GEORGE;;BUCHANAN JOHN L;;BUCKNER WILLIAM H;;CHAFFEE STUART C;;CHENG YUAN;;CHOQUETTE DEBORAH;;DIPIETRO LUCIAN V;;GERMAIN JULIE;;GRACEFFA RUSSELL;;HABGOOD GREGORY J;;HARMANGE JEAN-CHRISTOPHE;;HODOUS BRIAN L;;KIM TAE-SEONG;;KIM JOSEPH L;;LA DANIEL;;MARTIN MATTHEW W;;MASSE CRAIG E;;MCGOWAN DAVID C;;NUNES JOSEPH J;;PATEL VINOD F;;POTASHMAN MICHELE;;TASKER ANDREW;;WEISS MATTHEW;;WHITTINGTON DOUGLAS A;;XI NING;;XU SHIMIN,,https://lens.org/169-559-042-488-435,Limited Patent,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/505;;A61K31/47;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,EXPIRED
256,US,B2,US 8178557 B2,023-529-186-838-316,2012-05-15,2012,US 15730308 A,2008-06-09,US 15730308 A;;US 4263405 A;;US 53869104 P,2004-01-23,Compounds and methods of use,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;HABGOOD GREGORY J;;PATEL VINOD F;;LA DANIEL;;AMGEN INC,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;HABGOOD GREGORY J;;PATEL VINOD F;;LA DANIEL,,https://lens.org/023-529-186-838-316,Granted Patent,yes,56,1,29,29,2,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D213/64;;A61K31/04;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,514/312,52,41,064-587-004-694-538;;007-099-343-098-431;;134-586-032-402-486;;116-583-311-859-888;;054-244-419-978-084;;077-384-887-711-54X;;049-795-215-509-382;;051-916-753-166-858;;102-308-616-404-433;;011-357-901-786-903;;020-724-176-721-063;;031-195-428-877-549;;033-815-673-718-24X;;146-746-326-905-789;;065-953-116-264-771;;032-052-676-841-922;;068-779-407-471-488;;023-045-231-901-281;;141-331-019-052-249;;009-583-327-532-944;;050-802-478-126-728;;070-058-456-779-675;;001-710-188-126-409;;028-634-212-212-197;;078-225-077-337-603;;046-912-486-433-691;;071-822-037-498-657;;133-402-022-290-569;;035-863-506-077-798;;013-599-527-628-044;;151-767-590-111-631;;040-599-273-747-72X;;048-419-522-057-149;;133-076-320-029-771;;007-430-332-496-44X;;081-650-113-264-09X;;005-981-084-406-350;;166-017-983-777-962;;119-035-143-682-965;;018-372-145-491-105;;090-652-640-329-225,17340192;;10.1007/s10875-007-9083-1;;8073946;;10.1016/s0065-2776(08)60451-4;;10.1016/0092-8674(92)90309-z;;1516132;;1826679;;9389480;;10.1038/37126;;9143693;;10.1146/annurev.immunol.15.1.371;;1383237;;pmc2289675;;10.1083/jcb.119.3.629;;10.1016/s0960-894x(01)00219-0;;11378364;;8380919;;10.1016/s0960-894x(97)10059-2;;8380644;;pmc45721;;10.1073/pnas.90.2.649;;10.1172/jci3205;;pmc508901;;9664084;;10.1021/bi00104a029;;1655021;;10.1016/0006-291x(91)91493-v;;1704229;;10.1007/bf00204976;;10.1007/s001090050053;;8892055;;10781399;;10.1016/s0952-7915(00)00083-2;;10.1021/ja992553j;;10.1002/chin.198336258;;10.1016/s0040-4039(00)70185-7;;10.1016/0006-291x(91)90887-d;;1708252;;10.1016/j.bmc.2004.06.016;;15265485;;10.1016/s1359-6101(01)00029-6;;11750879;;1878968;;10.1016/0092-8674(91)90115-f;;10.1016/0006-291x(84)91253-1;;6477569;;10.1002/j.1460-2075.1991.tb07836.x;;1655405;;pmc452997;;2819873;;pmc299079;;10.1073/pnas.84.18.6379;;10.1021/ja01212a011;;20994948;;1334253;;pmc50821;;1824873;;10.1073/pnas.88.2.415;;10.1016/0270-9139(91)92573-q;;10.1002/hep.1840130421;;2010169;;1997203;;10.1016/0092-8674(91)90499-o;;10.1016/0168-9525(91)90056-v;;2952888;;10.1038/327239a0;;02952888;;10.1002/chin.197843237;;10.1038/35037021;;10586892;;10.4049/jimmunol.168.12.6446;;12055264;;pmc2116316;;10.1083/jcb.111.5.2097;;2146276;;10.1080/10426509408545396;;14684309;;10.1016/j.bmcl.2003.10.010;;15157501;;10.1016/0962-8924(96)84935-x;;10.1517/13543776.11.1.77,"Carvalho, J Clin Immunology, vol. 27, No. 3, May 2007, pp. 246-256.;;Anderson et al., Involvement of the protein tyrosine kinase p56Ick in T cell signaling and thymocyte development, Advances in Immunology, 56:151-178 (1994).;;Appleby et al., Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn, Cell, 70:751-763 (1992).;;Asami et al., Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats, Journal of Biochemistry, 109:8-13 (1991).;;Asano et al., Silver halide color photographic materials, Abstract 113:181318 (1990).;;Boehm et al., Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance, Nature, 390:404-407 (1997).;;Bolen et al., Leukocyte protein tyrosine kinases: Potential targets for drug discovery, Annu. Rev. Immunology, 15:371-404 (1997).;;Brazhko et al., Investigations of the biological activity 4-thioquinolines. Abstract 135:189745, 2001.;;Bussolino et al., Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth, The Journal of Cell Biology, 119(3):629-641 (1992).;;Chan et al., Isoforms of human HGF and their biological activities, Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor, pp. 67-79, Goldberg and Rosen (Eds.), Birkhauser Verlag Basel, Switzerland (1993).;;Chatterjee, A.K., 4-Aminoquinolines. III. Some 4-(quinolylamino)quinolines, Science and Culture 23:195 (1957).;;Cockerill et al., Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2, Bioorganic & Medicinal Chemistry Letters, 11:1401-1405 (2001).;;Di Renzo et al., Selective expression of the Met/HGF receptor in human central nervous system microglia, Oncogene, 8:219-222 (1992).;;Gibson et al., Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumor activity of novel quinazolines, Bioorganic & Medicinal Chemistry Letters, 7(21):2723-2728 (1997).;;Giordano et al., Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene, Proceedings of the National Academy of Sciences, USA, 90:649-653 (1993).;;Goldman et al, Defective expression of p56lck in an infant with severe combined immunodeficiency, Journal of Clinical Investigations, 102(2):421-429 (1998).;;Han et al., Characterization of the DNF15S2 locus on human chromosome 3: Identification of a gene coding for four kringle domains with homology to hepatocyte growth factor, Biochemistry, 30:9768-9780 (1991).;;Igawa et al., Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells, Biochemical and Biophysical Research Communications, 174(2):831-838 (1991).;;Jeffers et al., Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis, J. Mol. Med., 74:505-513 (1996).;;Kane et al., Signal transduction by the TCR for antigen, Current Opinion in Immunology, 12:242-249 (2000).;;Kasai et al., Flexible coordination networks with fluorinated backbones, remarkable ability for induced-fit enclathration of organic molecules, Journal of American Chemical Society, 122:2140-2141 (2000).;;Konishi et al., Preparation of thioquinoline derivatives as antibacterial agents for Helicobacter pylori, Chemical Abstracts 125:247631, 1996.;;Lempert-Sreter et al., the synthesis of di(1-isoquinolinyl) and di(4-quinazolinyl) disulfides form 1(2H)-isoquinolinethiones and 4(3H)-quinazolinethiones, respectively, with tosyl chloride and sodium ethoxide, Acta Chemica Hungarica, 112(1):83-87 (1983).;;Makisumi, Yasuo, The Thio-claisen rearrangement of allyl 4-quinolyl sulfides, Tetrahedron Letters, 51:6399-6403 (1966).;;Maslankiewicz, M.J., Reactions of beta- and gamma-quinolinyl sulfides with a nitrating mixture, Polish Journal of Chemistry, 68(12):2545-2552 (1994).;;Matsumoto et al., Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth, Biochemical and Biophysical Research Communications, 176(1):45-51 (1991).;;Matsunaga et al., C17,20-lyase inhibitors. Part 2:Design, synthesis and structure-activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C17,20-lyase inhibitors, Bioorganic & Medicinal Chemistry, 12:4313-4336 (2004).;;Maulik et al., Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition, Cytokine & Growth Factor Reviews, 13:41-59 (2002).;;Montesano et al., Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors, Cell, 66:697-711 (1991).;;Monti et al., IV. Abstract 55:2681, 1959.;;Moszew et al., Thermal reactions of gamma-thiols in pyridine and quinoline series. Abstract 77:164418, 1972.;;Nakamura et al., Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats, Biochemical and Biophysical Research Communications, 122(3):1450-1459 (1984).;;Naldini et al., Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor, EMBO Journal, 10:2867-2878 (1991).;;Park et al., Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors, Proceedings of the National Academy of Sciences, USA, 84:6379-6383 (1987).;;Renfrew, Alice G., Studies in the Quinoline Series. IV. Quinolyl Mercaptans and Sulfides, J. American Chemical Society, 1433-1436 (1946).;;Di Renzo et al., Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas, Oncogene, 7:2549-2553 (1992).;;Rubin et al., A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor, Proceedings of the National Academy of Sciences, USA, 88:415-419 (1991).;;Sinyak et al., The synthesis and biological properties of the derivatives of 4-heterylmercaptoquinazoline, Khimiko-Farmatsevticheskii Zhurnal, 20(2), 168-171 (1986). Abstract 104:199594.;;Solbreux et al., Extrahepatic bile duct growth in mice repeatedly injected with human normal serum, IgA-deficient serum or purified secretory IgA, Hepatology, 13:735-742 (1991).;;Soriano et al., Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice, Cell, 64:693-702 (1991).;;Stern et al., Epithelial scatter factor and development of the chick embryonic axis, Development 110:1271-1284 (1990).;;Stoker et al., Scatter factor is a fibroblast-derived modulator of epithelial cell mobility, Nature, 327:239-242 (1987).;;Thakore, P.V. et al., Studies in the synthesis of quinoline derivatives. Part VIII. Synthesis of 4:3'-methylenebis(2,2'-dichloro-4'-methylquinoline) derivatives, Journal of the Indian Chemical Society, 54(12)1204-1206 (1977).;;Turner et al., Signalling through the high-affinity IgE receptor FcepsilonRI, Nature, 402:B24-B30 (1999).;;Vicentini et al., Fgr deficiency results in defective eosinophil recruitment to the lung during allergic airway inflammation, The Journal of Immunology, 168:6446-6454 (2002).;;Weidner et al., Scatter Factor: Molecular characteristics and effect on the invasiveness of epithelial cells, The Journal of Cell Biology, 111:2097-2108 (1990).;;Wyszomirski et al., Conformations of monosubstituted and disubstituted 3,4'-, 3,3'- and 4,4'-diquinolinyl sulfides studied by NMR spectroscopy, Phosphorus, Sulfur, and Silicon, 95-96:415-416 (1994).;;Zhang et al., Synthesis and antimalarial activity of 2-dialkylaminomethyl-4-(heterocyclic amino)-5,6,7,8-tetrahydronaphthol derivatives. Abstract 103:87753, 1985.;;Zhang et al., Synthesis and SAR of potent EGFR/erbB2 dual inhibitors, Bioorganic & Medicinal Chemistry Letters, 14:111-114 (2004).;;Breier et al., The role of vascular endothelial growth factor in blood vessel formation, Trends in Cell Biology, 6:454-456 (1996).;;Paolo M. Comoglio, ""Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells"", Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor, eds. Goldberg and Rosen, Birkhauser Verlag Basel, Switzerland, 131-165 (1993).;;Connell et al., ""Patent focus on cancer chemotherapeutics. II Angiogenesis agents: Apr. 2000-Sep. 2000"", Expert Opinion on Therapeutic Patents, 11(1):77-114 (2001).",ACTIVE
257,TN,A1,TN SN06228 A1,065-747-058-305-872,2007-12-03,2007,TN SN06228 A,2006-07-21,US 2005/0002326 W;;US 53869104 P,2004-01-23,Compounds and methods of use,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",AMGEN INC,BUCKNER WILLIAM H;;POTASHMAN MICHELE;;KIM TAE-SEONG;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;LA DANIEL;;PATEL VINOD F;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE,,https://lens.org/065-747-058-305-872,Patent Application,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/47;;A61K31/505;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,PENDING
258,CA,A1,CA 2553423 A1,192-179-426-514-304,2005-08-04,2005,CA 2553423 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,COMPOUNDS AND METHODS OF USE,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. Th e subject invention also relates to processes for making such compounds as wel l as to intermediates useful in such processes.",AMGEN INC,KIM JOSEPH L;;XI NING;;HABGOOD GREGORY J;;BELLON STEVEN;;HODOUS BRIAN L;;POTASHMAN MICHELE;;BUCHANAN JOHN L;;NUNES JOSEPH J;;BUCKNER WILLIAN H;;TASKER ANDREW;;MASSE CRAIG E;;GRACEFFA RUSSELL;;DIPIETRO LUCIAN V;;GERMAIN JULIE;;KIM TAE-SEONG;;CHAFFEE STUART C;;WEISS MATTHEW;;CHOQUETTE DEBORAH;;BORG GEORGE;;MARTIN MATTHEW W;;BOOKER SHON;;HARMANGE JEAN-CHRISTOPHE;;XU SHIMIN;;WHITTINGTON DOUGLAS A;;CHENG YUAN;;MCGOWAN DAVID C;;PATEL VINOD F,,https://lens.org/192-179-426-514-304,Patent Application,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/47;;A61K31/505;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
259,BR,A,BR PI0507373 A,146-917-427-340-223,2007-07-10,2007,BR PI0507373 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,compostos e método de uso,"COMPOSTO E MéTODO DE USO. Os compostos selecionados são eficazes para a profilaxia e o tratamento de doenças, tais como, as doenças mediadas HGF. A invenção abrange novos compostos, análogos, pró-drogar e sais aceitáveis farmaceuticamente destes, composições e métodos para a profilaxia e o tratamento das doenças e outros enfermidades ou circunstâncias que envolvem, câncer e outras. A invenção relaciona-se também aos processos para produzir compostos bem como aos intermediários úteis em tais processos.",AMGEN INC,BELLON STEVEN;;BORG GEORGE;;BUCKNER WILLIAM H;;CHENG YUAN;;BOOKER SHON;;BUCHANAN JOHN L;;CHAFFEE STUART C;;CHOQUETTE DEBORAH;;DIPIETRO LUCIAN V;;GRACEFFA RUSSELL;;HARMANGE JEAN-CHRISTOPHE;;KIM TAE-SEONG;;LA DANIEL;;MASSE CRAIG E;;NUNES JOSEPH J;;POTASHMAN MICHELE;;WEISS MATTHEW;;GERMAIN JULIE;;HABGOOD GREGORY J;;HODOUS BRIAN L;;KIM JOSEPH L;;MARTIN MATTHEW W;;MCGOWAN DAVID C;;PATEL VINOD F;;TASKER ANDREW;;WHITTINGTON DOUGLAS A;;XI NING;;XU SHIMIN,,https://lens.org/146-917-427-340-223,Patent Application,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/505;;A61K31/47;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,DISCONTINUED
260,CA,C,CA 2553423 C,028-818-009-461-266,2012-03-20,2012,CA 2553423 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER AND THE INHIBITION OF ANGIOGENESIS,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",AMGEN INC,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAN H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;PATEL VINOD F;;LA DANIEL,,https://lens.org/028-818-009-461-266,Granted Patent,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D215/22;;A61K31/4709;;A61K45/08;;A61P9/00;;A61P27/02;;A61P35/00;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
261,US,B2,US 7435823 B2,080-360-399-638-63X,2008-10-14,2008,US 4263405 A,2005-01-24,US 4263405 A;;US 53869104 P,2004-01-23,Compounds and methods of use,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",AMGEN INC,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;LA DANIEL;;PATEL VINOD F,AMGEN INC (2005-06-14),https://lens.org/080-360-399-638-63X,Granted Patent,yes,52,19,29,29,2,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D213/64;;C07D215/38;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D265/34;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,546/153;;546/15;;544/99;;544/105,52,40,090-652-640-329-225;;007-099-343-098-431;;134-586-032-402-486;;116-583-311-859-888;;054-244-419-978-084;;077-384-887-711-54X;;049-795-215-509-382;;051-916-753-166-858;;102-308-616-404-433;;011-357-901-786-903;;020-724-176-721-063;;031-195-428-877-549;;033-815-673-718-24X;;146-746-326-905-789;;065-953-116-264-771;;032-052-676-841-922;;068-779-407-471-488;;023-045-231-901-281;;141-331-019-052-249;;009-583-327-532-944;;050-802-478-126-728;;070-058-456-779-675;;001-710-188-126-409;;028-634-212-212-197;;078-225-077-337-603;;046-912-486-433-691;;071-822-037-498-657;;133-402-022-290-569;;035-863-506-077-798;;013-599-527-628-044;;151-767-590-111-631;;040-599-273-747-72X;;048-419-522-057-149;;133-076-320-029-771;;007-430-332-496-44X;;081-650-113-264-09X;;005-981-084-406-350;;166-017-983-777-962;;119-035-143-682-965;;018-372-145-491-105,10.1517/13543776.11.1.77;;8073946;;10.1016/s0065-2776(08)60451-4;;10.1016/0092-8674(92)90309-z;;1516132;;1826679;;9389480;;10.1038/37126;;9143693;;10.1146/annurev.immunol.15.1.371;;1383237;;pmc2289675;;10.1083/jcb.119.3.629;;10.1016/s0960-894x(01)00219-0;;11378364;;8380919;;10.1016/s0960-894x(97)10059-2;;8380644;;pmc45721;;10.1073/pnas.90.2.649;;10.1172/jci3205;;pmc508901;;9664084;;10.1021/bi00104a029;;1655021;;10.1016/0006-291x(91)91493-v;;1704229;;10.1007/bf00204976;;10.1007/s001090050053;;8892055;;10781399;;10.1016/s0952-7915(00)00083-2;;10.1021/ja992553j;;10.1002/chin.198336258;;10.1016/s0040-4039(00)70185-7;;10.1016/0006-291x(91)90887-d;;1708252;;10.1016/j.bmc.2004.06.016;;15265485;;10.1016/s1359-6101(01)00029-6;;11750879;;1878968;;10.1016/0092-8674(91)90115-f;;10.1016/0006-291x(84)91253-1;;6477569;;10.1002/j.1460-2075.1991.tb07836.x;;1655405;;pmc452997;;2819873;;pmc299079;;10.1073/pnas.84.18.6379;;10.1021/ja01212a011;;20994948;;1334253;;pmc50821;;1824873;;10.1073/pnas.88.2.415;;10.1016/0270-9139(91)92573-q;;10.1002/hep.1840130421;;2010169;;1997203;;10.1016/0092-8674(91)90499-o;;10.1016/0168-9525(91)90056-v;;2952888;;10.1038/327239a0;;02952888;;10.1002/chin.197843237;;10.1038/35037021;;10586892;;10.4049/jimmunol.168.12.6446;;12055264;;pmc2116316;;10.1083/jcb.111.5.2097;;2146276;;10.1080/10426509408545396;;14684309;;10.1016/j.bmcl.2003.10.010;;15157501;;10.1016/0962-8924(96)84935-x,"U.S. Appl. No. 11/412,302, filed Apr. 2005, Kim.;;Paolo M. Comoglio, ""Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells"", Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor, eds. Goldberg and Rosen, Birkhauser Verlag Basel, Switzerland, 131-165 (1993).;;Connell et al., ""Patent focus on cancer chemotherapeutics. II Angiogenesis agents: Apr. 2000-Sep. 2000"", Expert Opinion on Therapeutic Patents, 11(1):77-114 (2001).;;Anderson et al., Involvement of the protein tyrosine kinase p56<SUP>lck </SUP>in T cell signaling and thymocyte development, Advances in Immunology, 56:151-178 (1994).;;Appleby et al., Defective T cell receptor signaling in mice lacking the thymic isoform of p59<SUP>fyn</SUP>, Cell, 70:751-763 (1992).;;Asami et al., Purification and characterization of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats, Journal of Biochemistry, 109:8-13 (1991).;;Asano et al., Silver halide color photographic materials, Abstract 113:181318 (1990).;;Boehm et al., Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance, Nature, 390:404-407 (1997).;;Bolen et al., Leukocyte protein tyrosine kinases: Potential targets for drug discovery, Annu. Rev. Immunology, 15:371-404 (1997).;;Brazhko et al., Investigations of the biological activity 4-thioquinolines. Abstract 135:189745, 2001.;;Bussolino et al., Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth, The Journal of Cell Biology, 119(3):629-641 (1992).;;Chan et al., Isoforms of human HGF and their biological activities, Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor, pp. 67-79, Goldberg and Rosen (Eds.), Birkhauser Verlag Basel, Switzerland (1993).;;Chatterjee, A.K., 4-Aminoquinolines. III. Some 4-(quinolylamino)quinolines, Science and Culture 23:195 (1957).;;Cockerill et al., Indazolylamino quinazolines and pyridopyrimidines as inhibitors of the EGFr and C-erbB-2, Bioorganic & Medicinal Chemistry Letters, 11:1401-1405 (2001).;;Di Renzo et al., Selective expression of the Met/HGF receptor in human central nervous system microglia, Oncogene, 8:219-222 (1992).;;Gibson et al., Epidermal growth factor receptor tyrosine kinase: Structure-activity relationships and antitumor activity of novel quinazolines, Bioorganic & Medicinal Chemistry Letters, 7(21):2723-2728 (1997).;;Giordano et al., Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene, Proceedings of the National Academy of Sciences, USA, 90:649-653 (1993).;;Goldman et al, Defective expression of p56lck in an infant with severe combined immunodeficiency, Journal of Clinical Investigations, 102(2):421-429 (1998).;;Han et al., Characterization of the DNF15S2 locus on human chromosome 3: Identification of a gene coding for four kringle domains with homology to hepatocyte growth factor, Biochemistry, 30:9768-9780 (1991).;;Igawa et al., Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells, Biochemical and Biophysical Research Communications, 174(2):831-838 (1991).;;Jeffers et al., Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis, J. Mol. Med., 74:505-513 (1996).;;Kane et al., Signal transduction by the TCR for antigen, Current Opinion in Immunology, 12:242-249 (2000).;;Kasai et al., Flexible coordination networks with fluorinated backbones, remarkable ability for induced-fit enclathration of organic molecules, Journal of American Chemical Society, 122:2140-2141 (2000).;;Konishi et al., Preparation of thioquinoline derivatives as antibacterial agents for Helicobacter pylori, Chemical Abstracts 125:247631, 1996.;;Lempert-Streter et al., The synthesis of di(1-isoquinolinyl) and di(4-quinazolinyl) disulfides form 1(2H)-isoquinolinethiones and 4(3H)-quinazolinethiones, respectively, with tosyl chloride and sodium ethoxide, Acta Chemica Hungarica, 112(1):83-87 (1983).;;Makisumi, Yasuo, The Thio-claisen rearrangement of allyl 4-quinolyl sulfides, Tetrahedron Letters, 51:6399-6403 (1966).;;Maslankiewicz, M.J., Reactions of beta- and gamma-quinolinyl sulfides with a nitrating mixture, Polish Journal of Chemistry, 68(12):2545-2552 (1994).;;Matsumoto et al., Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth, Biochemical and Biophysical Research Communications, 176(1):45-51 (1991).;;Matsunaga et al., C<SUB>17,20</SUB>-lyase inhibitors. Part 2:Design, synthesis and structure-activity relationships of (2-naphthylmethyl)-1H-imidazoles as novel C<SUB>17,20</SUB>-lyase inhibitors, Bioorganic & Medicinal Chemistry, 12:4313-4336 (2004).;;Maulik et al., Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition, Cytokine & Growth Factor Reviews, 13:41-59 (2002).;;Montesano et al., Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors, Cell, 66:697-711 (1991).;;Monti et al., IV. Abstract 55:2681, 1959.;;Moszew et al., Thermal reactions of gamma-thiols in pyridine and quinoline series. Abstract 77:164418, 1972.;;Nakamura et al., Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats, Biochemical and Biophysical Research Communications, 122(3):1450-1459 (1984).;;Naldini et al., Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor, EMBO Journal, 10:2867-2878 (1991).;;Park et al., Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors, Proceedings of the National Academy of Sciences, USA, 84:6379-6383 (1987).;;Renfrew, Alice G., Studies in the Quinoline Series. IV. Quinolyl Mercaptans and Sulfides, J. American Chemical Society, 1433-1436 (1946).;;Di Renzo et al., Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas, Oncogene, 7:2549-2553 (1992).;;Rubin et al., A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor, Proceedings of the National Academy of Sciences, USA, 88:415-419 (1991).;;Sinyak et al., The synthesis and biological properties of the derivatives of 4-heterylmercaptoquinazoline, Khimiko-Farmatsevticheskii Zhurnal, 20(2), 168-171 (1986). Abstract 104:199594.;;Solbreux et al., Extrahepatic bile duct growth in mice repeatedly injected with human normal serum, IgA-deficient serum or purified secretory IgA, Hepatology, 13:735-742 (1991).;;Soriano et al., Targeted disruption of the C-src proto-oncogene leads to osteopetrosis in mice, Cell, 64:693-702 (1991).;;Stern et al., Epithelial scatter factor and development of the chick embryonic axis, Development 110:1271-1284 (1990).;;Stoker et al., Scatter factor is a fibroblast-derived modulator of epithelial cell mobility, Nature, 327:239-242 (1987).;;Thakore, P.V. et al., Studies in the synthesis of quinoline derivatives. Part VIII. Synthesis of 4:3'-methylenebis(2,2'-dichloro-4'-methylquinoline) derivatives, Journal of the Indian Chemical Society, 54(12):1204-1206 (1977).;;Turner et al., Signalling through the high-affinity IgE receptor Fcepsilon Rl, Nature, 402:B24-B30 (1999).;;Vicentini et al., Fgr deficiency results in defective eosinophil recruitment to the lung during allergic airway inflammation, The Journal of Immunology, 168:6446-6454 (2002).;;Weidner et al., Scatter Factor: Molecular characteristics and effect on the invasiveness of epithelial cells, The Journal of Cell Biology, 111:2097-2108 (1990).;;Wyszomirski et al., Conformations of monosubstituted and disubstituted 3,4'-, 3,3'- and 4,4'-diquinolinyl sulfides studied by NMR spectroscopy, Phosphorus, Sulfur, and Silicon, 95-96:415-416 (1994).;;Zhang et al., Synthesis and antimalarial activity of 2-dialkylaminomethyl-4-(heterocyclic amino)-5,6,7,8-tetrahydronaphthol derivatives. Abstract 103:87753, 1985.;;Zhang et al., Synthesis and SAR of potent EGFR/erbB2 dual inhibitors, Bioorganic & Medicinal Chemistry Letters, 14:111-114 (2004).;;Breier et al., The role of vascular endothelial growth factor in blood vessel formation, Trends in Cell Biology, 6:454-456 (1996).",ACTIVE
262,US,A1,US 2009/0176774 A1,098-068-401-495-005,2009-07-09,2009,US 15730308 A,2008-06-09,US 15730308 A;;US 4263405 A;;US 53869104 P,2004-01-23,Compounds and methods of use,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",AMGEN INC,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;HABGOOD GREGORY J;;PATEL VINOD F;;LA DANIEL,,https://lens.org/098-068-401-495-005,Patent Application,yes,21,0,29,29,2,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/536;;A61K31/4709;;A61K31/498;;A61K31/502;;A61K31/517;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,514/230.5;;514/248;;514/249;;514/266.2,0,0,,,,ACTIVE
263,AU,A1,AU 2005/206571 A1,080-510-429-713-786,2005-08-04,2005,AU 2005/206571 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,Compounds and methods of use,,AMGEN INC,BORG GEORGE;;BUCHANAN JOHN L;;DIPIETRO LUCIAN V;;KIM JOSEPH L;;WEISS MATTHEW;;XU SHIMIN;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;POTASHMAN MICHELE;;BOOKER SHON;;TASKER ANDREW;;GRACEFFA RUSSELL;;CHOQUETTE DEBORAH;;GERMAIN JULIE;;BELLON STEVEN;;MARTIN MATTHEW W;;MASSE CRAIG E;;XI NING;;KIM TAE-SEONG;;BUCKNER WILLIAN H;;HABGOOD GREGORY J;;CHENG YUAN;;CHAFFEE STUART C;;HODOUS BRIAN L;;PATEL VINOD F;;HARMANGE JEAN-CHRISTOPHE;;NUNES JOSEPH J,,https://lens.org/080-510-429-713-786,Patent Application,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D413/12;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
264,AU,B8,AU 2005/206571 B8,058-505-178-567-070,2010-09-02,2010,AU 2005/206571 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,Compounds and methods of use,,AMGEN INC,BORG GEORGE;;BUCHANAN JOHN L;;DIPIETRO LUCIAN V;;KIM JOSEPH L;;WEISS MATTHEW;;XU SHIMIN;;MCGOWAN DAVID C;;LA DANIEL;;WHITTINGTON DOUGLAS A;;POTASHMAN MICHELE;;BOOKER SHON;;TASKER ANDREW;;GRACEFFA RUSSELL;;CHOQUETTE DEBORAH;;GERMAIN JULIE;;BELLON STEVEN;;MARTIN MATTHEW W;;MASSE CRAIG E;;XI NING;;KIM TAE-SEONG;;BUCKNER WILLIAM H;;HABGOOD GREGORY J;;CHENG YUAN;;CHAFFEE STUART C;;HODOUS BRIAN L;;PATEL VINOD F;;HARMANGE JEAN-CHRISTOPHE;;NUNES JOSEPH J,,https://lens.org/058-505-178-567-070,Amended Patent,no,5,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D413/12;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
265,EA,B1,EA 011402 B1,100-935-436-589-469,2009-02-27,2009,EA 200601350 A,2005-01-24,US 53869104 P;;US 2005/0002326 W,2004-01-23,NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL USE THEREOF,"Selected compounds are effective for prophylaxis and treatment of diseases, such as HGF mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutically compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.",AMGEN INC,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHININ;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAN H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;LA DANIEL;;PATEL VINOD F,,https://lens.org/100-935-436-589-469,Granted Patent,no,9,1,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K31/505;;A61K31/47;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
266,MA,B1,MA 28437 B1,048-282-192-267-818,2007-02-01,2007,MA 29279 A,2006-08-22,US 53869104 P,2004-01-23,COMPOSES ET LEURS PROCEDES D'UTILISATION,"COMPOSES ET METHODES D'USAGE Des composés sélectionnés sont efficaces pour la prophylaxie et le traitement de maladies, telles que les maladies régulées par HGF. L'invention concerne de nouveaux composés, analogues, promédicaments et sels pharmaceutiquement acceptables de ceux-là, compositions pharmaceutiques et méthodes pour la prophylaxie et le traitement des maladies et d'autres maladies ou pathologies impliquant, le cancer et celles semblables. L'invention sujet concerne aussi des procédés pour fabriquer de tels composés ainsi que des intermédiaires utiles dans de tels procédés.",CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;LA DANIEL;;PATEL VINOD F,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAN H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;LA DANIEL;;PATEL VINOD F,,https://lens.org/048-282-192-267-818,Granted Patent,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
267,ZA,B,ZA 200606941 B,154-970-653-181-331,2008-02-27,2008,ZA 200606941 A,2006-08-21,US 53869104 P,2004-01-23,Compounds and methods of use,,AMGEN INC,STEVEN BELLON;;SHON BOOKER;;GEORGE BORG;;BUCHANAN JOHN L;;BUCKNER WILLIAM H;;CHAFFEE STUART C;;YUAN CHENG;;DEBORAH CHOQUETTE;;DIPIETRO LUCIAN V;;JULIE GERMAIN;;RUSSELL GRACEFFA;;HABGOOD GREGORY J;;JEAN-CHRISTOPHE HARMANGE;;HODOUS BRIAN L;;TAE-SEONG KIM;;KIM JOSEPH L;;DANIEL LA;;MARTIN MATTHEW W;;MASSE CRAIG E;;MCGOWAN DAVID C;;NUNES JOSEPH J;;PATEL VINOD F;;MICHELE POTASHMAN;;ANDREW TASKER;;MATTHEW WEISS;;WHITTINGTON DOUGLAS A;;NING XI;;SHIMIN XU,,https://lens.org/154-970-653-181-331,Granted Patent,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,A61K/;;C07D/;;C07D213/64;;C07D213/81;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,ACTIVE
268,EC,A,EC SP066730 A,148-589-785-496-183,2006-10-31,2006,EC SP066730 A,2006-07-27,US 53869104 P,2004-01-23,COMPUESTOS Y PROCEDIMIENTOS PARA USO,"Los compuestos seleccionados son eficaces para la profilaxis y tratamiento de enfermedades, tales como enfermedades mediadas por HGF. La invención abarca nuevos compuestos, análogos, profármacos y sales farmacéuticamente aceptables de los mismos, composiciones farmacéuticas y procedimientos para la profilaxis y tratamiento de enfermedades y otros trastornos o afecciones que implican cáncer y similares. La presente invención también se refiere a procedimientos para preparar tales compuestos así como a intermedios útiles en tales procedimientos.",AMGEN INC,POTASHMAN MICHELE;;KIM TAE-SEONG;;BELLON STEVEN;;BOOKER SHON;;CHENG YUAN;;KIM JOSEPH L KIM JOSEPH L;;TASKER ANDREW;;XI NING;;XU SHIMIN;;HARMANGE JEAN-CHRISTOPHE;;BORG GEORGE;;WEISS MATTHEW;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHOQUETTE DEBORAH;;MARTIN MATTHEW W;;GERMAIN JULIE;;DIPIETRO LUCIAN V;;CHAFFEE STUART C;;NUNES JOSEPH J;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;MCGOWAN DAVID C;;WHITTINGTON DOUGLAS A;;LA DANIEL;;PATEL VINOD FRANCIS,,https://lens.org/148-589-785-496-183,Patent Application,no,0,0,29,29,0,C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D237/34;;C07D239/34;;C07D239/47;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;A61P11/06;;A61P15/00;;A61P17/06;;A61P19/02;;A61P27/02;;A61P29/00;;A61P35/00;;A61P35/02;;A61P43/00;;A61P9/00;;A61P9/10;;C07D217/24;;C07D401/12;;C07D403/12;;C07D407/12;;C07D213/64;;C07D213/81;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;A61K31/47;;C07D213/64;;C07D409/12;;C07D215/233;;C07D471/04;;C07D215/54;;C07D239/94;;C07D213/81;;C07D239/47;;C07D403/12;;C07D413/12;;C07D401/12;;C07D487/04;;C07D405/12;;C07D215/38;;C07D417/12;;C07D239/84;;C07D237/34;;C07D215/48;;C07D239/34,C07D213/64;;C07D213/81;;C07D215/00;;C07D215/22;;C07D215/233;;C07D215/38;;C07D215/48;;C07D215/54;;C07D217/24;;C07D237/34;;C07D239/30;;C07D239/34;;C07D239/46;;C07D239/84;;C07D239/94;;C07D401/12;;C07D403/12;;C07D405/12;;C07D407/12;;C07D409/12;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04,,0,0,,,,PENDING
269,CA,C,CA 2582029 C,132-510-104-911-885,2011-12-06,2011,CA 2582029 A,2005-10-03,US 61553504 P;;US 24059005 A;;US 2005/0035873 W,2004-10-01,ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND METHODS OF USE,"The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I, wherein A1, A2, A3, B, R1, R2, R3 and R4 are defined herein. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of kinase mediated diseases using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention.",AMGEN INC,PATEL VINOD F;;KIM JOSEPH L;;GEUNS-MEYER STEPHANIE D;;CHAFFEE STUART C;;CEE VICTOR J;;HODOUS BRIAN L;;BELLON STEVEN;;HARMANGE JEAN-CHRISTOPHE;;OLIVIERI PHILIP R;;THAMAN MAYA C;;DIMAURO ERIN F;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;ALBRECHT BRIAN K;;DEAK HOLLY L;;BEMIS JEAN E;;WHITE RYAN;;MARTIN MATTHEW W;;HABGOOD GREGORY J;;TEMPEST PAUL A;;MASSE CRAIG E;;BUCKNER WILLIAM H;;HERBERICH BRADLEY J;;GRACEFFA RUSSELL;;ZHANG DAWEI;;XU SHIMIN;;SHAM KELVIN;;RZASA ROBERT M;;FALSEY JAMES RICHARD;;CHAKRABARTI PARTHA P;;CAO GUO-QIANG;;TOMLINSON SUSAN ANN;;PETTUS LIPING H;;SMITH ADRIAN LEONARD;;PARAS NICK A;;LIU GANG;;DEMORIN FRENEL F;;TASKER ANDREW;;REED ANTHONY,,https://lens.org/132-510-104-911-885,Granted Patent,no,0,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84;;C07D215/12;;C07D239/95;;C07D401/04;;C07D401/12;;C07D403/10;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04,,0,0,,,,ACTIVE
270,US,A1,US 2007/0054916 A1,109-552-700-867-050,2007-03-08,2007,US 24059005 A,2005-09-30,US 24059005 A;;US 61553504 P,2004-10-01,Aryl nitrogen-containing bicyclic compounds and methods of use,"The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I wherein A 1 , A 2 , A 3 , B, R 1 , R 2 , R 3 and R 4 are defined herein. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of kinase mediated diseases using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention.",AMGEN INC,PATEL VINOD F;;KIM JOSEPH L;;GEUNS-MEYER STEPHANIE D;;CHAFFEE STUART C;;CEE VICTOR J;;HODOUS BRIAN L;;BELLON STEVEN;;HARMANGE JEAN-CHRISTOPHE;;OLIVIERI PHILIP R;;THAMAN MAYA C;;DIMAURO ERIN F;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;ALBRECHT BRIAN K;;DEAK HOLLY L;;BEMIS JEAN E;;WHITE RYAN;;MARTIN MATTHEW W;;HABGOOD GREGORY J;;TEMPEST PAUL A;;MASSE CRAIG E;;BUCKNER WILLIAM H;;HERBERICH BRADLEY J;;GRACEFFA RUSSELL;;ZHANG DAWEI;;XU SHIMIN;;SHAM KELVIN;;RZASA ROBERT M;;FALSEY JAMES R;;CHAKRABARTI PARTHA P;;CAO GUO-QIANG;;TOMLINSON SUSAN A;;PETTUS LIPING H;;SMITH ADRIAN L;;PARAS NICK A;;LIU GANG;;DEMORIN FRENEL F;;TASKER ANDREW;;REED ANTHONY,AMGEN INC (2005-11-16),https://lens.org/109-552-700-867-050,Patent Application,yes,12,94,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,A61K31/525;;A61K31/517;;A61K31/519,514/251;;514/266.1;;514/264.1;;544/279;;544/284;;544/257,0,0,,,,DISCONTINUED
271,MX,A,MX 2007003784 A,159-677-613-183-788,2007-04-24,2007,MX 2007003784 A,2005-10-03,US 61553504 P;;US 24059005 A;;US 2005/0035873 W,2004-10-01,ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS.,"The present invention comprises a new class of compounds useful for the prophylaxisand treatment of protein kinase mediated diseases, including inflammation,cancer and related conditions. The compounds have a general Formula I, whereinA1, A2, A3, B, R1, R2, R3 and R4 are defined herein. Accordingly, the inventionalso comprises pharmaceutical compositions comprising the compounds of theinvention, methods for the prophylaxis and treatment of kinase mediated diseasesusing the compounds and compositions of the invention, and intermediates andprocesses useful for the preparation of compounds of the invention.",AMGEN INC,TASKER ANDREW;;BEMIS JEAN E;;BUCHANAN JOHN L;;HABGOOD GREGORY J;;KIM JOSEPH L;;GEUNS-MEYER STEPHANIE D;;PATEL VINOD F;;XU SHIMIN;;CHAKRABARTI PARTHA P;;HARMANGE JEAN-CHRISTOPHE;;CAO GUO-QIANG;;PETTUS LIPING H;;MARTIN MATTHEW W;;MCGOWAN DAVID C;;REED ANTHONY;;THAMAN MAYA C;;ZHANG DAWEI;;HERBERICH BRADLEY J;;BELLON STEVEN;;HODOUS BRIAN L;;GRACEFFA RUSSELL;;BUCKNER WILLIAM H;;MASSE CRAIG E;;CHAFFEE STUART C;;FALSEY JAMES RICHARD;;ALBRECHT BRIAN K;;CEE VICTOR J;;DEAK HOLLY L;;OLIVIERI PHILIP R;;TEMPEST PAUL A;;DIMAURO ERIN F;;WHITE RYAN;;SHAM KELVIN;;RZASA ROBERT M;;TOMLINSON SUSAN ANN;;SMITH ADRIAN LEONARD;;PARAS NICK A;;LIU GANG;;DEMORIN FRENEL F,,https://lens.org/159-677-613-183-788,Patent Application,no,0,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84;;C07D215/12;;C07D239/95;;C07D401/04;;C07D401/12;;C07D403/10;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04,,0,0,,,,ACTIVE
272,EP,B2,EP 1836174 B2,168-090-468-728-094,2019-10-02,2019,EP 05818381 A,2005-10-03,US 2005/0035873 W;;US 61553504 P;;US 24059005 A,2004-10-01,ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS,,AMGEN INC,PATEL VINOD F;;KIM JOSEPH L;;GEUNS-MEYER STEPHANIE D;;CHAFFEE STUART C;;CEE VICTOR J;;HODOUS BRIAN L;;BELLON STEVEN;;HARMANGE JEAN-CHRISTOPHE;;OLIVIERI PHILIP R;;THAMAN MAYA C;;DIMAURO ERIN F;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;ALBRECHT BRIAN K;;DEAK HOLLY L;;BEMIS JEAN E;;WHITE RYAN;;MARTIN MATTHEW W;;HABGOOD GREGORY J;;MASSE CRAIG E;;BUCKNER WILLIAM H;;TEMPEST PAUL A;;HERBERICH BRADLEY J;;GRACEFFA RUSSELL;;ZHANG DAWEI;;XU SHIMIN;;SHAM KELVIN;;RZASA ROBERT M;;FALSEY JAMES RICHARD;;CHAKRABARTI PARTHA P;;CAO GUO-GIANG;;TOMLINSON SUSAN ANN;;PETTUS LIPING H;;SMITH ADRIAN LEONARD;;PARAS NICK A;;LIU GANG;;DEMORIN FRENEL F;;TASKER ANDREW;;REED ANTHONY,,https://lens.org/168-090-468-728-094,Granted Patent,yes,4,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84,,2,2,057-959-500-577-841;;050-228-372-431-616,10.1021/jm0004291;;11384237;;15503866,"SCHROEDER M C; ET AL: ""SOLUBLE 2-SUBSTITUTED AMINOPYRIDOÄ2,3-DÜPYRIMIDIN-7-YL UREAS. STRUCTURE-ACTIVITY RELATIONSHIPS AGAINST SELECTED TYROSINE KINASES AND EXPLORATION OF IN VITRO AND IN VIVO ANTICANCER ACTIVITY"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 44, no. 12, 7 June 2001 (2001-06-07), pages 1915 - 1926, XP001152609;;MOL, C. ET AL, CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, vol. 7, no. 5, 2004, pages 639 - 648",ACTIVE
273,CA,A1,CA 2582029 A1,183-933-548-722-529,2006-04-13,2006,CA 2582029 A,2005-10-03,US 61553504 P;;US 24059005 A;;US 2005/0035873 W,2004-10-01,ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE ASKINASE INHIBITORS,,AMGEN INC,DEAK HOLLY L;;HABGOOD GREGORY J;;CAO GUO-QIANG;;TEMPEST PAUL A;;CHAKRABARTI PARTHA P;;MCGOWAN DAVID C;;ALBRECHT BRIAN K;;SHAM KELVIN;;KIM JOSEPH L;;PATEL VINOD F;;FALSEY JAMES RICHARD;;RZASA ROBERT M;;XU SHIMIN;;ZHANG DAWEI;;DIMAURO ERIN F;;THAMAN MAYA C;;MASSE CRAIG E;;BUCHANAN JOHN L;;GEUNS-MEYER STEPHANIE D;;CHAFFEE STUART C;;HODOUS BRIAN L;;OLIVIERI PHILIP R;;TOMLINSON SUSAN ANN;;GRACEFFA RUSSELL;;CEE VICTOR J;;HERBERICH BRADLEY J;;PETTUS LIPING H;;BELLON STEVEN;;REED ANTHONY;;MARTIN MATTHEW W;;BUCKNER WILLIAM H;;WHITE RYAN;;DEMORIN FRENEL F;;TASKER ANDREW;;HARMANGE JEAN-CHRISTOPHE;;LIU GANG;;PARAS NICK A;;SMITH ADRIAN LEONARD;;BEMIS JEAN E,,https://lens.org/183-933-548-722-529,Patent Application,no,0,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84;;C07D215/12;;C07D239/95;;C07D401/04;;C07D401/12;;C07D403/10;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04,,0,0,,,,ACTIVE
274,ES,T3,ES 2405783 T3,067-959-905-978-785,2013-06-03,2013,ES 05818381 T,2005-10-03,US 61553504 P;;US 24059005 A;;US 2005/0035873 W,2004-10-01,Compuestos bicíclicos que contienen nitrógeno de arilo y su uso como inhibidores de cinasas,"Compuesto de fórmula I: **Fórmula** o estereoisómero, tautómero, solvato o sal farmacéuticamente aceptable del mismo, en la que A1 es CR5 o N; A2 es CR5 o N; en la que al menos uno de A1 y A2 es N; A3 es CR5 o N; B es un enlace directo, R1 es H, halo, haloalquilo, NO2, CN, R7, NR7R7, NR7R8, OR7; SR7, OR8, SR8, C(O)R7, OC(O)R7, COOR7,C(O)R8, OC(O)R8, COOR8, C(O)NR7R7, C(S)NR7R7, NR7C(O)R7, NR7C(S)R7, NR7C(O)NR7R7,NR7C(S)NR7R7, NR7(COOR7), OC(O)NR7R7, C(O)NR7R8, C(S)NR7R8, NR7C(O)R8, NR7C(S)R8,NR7C(O)NR7R8, NR7C(S)NR7R8, NR7(COOR8), OC(O)NR7R8, S(O)2R7, S(O)2NR7R7, NR7S(O)2NR7R7,NR7S(O)2R7, S(O)2R8, S(O)2NR7R8, NR7S(O)2NR7R8 o NR7S(O)2R8;",AMGEN INC,PATEL VINOD F;;KIM JOSEPH L;;GEUNS-MEYER STEPHANIE D;;CHAFFEE STUART C;;CEE VICTOR J;;HODOUS BRIAN L;;BELLON STEVEN;;HARMANGE JEAN-CHRISTOPHE;;OLIVIERI PHILIP R;;THAMAN MAYA C;;DIMAURO ERIN F;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;ALBRECHT BRIAN K;;DEAK HOLLY L;;BEMIS JEAN E;;WHITE RYAN;;MARTIN MATTHEW W;;HABGOOD GREGORY J;;MASSE CRAIG E;;BUCKNER WILLIAM H;;TEMPEST PAUL A;;HERBERICH BRADLEY J;;GRACEFFA RUSSELL;;ZHANG DAWEI;;XU SHIMIN;;SHAM KELVIN;;RZASA ROBERT M;;FALSEY JAMES RICHARD;;CHAKRABARTI PARTHA P;;CAO GUO-GIANG;;TOMLINSON SUSAN ANN;;PETTUS LIPING H;;SMITH ADRIAN LEONARD;;PARAS NICK A;;LIU GANG;;DEMORIN FRENEL F;;TASKER ANDREW;;REED ANTHONY,,https://lens.org/067-959-905-978-785,Granted Patent,no,0,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84,,0,0,,,,ACTIVE
275,AU,B2,AU 2005/292152 B2,036-268-839-686-321,2010-08-12,2010,AU 2005/292152 A,2005-10-03,US 61553504 P;;US 24059005 A;;US 2005/0035873 W,2004-10-01,Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors,,AMGEN INC,FALSEY JAMES RICHARD;;KIM JOSEPH L;;DEAK HOLLY L;;CHAKRABARTI PARTHA P;;CEE VICTOR J;;DEMORIN FRENEL F;;HARMANGE JEAN-CHRISTOPHE;;ALBRECHT BRIAN K;;CHAFFEE STUART C;;LIU GANG;;MASSE CRAIG E;;TASKER ANDREW;;XU SHIMIN;;RZASA ROBERT M;;GEUNS-MEYER STEPHANIE D;;MCGOWAN DAVID C;;HERBERICH BRADLEY J;;HODOUS BRIAN L;;CAO GUO-QIANG;;BEMIS JEAN E;;REED ANTHONY;;SMITH ADRIAN LEONARD;;GRACEFFA RUSSELL;;BELLON STEVEN;;HABGOOD GREGORY J;;PATEL VINOD F;;ZHANG DAWEI;;MARTIN MATTHEW W;;DIMAURO ERIN F;;PETTUS LIPING H;;BUCHANAN JOHN L;;SHAM KELVIN;;BUCKNER WILLIAM H;;OLIVIERI PHILIP R;;TOMLINSON SUSAN ANN;;WHITE RYAN;;THAMAN MAYA C;;TEMPEST PAUL A;;PARAS NICK A,,https://lens.org/036-268-839-686-321,Granted Patent,no,3,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84;;C07D215/12;;C07D239/95;;C07D401/04;;C07D401/12;;C07D403/10;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04,,0,0,,,,ACTIVE
276,WO,A3,WO 2006/039718 A3,059-029-704-106-664,2006-07-13,2006,US 2005/0035873 W,2005-10-03,US 61553504 P;;US 24059005 A,2004-10-01,ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS,"The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I, wherein A1, A2, A3, B, R1, R2, R3 and R4 are defined herein. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of kinase mediated diseases using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention.",AMGEN INC,PATEL VINOD F;;KIM JOSEPH L;;GEUNS-MEYER STEPHANIE D;;CHAFFEE STUART C;;CEE VICTOR J;;HODOUS BRIAN L;;BELLON STEVEN;;HARMANGE JEAN-CHRISTOPHE;;OLIVIERI PHILIP R;;THAMAN MAYA C;;DIMAURO ERIN F;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;ALBRECHT BRIAN K;;DEAK HOLLY L;;BEMIS JEAN E;;WHITE RYAN;;MARTIN MATTHEW W;;HABGOOD GREGORY J;;TEMPEST PAUL A;;MASSE CRAIG E;;BUCKNER WILLIAM H;;HERBERICH BRADLEY J;;GRACEFFA RUSSELL;;ZHANG DAWEI;;XU SHIMIN;;SHAM KELVIN;;RZASA ROBERT M;;FALSEY JAMES RICHARD;;CHAKRABARTI PARTHA P;;CAO GUO-QIANG;;TOMLINSON SUSAN ANN;;PETTUS LIPING H;;SMITH ADRIAN LEONARD;;PARAS NICK A;;LIU GANG;;DEMORIN FRENEL F;;TASKER ANDREW;;REED ANTHONY,,https://lens.org/059-029-704-106-664,Search Report,yes,12,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84;;C07D215/12;;C07D239/95;;C07D401/04;;C07D401/12;;C07D403/10;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04,,10,9,073-296-110-010-925;;013-546-149-036-877;;059-050-257-112-857;;125-832-860-050-310;;006-678-838-875-757;;078-774-639-377-298;;029-635-824-443-050;;169-853-374-959-499;;072-837-897-988-267,10.3987/com-93-6412;;12086480;;10.1021/jm020074g;;10.1021/jm981129a;;10514281;;8667360;;10.1021/jm950727b;;10.1021/jm00310a016;;5671229;;10.1021/ja00800a043;;10.1016/s0040-4039(97)01619-5;;10.1021/jo00824a016;;10.1002/jhet.5570170628,"E.A. COATS ET. AL.: ""Comparative QSAR of antibacterial dihydrofolate reductase inhibitors, pages 71-85"", 1984, PROUS, BARCELONA, ES, XP009020318;;P. VICTORY ET. AL.: ""Synthesis of 4-Amino-8-cyanoquinazolines from enones and enals."", HETEROCYCLES, vol. 36, no. 10, 1993, pages 2273 - 2280, XP009065422;;H. MATTER ET. AL.: ""Structural Requirements for Inhibition of the Neuronal Nitric Oxide Synthase (NOS-1): 3D QSAR Analysis of 4-Oxo- and 4-Amino-Pteridine Based Inhibitors."", JOURNAL OF MEDICINAL CHEMISTRY, vol. 45, 2002, pages 2923 - 2941, XP002377951;;L. G. FRÖHLICH ET. AL.: ""Inhibition of Neuronal Nitric Oxide Synthase by 4-Amino Pteridine Derivatives: Structure Activity Relationship of Antagonists of (6R)-5,6,7,8-Tetrahydrobiopterin Cofactor."", JOURNAL OF MEDICINAL CHEMISTRY, vol. 42, 1999, pages 4108 - 4121, XP002377952;;A. GAZIT ET. AL.: ""Tyrphostins. 5. Potent Inhibitors of Platelet Derived Growth Factor Receptor Tyrosine Kinase: Structure Activity Relationships in Quinoxalines, Quinolines and Indole Tyrphostins"", JOURNAL OF MEDICINAL CHEMISTRY, vol. 39, 1996, pages 2170 - 2177, XP002377953;;B.S. HURLBERT ET. AL.: ""Studies of Condensed Pyrimidine Sytems. XXIV. The Condensation of 2,4,6-Triaminopyrimidine with Malondialdehyde Derivatives."", JOURNAL OF MEDICINAL CHEMISTRY, vol. 11, 1968, pages 708 - 710, XP002377954;;E.C. TAYLOR ET. AL.: ""Pteridines. XXIX. An Unequivocal Route to 2,4-Diamino-6-substituted Pteridines."", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 95, 1973, pages 6413 - 6418, XP002377955;;S. TAGHAVI-MOGHADAM ET. AL.: ""A New, General and Regioselective Method for the Synthesis of 2,6-Disubstituted 4-Aminopteridines."", TETRAHEDRON LETTERS, vol. 38, 1997, pages 6835 - 6836, XP002377956;;C.B. STORM ET. AL.: ""Preparation of 6-Substituted Pterins via the Isay Reaction."", JOURNAL OF ORGANIC CHEMISTRY, vol. 36, no. 25, 1971, pages 3925 - 3927, XP002377957;;L. N. PRIDGEN ET. AL.: ""Versatile and Efficient Synthesis of Aryl-1,2,3,4-tetrahydroisoquinolines: Nickel(II) Phosphine Ligand Cytalysed Coupling of Arylmagnesium Halides to Haloisoquinolines."", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 17, 1980, pages 1289 - 1291, XP002377958",PENDING
277,WO,A2,WO 2006/039718 A2,156-477-421-200-250,2006-04-13,2006,US 2005/0035873 W,2005-10-03,US 61553504 P;;US 24059005 A,2004-10-01,ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND METHODS OF USE,"The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation, cancer and related conditions. The compounds have a general Formula I, wherein A1, A2, A3, B, R1, R2, R3 and R4 are defined herein. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of kinase mediated diseases using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention.",AMGEN INC,PATEL VINOD F;;KIM JOSEPH L;;GEUNS-MEYER STEPHANIE D;;CHAFFEE STUART C;;CEE VICTOR J;;HODOUS BRIAN L;;BELLON STEVEN;;HARMANGE JEAN-CHRISTOPHE;;OLIVIERI PHILIP R;;THAMAN MAYA C;;DIMAURO ERIN F;;BUCHANAN JOHN L;;MCGOWAN DAVID C;;ALBRECHT BRIAN K;;DEAK HOLLY L;;BEMIS JEAN E;;WHITE RYAN;;MARTIN MATTHEW W;;HABGOOD GREGORY J;;TEMPEST PAUL A;;MASSE CRAIG E;;BUCKNER WILLIAM H;;HERBERICH BRADLEY J;;GRACEFFA RUSSELL;;ZHANG DAWEI;;XU SHIMIN;;SHAM KELVIN;;RZASA ROBERT M;;FALSEY JAMES RICHARD;;CHAKRABARTI PARTHA P;;CAO GUO-QIANG;;TOMLINSON SUSAN ANN;;PETTUS LIPING H;;SMITH ADRIAN LEONARD;;PARAS NICK A;;LIU GANG;;DEMORIN FRENEL F;;TASKER ANDREW;;REED ANTHONY,,https://lens.org/156-477-421-200-250,Patent Application,yes,1,248,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84;;C07D239/95;;C07D401/12;;C07D409/04;;C07D405/12;;C07D409/14;;C07D405/04;;C07D403/10;;C07D401/04;;C07D471/04;;C07D403/12;;C07D413/12;;C07D417/12;;C07D409/12;;C07D215/12,,0,0,,,,PENDING
278,AU,A1,AU 2005/292152 A1,086-421-694-715-436,2006-04-13,2006,AU 2005/292152 A,2005-10-03,US 61553504 P;;US 24059005 A;;US 2005/0035873 W,2004-10-01,Aryl nitrogen-containing bicyclic compounds and their use as kinase inhibitors,,AMGEN INC,FALSEY JAMES RICHARD;;KIM JOSEPH L;;DEAK HOLLY L;;CHAKRABARTI PARTHA P;;CEE VICTOR J;;DEMORIN FRENEL F;;HARMANGE JEAN-CHRISTOPHE;;ALBRECHT BRIAN K;;CHAFFEE STUART C;;LIU GANG;;MASSE CRAIG E;;TASKER ANDREW;;XU SHIMIN;;RZASA ROBERT M;;GEUNS-MEYER STEPHANIE D;;MCGOWAN DAVID C;;HERBERICH BRADLEY J;;HODOUS BRIAN L;;CAO GUO-QIANG;;BEMIS JEAN E;;REED ANTHONY;;SMITH ADRIAN LEONARD;;GRACEFFA RUSSELL;;BELLON STEVEN;;HABGOOD GREGORY J;;PATEL VINOD F;;ZHANG DAWEI;;MARTIN MATTHEW W;;DIMAURO ERIN F;;PETTUS LIPING H;;BUCHANAN JOHN L;;SHAM KELVIN;;BUCKNER WILLIAM H;;OLIVIERI PHILIP R;;TOMLINSON SUSAN ANN;;WHITE RYAN;;THAMAN MAYA C;;TEMPEST PAUL A;;PARAS NICK A,,https://lens.org/086-421-694-715-436,Patent Application,no,0,0,14,14,0,C07C205/37;;C07D215/12;;C07D215/38;;C07D217/12;;C07D217/22;;C07D217/26;;C07D239/26;;C07D239/84;;C07D239/94;;C07D239/95;;C07D401/04;;C07D401/12;;C07D401/14;;C07D403/04;;C07D403/10;;C07D403/12;;C07D403/14;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04;;C07D487/04;;C07D495/04;;A61P1/04;;A61P11/00;;A61P11/06;;A61P13/12;;A61P15/00;;A61P17/00;;A61P17/06;;A61P17/14;;A61P19/02;;A61P19/08;;A61P21/00;;A61P25/00;;A61P25/28;;A61P27/02;;A61P27/16;;A61P29/00;;A61P35/00;;A61P35/02;;A61P37/02;;A61P37/06;;A61P37/08;;A61P43/00;;A61P7/06;;A61P9/00;;A61P9/10;;A61P3/10;;C07D215/38;;C07D417/12;;C07D239/84;;C07D495/04;;C07D401/12;;C07D403/12;;C07D239/94;;C07D239/26;;C07D409/12;;C07D471/04;;C07D217/26;;C07D487/04;;C07D217/22;;C07D409/04;;C07D401/04;;C07D405/12;;C07D401/14;;C07D405/04;;C07D403/04;;C07D403/10;;C07D215/12;;C07D409/14;;C07D217/12;;C07D403/14;;C07C205/37;;C07D413/12;;C07D239/95,C07D239/84;;C07D215/12;;C07D239/95;;C07D401/04;;C07D401/12;;C07D403/10;;C07D403/12;;C07D405/04;;C07D405/12;;C07D409/04;;C07D409/12;;C07D409/14;;C07D413/12;;C07D417/12;;C07D471/04,,0,0,,,,ACTIVE
